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Summary 
 
ClC chloride channels and transporters catalyze the selective flow of chloride ions across 
the membranes of prokaryotic and eukaryotic cells. In eukaryotes, ClC proteins play 
important roles in the stabilization of membrane potential, transepithelial ion transport and 
vesicular acidification. The unique feature of the ClC family is that it contains chloride 
selective channels and secondary active chloride/proton antiporters. Despite this functional 
diversity, the molecular architecture of the family is conserved consisting of a 
transmembrane transport domain and a cytoplasmic regulatory domain.  
  Cytoplasmic domains in eukaryotic ClC proteins have been shown to be crucial for 
protein function and to be involved in the functional regulation of chloride transport. They 
have been associated with processes like the regulation of channel gating in response to 
ligand binding. Since the interaction between the cytoplasmic domains within the 
homodimeric protein is thought to be crucial for the structural basis of regulation, the aim 
of my PhD thesis was to reveal the oligomeric assembly of the cytoplasmic domains in 
eukaryotic ClC proteins. The structure of the cytoplasmic domain of the human channel 
ClC-Ka determined in this work has been valuable in this respect. The unusual mode of 
dimerization found in the crystals of the ClC-Ka domain was confirmed to be preserved in 
solution by combining mutagenesis, cross-linking and analytical ultracentrifugation. The 
complementary experiments on the ClC-0 cytoplasmic domain have shown that this 
domain exhibits similar structural organization and that the interaction is likely preserved 
in the context of the full-length ClC-0 protein. In this way, the previously ambiguous 
oligomeric structure of the cytoplasmic components in eukaryotic ClC proteins has been 
clarified.  
 In order to relate the conformational changes in the cytoplasmic domain with the 
transmembrane pore, the structure of a full length ClC protein is necessary. However, the 
current structural information on the ClC family exists only for the transmembrane and 
cytoplasmic domains in isolation. Therefore, an additional aim of my PhD thesis was to 
establish the overexpression and purification of a ClC protein containing cytoplasmic 
domain that would serve as a model systems for structural and functional studies. For that 
purpose, a set of prokaryotic ClC homologs containing cytoplasmic domains was identified 
and investigated with respect to their expression in E. coli, purification and crystallization 
behaviour. After extensive examination a ClC homolog from the bacterium Ralstonia 
metallidurans, named Rm1ClC, was selected as the only suitable for crystallization 
screening. Although broad crystallization attempts were performed for the full-length 
 Summary 
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Rm1ClC, no crystals have been obtained possibly because of the flexible connections 
between the cytoplasmic domains and the transmembrane part. For that reason, the 
transmembrane and the cytoplasmic domain of Rm1ClC were expressed and crystallized in 
isolation. While the poorly diffracting crystals of the Rm1ClC transmembrane domain 
have not allowed its detailed structure determination, the structure of the Rm1ClC 
cytoplasmic domain was determined at 1.6 Ǻ resolution providing a detailed insight into 
the structural organization of the prokaryotic ClC cytoplasmic domain. Despite the typical 
CBS fold of this domain, the dimeric arrangement found to be conserved in the eukaryotic 
ClC proteins was not observed. The Rm1ClC domain was shown to be in a monomeric 
state in solution indicating at a potential different arrangement between the cytoplasmic 
domains in prokaryotic ClC proteins.  
 In summary, the studies presented in this work provide the structural and 
biochemical information on the oligomeric assembly of the cytoplasmic components in 
eukaryotic and prokaryotic ClC proteins. This information will serve as the structural basis 
for future investigations that may reveal the mechanisms of regulation by the cytoplasmic 
domains in ClC chloride channels and transporters.   
 Zusammenfassung 
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Zusammenfassung 
 
 
Die Familie der ClC Chloridkanäle und -transporter ist für die spezifische Translokation 
von Chloridionen über die Membran pro- und eukaryotischer Zellen verantwortlich. In 
Eukaryoten spielen die ClC Proteine wichtige Rollen bei der Stabilisierung des 
Membranpotentials, dem transepithelialen Ionentransport und der vesikulären Ansäuerung. 
Als Alleinstellungsmerkmal der ClC Familie kommen in dieser sowohl chloridspezifische 
Kanäle als auch sekundäraktive Chlorid/Proton Antiporter vor. Dieser funktionalen 
Vielseitigkeit steht ein konservierter, gemeinsamer Aufbau gegenüber, welcher aus einer 
transmembranen Transportdomäne und einer zytoplasmitschen Regulationsdomäne 
besteht. 
Die zytoplasmatischen Domänen eukaryotischer ClC Proteine sind von 
entscheidender Bedeutung für deren Funktion und sind an der funktionalen Regulation des 
Chloridtransports beteiligt. Sie wurden mit Vorgängen wie der Regulierung der 
Kanalaktivität durch Ligandenbindung in Verbindung gebracht. Man geht davon aus, dass 
diese Regulation durch die Interaktionen zwischen den zytoplasmatischen Domänen des 
homodimeren Proteins bewirkt wird. Daher war es das Ziel dieser Dissertation, den 
oligomeren Aufbau der zytoplasmatischen Domänen aufzuklären. Die Struktur der 
zytoplasmatischen Domäne des humanen ClC-Ka Kanals, welche im Rahmen dieser Arbeit 
bestimmt wurde, hat sich dabei als wertvoll erwiesen. Die Kristallstruktur der 
zytoplasmatischen Domäne des humanen ClC-Ka Kanals wies eine ungewöhnliche Art der 
Dimerisierung auf. Durch die Kombination von Mutagenese, chemischer Querverknüpfung 
und analytischer Ultrazentrifugation konnte gezeigt werden, dass diese ungewöhnliche 
Dimerisierung auch in Lösung vorliegt. Die entsprechenden ergänzenden Experimente mit 
der zytoplasmatischen Domäne von ClC-0 zeigten, dass diese Domäne einen 
vergleichbaren strukturellen Aufbau besitzt und dass diese Wechselwirkungen sehr 
wahrscheinlich auch beim vollständigen ClC-0 Protein auftreten. Auf diese Weise konnte 
der zuvor nur uneindeutig bekannte oligomere Aufbau der zytoplasmatischen Bestandteile 
der eukaryotischen ClC Proteine bestimmt werden. 
Um die Konformationsänderungen der zytoplasmatischen Domäne im 
Zusammenhang mit der Transmembrandomäne zu verstehen, benötigt man die Struktur 
eines vollständigen ClC Proteins. Derzeit kennt man jedoch nur die Strukturen von 
isolierten Transmembran- und zytoplasmatischen Domänen der ClC Familie. Daher war es 
ein weiteres Ziel dieser Dissertation die Überproduktion und Reinigung eines eine 
zytoplasmatische Domäne enthaltendes ClC Proteins zu etablieren. Dieses sollte als 
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Modellsystem für die strukturelle und funktionale Charakterisierung dienen. Zu diesem 
Zweck wurde eine Reihe prokaryotischer ClC Homologe mit zytoplasmatischer Domäne 
bestimmt und mit Hinblick auf Expression in E. coli, Reinigung und Kristallisation 
untersucht. Nach genauer Überprüfung wurde RmlClC, ein ClC Homolog aus dem 
Bakterium Ralstonia metallidurans, als einziges für Kristallisationsexperimente geeignete 
Protein ausgewählt. Trotz breit gefächerter Kristallisationsversuche mit dem vollständigen 
RmlClC konnten keine Kristalle erhalten werden. Wahrscheinlich liegt dies an einer 
beweglichen Verbindung zwischen der Transmembran- und der zytoplasmatischen 
Domäne. Daher wurden diese Domänen getrennt exprimiert und kristallisiert. Mit den nur 
schlecht beugenden Kristallen der Transmembrandomäne konnte keine detaillierte Struktur 
bestimmt werden. Die Struktur der zytoplasmatischen Domäne konnte jedoch mit einer 
Auflösung von 1.6 Ǻ bestimmt werden und zeigt im Detail den strukturellen Aufbau dieser 
Domäne in prokaryotischen ClC Proteinen. Obwohl diese Domäne eine typische CBS 
Faltung aufweist, liegt nicht die in Eukaryoten konservierte dimere Anordnung vor. Es 
konnte gezeigt werden, dass die zytoplasmatische Domäne von RmlClC in Lösung als 
Monomer auftritt, was möglicherweise auf eine andere Anordung der zytoplasmatischen 
Domänen in prokaryotischen ClC Proteinen hinweist. 
Die in dieser Arbeit vorgestellten Untersuchungen beschreiben die strukturellen 
und biochemischen Eigenschaften des oligomeren Aufbaus der zytoplasmatischen 
Bestandteile in eukaryotischen und prokaryotischen ClC Proteinen. Diese Ergebnisse 
werden als Grundlage für zukünftige Untersuchungen dienen, welche möglicherweise die 
Mechanismen der Regulierung durch die zytoplasmischen Domänen von ClC 
Chloridkanälen und –transportern aufzeigen.  
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1 Introduction 
 
 
1.1 Principles of ion transport 
 
All living cells are surrounded by membranes that separate the cytoplasm from the 
extracellular environment. In eukaryotic cells, membranes in addition compartmentalize 
the intracellular organelles. Membranes are composed of amphiphilic phospholipids. In 
these molecules hydrophilic head groups that contain a phosphate moiety and hydrophobic 
tails of two fatty acid side chains are bound as esters to a central glycerol molecule. 
Phospholipids spontaneously form lipid bilayers in water, where the head groups are 
exposed to the aqueous environment and the tails form a hydrophobic core. The dielectric 
constant of the hydrophobic core is around 2, which is drastically lower than the dielectric 
constant of water (εwater=80). Due to this property membranes serve as barriers for 
hydrophilic and particularly charged molecules and they behave like electric capacitors 
that create and conserve an electric membrane potential.  
 Specific proteins associated with the membrane have evolved to catalyze the 
transport of different solutes like metabolites and ions through the lipid bilayer. These 
membrane transport proteins are also amphiphilic, having a hydrophilic surface that is in 
contact with the aqueous solution or the polar group of phospholipids, and a hydrophobic 
belt that interacts with alkyl side chains of lipids in the core of the membrane.  
 The selective transport of ions across biological membranes is an essential feature 
of living cells. The movement of potassium, sodium, calcium and chloride underlines 
important processes like electrical signaling in neurons and muscles, cell volume 
regulation and transepithelial transport. The proteins that facilitate the transport of ions 
across cell membranes are divided in two classes, channels and transporters, based on the 
difference in the thermodynamics of their transport mechanism. Independent of the 
mechanism, both channels and transporters provide ions with hydrophilic interactions to 
mimic the dielectric environment of water during the transport through the membrane.  
 Ion channels act as passive conduits through which ions rush down their 
electrochemical gradient. Ion flow through channels generates transmembrane electric 
currents that can cause changes in membrane potential. Two fundamental properties of ion 
channels are ion selectivity and gating. Selectivity refers to the ability of some channels to 
discriminate between ion species, allowing some to pass through the pore while excluding 
the others. This discrimination takes place at the narrowest part of the pore known as 
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selectivity filter. Gating is the process of transition between the open and the closed state 
of a channel. The gating can be regulated by binding of intracellular or extracellular 
ligands (ligand-gated channels), changes in membrane potential (voltage-gated channels), 
and changes in temperature or mechanical stress. A structural entity that acts as a physical 
barrier to ion movement and renders the channel closed is called a gate.  
 Ion transporters move ions against their concentration gradient by coupling ion 
translocation to a secondary driving force like the hydrolysis of ATP (primary active 
transporters) or a downhill movement of another ion species (secondary active 
transporters). Typical primary active transporters are ion pumps like Na+/K+ ATPases and 
Ca2+ ATPases. Secondary active transporters can be divided into cotransporters and 
antiporters, according to the relative direction of the coupled downhill and uphill ion flows. 
During their catalytic process, ion transporters work by an alternate access mechanism that 
requires at least two distinct protein conformations. The two conformations expose ion-
binding sites to either side of the membrane and often have a high affinity for the ions on 
one side of the membrane and low affinity on the other side of the membrane. In some 
cases, there is a defined occluded state during the transport cycle where the ions are 
completely enclosed by the transporter. Although, ion selectivity and gating are terms 
mostly related to ion channels, these properties are important for ion transporters too. 
Regarding gates, whereas channels need only a single gate, transporters need at least two 
gates that should never be open at once (Figure 1.1).  
 
  A  Ion channels: single gate 
 
  
 
B  Ion transporters: alternating gates and  
     occluded states 
 
   
 
Figure 1.1. Ion channels versus ion transporters.  
(A) Schematic representation of an ion channel as a membrane-spanning pore through which ion (red 
spheres) movement is controlled by a single gate, represented by a hinged door. (B) Ion transporter as a 
membrane-spanning pore with two gates that open and close alternately. Occluded states, with both gates 
closed around bound ions, preclude inadvertent opening of the second gate before closure of the first gate, 
which would allow ions to flow down their electrochemical potential gradient several orders of magnitude 
faster than the pump can move them against that gradient. Pumped ion movement is rate limited by the gating 
reactions, rather than by electrodiffusion. Figure obtained from (Gadsby 2009). 
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 Due to their opposed tasks of downhill high-speed ion movement and uphill low-
speed ion movement, channels and transporters have traditionally been viewed as 
completely different entities. Certainly, there is unquestionable evidence for the existence 
of clear-cut ion channels, like potassium channels, and prototypical ion transporters, like P-
type ATPases. However, recent atomic resolution X-ray structures and high-resolution 
functional measurements have suggested that ion channels and transporters do not need to 
be as different as initially thought. The remarkable example for blurring this boundary is 
the ClC family of chloride transport proteins that includes representatives of both channels 
and transporters.  
 
1.1.2 Chloride transport 
 
Chloride is the most abundant anion in nature. Its intracellular concentration is usually low, 
ranging from 5 mM up to 30 mM, whereas the extracellular concentration is high and 
reaches 150 mM. Because of its abundance, chloride is the main permeant anion. It is 
transported by several distinct families of chloride transporting proteins including ClC 
channels and transporters, ligand-gated GABA and glycine receptors, cystic fibrosis 
conductance transmembrane regulators (CFTR), Cation Chloride Cotransporters and 
Cl¯/HCO3¯ exchangers. These proteins reside both in plasma membrane and membranes of 
intracellular organelles and contribute to a variety of essential processes like the regulation 
of electrical excitability, transepithelial transport, ion homeostasis and cell volume 
regulation (Jentsch, Stein et al. 2002). Among those, the ClC proteins encode for the 
largest family of chloride transport proteins.  
 
 
1.2 ClC chloride channels and transporters  
 
1.2.1 History 
 
The discovery of ClC chloride channels dates back to the early 1980s when a chloride 
channel from the electric organ of Torpedo californica was functionally reconstituted and 
characterized (White and Miller 1979). The name ClC originated from the term Cl¯ 
channel. Ten years later, expression cloning revealed a sequence of ClC-0, the voltage 
gated chloride channel from Torpedo marmorata (Jentsch, Steinmeyer et al. 1990). Shortly 
after, nine ClC homologs in humans have been identified and characterized by 
heterologous expression techniques (Steinmeyer, Ortland et al. 1991; Thiemann, Grunder 
et al. 1992; Kieferle, Fong et al. 1994; Brandt and Jentsch 1995; Steinmeyer, Schwappach 
et al. 1995). Homology screening and data base searches soon revealed that ClC family 
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members can be found in all phyla, from bacteria to humans. ClC proteins in model 
organisms like yeast Saccharomyces cerevisiae and nematode Caenorhabditis elegans 
yielded important insights into ClC function (Schwappach, Stobrawa et al. 1998; 
Schriever, Friedrich et al. 1999; Strange 2003). The breakthrough in the understanding of 
ClC structure originated from the structure determination of two bacterial homologs 
(Dutzler, Campbell et al. 2002). The crystal structures allowed for the first time to 
visualize the complex topology of the membrane embedded catalytic domain and the 
architecture of the ion translocation pore of this protein family (Dutzler, Campbell et al. 
2003). A detailed functional analysis of the crystallized bacterial homologs revealed that 
they are not chloride channels as previously supposed, but chloride-proton antiporters 
(Accardi and Miller 2004). This unexpected finding motivated closer examination of the 
eukaryotic ClC proteins leading to the discovery that some mammalian ClCs also function 
as Cl¯/H+ antiporters (Picollo and Pusch 2005; Scheel, Zdebik et al. 2005).   
 
 
1.2.2 Overview of the family of ClC proteins 
 
The nine ClC family members in humans can be grouped into three branches by homology. 
Members of the first branch (ClC-1, -2, -Ka and -Kb) perform their function in the plasma 
membrane, while the members of the two other branches (comprising ClC-3, -4, -5, and 
ClC-6 and -7, respectively) are predominantly found in membranes of intracellular vesicles 
of the endosomal-lysosomal pathway. The proteins that reside in the plasma membrane 
function as gated chloride channels and play a role in the maintenance of the membrane 
potential and in epithelial ion transport. The intracellularly located ClCs likely all function 
as chloride-proton antiporters and are important for the vesicular acidification.   
 Most of the current knowledge about the physiological functions of mammalian 
ClCs has been obtained from animal disease models, human genetic diseases and knockout 
mice (Jentsch, Stein et al. 2002). The findings from these experiments indicate diverse 
roles for ClC-mediated ion transport.  
 ClC-1, the closest homolog of ClC-0 from the Torpedo electric organ, is expressed 
almost exclusively in skeletal muscle. Since about 80 % of the ion conductance in resting 
muscles is provided by ClC-1, the protein is responsible for the stabilization of the resting 
membrane potential of muscle cells and repolarisation of the membrane after action 
potentials (Steinmeyer, Ortland et al. 1991). The mutations in ClC-1 lead to mytonia, a 
form of muscle stiffness due to muscle hyperexcitabilty (Koch, Steinmeyer et al. 1992).  
 ClC-2 is very broadly expressed (Thiemann, Grunder et al. 1992). This inwardly 
rectifying Cl¯ channel is regulated by a variaty of different stimuli like hyperpolarization, 
cell swelling or extracellular acidification. It is thus believed to be involved in various 
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physiological processes. ClC-2 knockout mice, which showed a degeneration of the testis 
and the retina, suggest a function in the ion homeostasis of these organs (Bosl, Stein et al. 
2001).  
 Two highly homologous channels ClC-Ka and ClC-Kb are both expressed in 
certain epithelial cells of the kidney and the inner ear, where they have important role in 
transepithelial ion transport (Kieferle, Fong et al. 1994). They were the first ClC proteins 
for which a regulatory subunit was discovered (Estevez, Boettger et al. 2001). The β-
subunit, Barttin, is needed for the transport of the ClC-K channels to the plasma 
membrane, but also for the modulation of their physiological function (Scholl, Hebeisen et 
al. 2006). Mutational inactivation of ClC-Kb channel and Barttin leads to different forms 
of Bartter syndrome, which is associated with severe renal salt wasting and congenital 
deafness (Hebert 2003). The disruption of ClC-K1 in mice leads to diabetes insipidus 
(Matsumura, Uchida et al. 1999).  
 The roles of intracellular ClCs are best understood for ClC-5 and ClC-7. The 
transporter ClC-5 is predominantly expressed in the proximal tubule of the kidney, where it 
localizes to apical endosomes (Gunther, Luchow et al. 1998). ClC-5 co-localizes with the 
vesicular H+-ATPase and it is presumed that it dissipates the electric potential created by 
the ATPase during acidification of endosomes. Malfunction of ClC-5 leads to Dent's 
disease, an X-chromosome-linked disorder associated with proteinuria and kidney stones. 
ClC-7 is ubiquitously expressed and localizes prominently in lysosomes and late 
endosomes (Brandt and Jentsch 1995). Additionally, it is also found in the ruffled border of 
bone-resorbing osteoclasts, a specialized plasma membrane that faces the resorption 
lacuna. Similar as ClC-5, ClC-7 co-localizes with the V-type H+-ATPase, and is therefore 
thought to be involved in efficient acidification of vesicles and lacuna. Mutations in ClC-7 
are the cause of several variants of osteopetrosis, resulting from impaired bone resorption 
(Kornak, Kasper et al. 2001). It has recently been discovered that ClC-7 also interacts with 
a β-subunit, however, functional implications of this protein Ostm-1 are still unclear 
(Lange, Wartosch et al. 2006).  
` There is currently little data about the physiological function of ClC-3, -4 and -6. 
The knockout mice of ClC-3 showed severe degeneration of the hippocampus and the 
retina, but no association with human diseases could have been made so far (Stobrawa, 
Breiderhoff et al. 2001). ClC-4 is broadly expressed in intracellular membranes; it 
facilitates endosomal acidification and is important for endocytosis (Mohammad-Panah, 
Harrison et al. 2003). ClC-6 is expressed in neurons of the central and peripheral nervous 
system and its disruption leads to lysosomal storage diseases and reduced pain sensitivity 
(Poet, Kornak et al. 2006).  
 In summary, ClCs play a diverse role in a variety of physiological processes. 
However, several of their functions are still only poorly understood. The clarification of 
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these processes requires a thorough understanding of the behavior of ClC proteins on a 
molecular level.  
 
1.2.3 Molecular architecture and ion conduction in ClC proteins 
 
Despite their functional diversity the ClC proteins share a conserved structural 
organization consisting of a transmembrane catalytic domain and in many cases of a 
cytoplasmic regulatory domain. Already from the early functional experiments on ClC-0 it 
has been proposed that ClCs are homodimers with a gated pore contained in each subunit 
(Middleton, Pheasant et al. 1994). This double-barreled architecture was confirmed by the 
structure determination of two bacterial ClC homologs from Escherichia coli and 
Salmonella typhimurium (Dutzler, Campbell et al. 2002).   
 The high resolution structure of the bacterial homolog EcClC provides insight into 
the transmembrane architecture of the family and into the chemistry of chloride binding 
(Dutzler, Campbell et al. 2003). The tertiary structure of the catalytic domain of ClC 
proteins is complex and it is comprised of 18 α helices, 17 of which are embedded in the 
membrane. Only some of these transmembrane helices span the membrane completely and 
most are severely tilted with respect to the plane of the bilayer. The topology of the 
membrane domain of a single ClC subunit is shown in Figure 1.2.  
                  
Figure 1.2. Topology of eukaryotic ClC proteins.  
A schematic view of the ClC subunit containing a transmembrane and a cytoplasmic domain. The topology 
of the transmembrane domain is inferred from the known structure of EcClC. The 18 α helices are labeled A-
R and the two similar halves within the transmembrane domain are colored in green and blue. The sequence 
regions, which contribute to the Cl¯ selectivity filter, are marked with arrows and the respective conserved 
sequences are shown. The two CBS subdomains of the cytoplasmic part are shown as red and blue spheres.  
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 An interesting feature of the ClC subunit is its antiparallel architecture formed by 
structurally related N-terminal and C-terminal halves that span the membrane in opposite 
directions. At the interface between the two halves a translocation path for chloride is 
found. The structure of EcClC has revealed the residues, which coordinate chloride ions 
during their passage through the membrane. These residues are located in dispersed 
regions in the primary sequence of the protein and are highly conserved among ClC 
channels and transporters. As identified in the structure they create three selective binding 
sites for chloride, which were termed Sext, Scen and Sint based on their location along the 
translocation pathway (Figure 1.3B). In the wild type protein two of the binding sites (Scen 
and Sint) are occupied by Cl¯ ions, whereas the third site at the extracellular end of the 
selectivity filter is occupied by the side chain of a conserved glutamate residue (E148). 
When mutating this residue to glutamine, the binding site is released and binds a Cl¯ 
instead, while leaving the rest of the filter unchanged (Dutzler, Campbell et al. 2003). All 
three sites can bind chloride with similar affinities in the mM range as determined by 
crystallography (Lobet and Dutzler 2006). Recent biochemical experiments additionally 
revealed that the central binding site plays the most important role in chloride selectivity in 
EcClC (Picollo, Malvezzi et al. 2009).  
 
 
     A 
 
   B 
 
     
 
Figure 1.3. Structure of EcClC and its selectivity filter. 
(A) A side view of the EcClC dimer. Two subunits are colored in red and blue and bound ions in the 
selectivity filter of each subunit are shown as green spheres.  
(B) Selectivity filter of the wild type protein and of selectivity filter mutant. The protein backbone is shown 
as ribbon with the N-termini of α-helices colored in blue. Selected side chains are shown as sticks, and 
bound ions as red spheres. Aqueous cavities approaching the selectivity filter from both sides of the 
membrane are shown as blue mesh. The ion binding sites are labeled. Left: the selectivity filter in a 
closed conformation - two chloride ions are bound to the sites Sint and Scen, whereas the ion binding site 
Sext is occupied by the side chain of the conserved glutamate residue E148. Right: the selectivity filter of 
the mutant E148Q in an open-like conformation. The mutated side chain of the residue has moved out of 
the filter and points towards the extracellular solution. An additional ion has taken its place, binding to 
the site Sext. The filter is occupied by three ions that bind in a single file and bridge the aqueous 
solutions on both sides of the membrane. Figure derived from (Lobet and Dutzler 2006). 
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It was proposed that structure and ion binding properties of ClC channels and 
transporters are similar and that even the mechanisms of permeation and gating in channels 
and coupled transport in transporters have some common features (Miller 2006). 
Therefore, the molecular architecture of the ion translocation pore observed in EcClC 
serves as a valuable model for explanation of the mechanistic properties in both ClC 
channels and transporters.  
 
 
1.2.4 ClC chloride channels  
 
The key properties of ion channels, selective conductance and gating, have for ClC 
proteins been mainly revealed from electrophysiological experiments on the muscle type 
channels, ClC-0 and ClC-1. A reason for that is the high conductance that these channels 
show in comparison to other family members. The single channel conductances of ClC-0 
and ClC-1 are 10 pS (Miller and White 1984) and 1 pS (Pusch, Steinmeyer et al. 1994) 
respectively. The EcClC transporter, in contrast, transports only 2000 ions/s which is about 
5 orders of magnitude slower than observed for chloride transport in ClC-0.  
Since chloride is the most abundant permeant anion under physiological conditions, 
selectivity among different anions might not be of large physiological importance. ClC 
proteins thus are found to be permeant to different small monovalent anions with a 
preference for Cl¯ (i.e. the selectivity for ClC-0 is Cl¯ > Br¯ > NO3¯ (Rychkov, Pusch et al. 
1998)). 
Gating of ClC channels has been most extensively studied in ClC-0. Single channel 
recordings on the protein reconstituted in artificial lipid membranes have revealed some 
characteristic features (Figure 1.4). First, the equally spaced conductance states that are 
binominally distributed hinted at a protein with two identical and independent pores 
(Miller 1982). Second, a complex regulatory behavior includes individual gating acting on 
each pore separately and common gating affecting both pores simultaneously. Due to their 
kinetics in ClC-0 they have been also termed fast and slow gating, respectively.  
Individual gating is controlled by pH, chloride and voltage. Opening is favored by 
low pH, a high external chloride concentration and depolarizing voltage (inside positive). 
The voltage dependence of the individual gating is caused by the movement of a Cl¯ ion 
into the transmembrane electric field during the opening step (Pusch, Ludewig et al. 1995). 
Therefore, there is a link between the chloride concentration and membrane voltage in 
opening the channel. Lower extracellular Cl¯ concentrations shift the voltage dependence 
of the open probability to more positive potentials and like this render opening more 
difficult. This mechanism of gating by permeant ions is profoundly different from classical 
voltage-gated cation channels, where the gating charge is located on the protein in form of 
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several positively charged residues in a “voltage sensor” domain (Long, Campbell et al. 
2005). The structural determinant of the individual gating process has been identified to be 
a single glutamate residue that either occupies the extracellular binding site for chloride, 
thereby prohibiting ion flow in the closed state, or moves away from this site allowing 
chloride to diffuse through the selectivity filter in the open state of the channel (Figure 
1.3B).  
 
 
    Individual gating               Common gate closing  
 
           A                                      B 
                    
 
Figure 1.4. Gating in ClC-0. 
The upper panel shows single channel current trace of ClC-0. Three conductance states are indicated: closed 
(0), one pore open (1) and two pores open (2). The lower panels A and B schematically represent some of the 
conformations in the protein during the gating process. The two subunits with independent pores are colored 
in green and blue and the gating glutamate is shown. Chloride ions are colored in red. Bursts of activity with 
rapid fluctuations are correlated with the opening and closing of the individual gates. Temporary loss of 
conduction is associated with the closing of the common gate that blocks both pores simultaneously. The 
common gating is thought to include the movement of the cytoplasmic domains (green and blue ovals).  
 
 
The mechanism of common gating, acting on the two individual pores 
simultaneously, is less well understood. The common gate is influenced by the chloride 
concentration, temperature, pH and voltage. Membrane depolarization favors common gate 
closing in ClC-0, while in ClC-1 it favors opening (Fong, Rehfeldt et al. 1998; Accardi and 
Pusch 2000). Several experiments have suggested conformational changes in the channel 
underlying the concerted closing of both pores during common gating (Pusch, Ludewig et 
al. 1997; Bennetts, Roberts et al. 2001, Bykova, Zhang et al. 2006). Additionally, 
mutations in the dimer interface of the catalytic domains (Duffield, Rychkov et al. 2003) as 
well as in the cytoplasmic domains have been described to influence the common gate 
(Fong, Rehfeldt et al. 1998). The indications for an involvement of the intracellular 
segments of the ClCs in this regulatory process are discussed in the following chapters.  
0 
1 
2 
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1.2.5 ClC transporters 
 
The bacterial homolog EcClC, whose structure has been determined, was the first ClC that 
has been discovered to function as chloride proton antiporter (Accardi and Miller 2004). 
Although the detailed mechanism of exchange is unknown, several of its basic features are 
established. 
EcClC transports its substrate ions with a strict stoichiometry of 2 Cl¯ for 1 H+. 
Each subunit acts as an independent transporter with the transmembrane pathways in 
which chloride and protons move in opposite directions (Nguitragool and Miller 2007). 
The pathways for Cl¯ and H+ overlap on the extracellular side of the protein, but emerge at 
distant point on the intracellular surface of the protein (Figure 1.5) (Accardi, Walden et al. 
2005). The proton pathway cannot be visualized crystallographically at the current 
resolution of the structures, but functional experiments have identified some of its 
characteristics. It has been shown that the gating glutamate (Gluext) is the part of the proton 
path towards the extracellular side and that a corresponding glutamate residue exists on the 
intracellular side of the membrane (Gluint). Mutation of Gluext in EcClC uncouples Cl¯/H+ 
transport and converts the protein into a constitutively open chloride conductor (Accardi 
and Miller 2004). Mutation of Gluint abolishes proton transport but, in contrast to Gluext, it 
retains the activation by pH. The inner glutamate is conserved within the transporter 
branch of the ClC family and substituted by hydrophobic residues in the channels.  
 
 
           A 
          
B 
 
 
Figure 1.5. Separate ion pathways in Cl¯/H+ antiporters. 
(A) ClC dimer with the following side chains highlighted: E148, E203 (red); S107, Y445 (blue). Cl¯ 
ions are shown as green spheres. Proposed Cl¯ and H+ pathways are indicated in green and red, 
respectively. The region between E148 and E203, which the H+ must traverse, is indicated by the 
gray box. 
(B) Sequence alignment of the region of Gluint (indicated in red). The residue is conserved in ClC 
transporters, but not in ClC channels.  
Figures derived from (Accardi, Walden et al. 2005). 
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 As previously mentioned, transporters are believed to have two gates, one on each 
side of the membrane, that alternate their opening and closing in order to prevent free 
diffusion of the substrates. It was clear from the beginning that the Gluext plays the role of 
the extracellular gate in transporters. The intracellular gate, in contrast, was not 
immediately recognized, but recent experiments have shown that a tyrosine residue (Y445 
in EcClC) that is part of the central Cl¯ binding site is part of the intracellular gate 
(Jayaram, Accardi et al. 2008). It has thus been concluded that the structure of WT EcClC 
represents an occluded state with both gates closed. Removal of both gates by mutations 
converts EcClC to an uncoupled, ungated channel-like protein with increased conductance.  
 In the light of the bacterial transporter structure and known mechanistic features of 
H+/Cl¯ exchange, it has been argued that ClC channels appeared in evolution as “degraded” 
ClC transporters in which transmembrane proton movement was still coupled to the outer 
gate at Gluext, but the role of tyrosine residue as an inner gate had been lost (Miller 2006; 
Lisal and Maduke 2008). This hypothesis would explain the evolutionary relationship 
between the channels and transporters and the proposed similarities in their mechanisms of 
action. Nevertheless, a structure of a proper ClC chloride channel is needed to clarify the 
differences that have to exist in order to support the diverse modes of chloride transport.  
 
 
1.3 Cytoplasmic domains in ClC chloride channels and transporters 
 
Ion channels and transporters frequently have a modular architecture that consists of a 
membrane bound catalytic domain and a cytoplasmic regulatory domain. To fully 
understand the mechanism of ion transport and its regulation within the cell, it is critical to 
define the roles of cytoplasmic domains. The mechanisms by which these domains are 
coupled to the transmembrane pore, and how they recognize auxiliary subunits and 
intracellular signals, are some of the questions that are waiting to be answered. The 
superfamily of potassium channels offers detailed insight into the regulation of channel 
activity by cytoplasmic domains. The gating of potassium channels can, for example, be 
regulated by calcium in calcium-sensitive potassium channels or by cyclic nucleotides in 
cyclic-nucleotide-gated (CNG) and hyperpolarization-activated cation channels (HCN) 
(Roosild, Le et al. 2004). As part of the regulatory mechanism, cytoplasmic domains can 
upon ligand binding transiently vary their symmetry, as observed for the cytoplasmic 
domains of CNG and HCN channels (Zagotta, Olivier et al. 2003). 
 Cytoplasmic domains are found in all eukaryotic and in a number of prokaryotic 
ClC proteins. The prokaryotic ClCs of known atomic structure, however, do not have these 
cytoplasmic components. In eukaryotic proteins the cytoplasmic domains have been shown 
to be critical for proper protein function (Schmidt-Rose and Jentsch 1997; Maduke, 
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Williams et al. 1998). Their biological importance is emphasized by a number of mutations 
in these domains of various family members that lead to diseases like myotonia, Dent's 
disease, osteopetrosis and classical Bartter syndrome (Jentsch 2008).  
 Cytoplasmic domains vary in length, in different human ClC family members they 
range from about 155 to 398 amino acids. The common feature in all the members is the 
presence of two CBS subdomains (CBS1 and CBS2) that are conserved within the family. 
The variation is due to the different length of the interdispersed linker connecting the two 
subdomains and a so called C-peptide following CBS2.  
 
CBS subdomains. CBS subdomains are named after cystathionine β-synthase 
where they were initially described (Bateman 1997), but they are found in several other 
functionally unrelated families like metabolic enzymes, kinases, channels and transporters 
(Ignoul and Eggermont 2005). The CBS motifs are typically 60 residues long and have a 
fold that consists of three beta strands and two alpha helices in a β1 - α1 - β2 - β3 - α2 
arrangement. They usually occur as tandem pairs that associate in a pseudo two-fold 
arrangement via the antiparallel β-sheets of the two subdomains formed by β2 and β3 
(Figure 1.6). While the β-strands are tightly interacting, the α-helices are positioned at the 
periphery of the structure leaving a cleft in between the subdomains (Ignoul and 
Eggermont 2005).  
 
 
                      
  
Figure 1.6. Secondary structure of the CBS domain.  
Two CBS subdomains are colored in blue and red. Each subdomain has a conserved pattern β1-α1-β2-β3-α2. 
Two subdomains are interacting through the antiparallel β-sheets and leave the α-helices on the periphery.  
 
 
Dimerization of CBS domains. A general feature of CBS domains observed in 
different prokaryotic and eukaryotic proteins is their ability to dimerize. A number of 
determined 3D structures of mostly prokaryotic proteins revealed common dimerization 
modes in which two CBS domains interact via the alpha helices in two possible 
arrangements: head-to-head or head-to-tail (Figure 1.7 A and B). Assembled dimers have a 
disc-like appearance with a buried interaction interface of 3000 to 4000 Ǻ2. The self-
α1 
α2 
β1 
β2 β3 
α1 
α2 
β1 
β2 β3 
CBS2 CBS1 
linker 
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association is mediated by the hydrophobic surface of the α1 and α2 helices of both CBS 
subdomains. Besides the common dimerization modes where both subdomains are in 
contact, there are examples of CBS domain dimers where the interaction is formed only 
between α1 and α2 helices of one subdomain, either CBS1 or CBS2. In the structure of 
TM0892 protein from Thermatoga maritima the alpha helices of the CBS2 have a 
hydrophobic surface and mediate its self-association in a tail-to-tail manner (Figure 1.7C). 
The alpha helices of CBS1 have, in contrast, a hydrophilic surface and are splayed away 
from each other.  
 
    A 
     
B 
 
C 
 
 
Figure 1.7. Structures of representative CBS domain dimers.  
The protein chains are shown as ribbon, with the N-terminus colored in blue and the C-terminus colored in 
red.  
(A) Structure of the head-to-tail dimer of TM0935 from Thermatoga maritima (PDB entry 1O50). 
(B) Structure of the head-to-head dimer of YkuI from Bacillus subtilis (PDB entry 1YAV). 
(C) Structure of the tail-to-tail dimer of TM0892 from Thermatoga maritima (PDB entry 1VR9). There are 
no interactions between CBS1 subdomains due to its hydrophilic surface.  
 
 
Structural insights into CBS domains of ClC proteins. The structural knowledge 
on the cytoplasmic CBS domains of ClC proteins at the beginning of this work was 
obtained from two eukaryotic ClC proteins. The first determined structure was of the 
cytoplasmic domain of the voltage gated chloride channel ClC-0 from Torpedo marmorata 
(Meyer and Dutzler 2006), which revealed a well-ordered structural core of two tightly 
interacting CBS subdomains. The 96 residues long linker region between the two CBS 
subdomains and the C-peptide, in contrast, were not resolved in the X-ray structure. These 
disordered regions were later investigated by NMR spectroscopy, which has confirmed 
their large conformational heterogeneity on a fast timescale (Alioth, Meyer et al. 2007). 
Although the ClC-0 cytoplasmic domain forms dimers in solution, the dimeric arrangement 
was not found in the crystal. Therefore, a dimerization mode based on the dimeric structure 
of a prokaryotic CBS domain-containing protein was proposed (Meyer and Dutzler 2006).  
 The study on the cytoplasmic domain of the human transporter ClC-5 has revealed 
several novel structural aspects. First of all, the crystal structure of the ClC-5 CBS domain 
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revealed specific binding of adenosine nucleotides, which was subsequently quantified by 
binding assays (Meyer, Savaresi et al. 2007). Furthermore, the crystal structure of the ClC-
5 domain contained an unusual mode of dimerization for CBS motif containing proteins. In 
this dimeric arrangement the interface is formed predominantly between the CBS2 
subdomains of both chains placing the non-interacting CBS1 subdomains at a larger 
distance (Figure 1.8). The interaction buries 1600 Ǻ2, which is considerably smaller than in 
the head-to-head and head-to-tail dimers of other CBS domains.  
 
 
 
         
      
 
 
Figure 1.8. Dimeric arrangement of the ClC-5 CBS domain.  
The protein chains are shown as ribbon, with the N-terminus colored in blue and the C-terminus colored in 
red. The ATP molecules are presented as sticks. The relationship between the two views is indicated. The V-
shaped dimer is formed by the interaction between the CBS2 subdomains. 
 
 
Both the previously proposed interaction mode for the ClC-0 domain and the one observed 
in ClC-5 are possible models for the quaternary organization of the cytoplasmic component 
of ClC proteins. Therefore, the intersubunit organization remained ambiguous and needed 
to be clarified by further studies.  
The cytoplasmic domains in prokaryotic ClC proteins also consist of CBS motifs. 
The main difference to their eukaryotic counterparts is a smaller size: they are usually not 
longer than 150 amino acids. This feature is due to the short linker region between two 
CBS subdomains and a missing or a very short C-peptide. The degree of sequence 
similarity between eukaryotic and prokaryotic cytoplasmic domains is low, but this is a 
general characteristic for all CBS domains (Lucas, Encinar et al. 2009). The cytoplasmic 
domain of the prokaryotic ClC homolog from Picrophilus torridus has been crystallized 
and biochemically investigated (Looser 2008). The structure has a typical CBS domain 
organization. Both structural and biochemical data showed that this CBS domain, unlike its 
eukaryotic counterparts, exists as a monomer in solution. The crystallographic analysis of 
several crystal forms of the PtClC domain did not reveal any interaction in the crystals that 
90º 
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resembles head-to-head and head-to-tail dimers, or dimers found for eukaryotic ClC 
cytoplasmic domains. The only two-fold arrangement observed in the crystals is presented 
in Figure 1.9. A similar behavior was later found for the cytoplasmic domain of the ClC 
homolog from Ralstonia metallidurans, which is presented in this work (see Results 2.2.3). 
 
 
                              
                                   
                       
 
Figure 1.9. Dimeric arrangement of the cytoplasmic domains of the PtClC homolog found in the p3121 
crystal form. The protein chains are shown as ribbon, with the N-terminus colored in blue and the C-
terminus colored in red. The relationship between the two views is indicated. The interaction is formed 
between the residues of CBS1 subdomains burying the combined surface of 640 Ǻ2. 
 
1.3.1 Regulatory role of cytoplasmic CBS domains  
 
Depending on the protein in which they occur, CBS domains have been proposed to have 
different regulatory roles including the oligomerization and sorting of proteins, channel 
gating and ligand binding (Ignoul and Eggermont 2005). However, the exact functional 
purpose for most of the CBS domains in the context of the full length proteins is to this 
point not fully understood.   
A regulatory role has been assigned to the cytoplasmic domains of ClC proteins 
already in the early studies that included investigations of the effects of deletions and 
mutations in the CBS domain region on the expression and function of different channels 
and transporters. Several results suggested an involvement of the intracellular domains in 
folding and trafficking of ClCs (Schwappach, Stobrawa et al. 1998; Schwake, Friedrich et 
al. 2001). In addition, an influence of the cytoplasmic domains on the modulation of 
conduction properties of the ClC channels has been reported (Estevez, Pusch et al. 2004). 
Several mutations that affect common gating of ClC-1 channel and lead to myotonia have 
90º 
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been identified in its carboxyl tail (Aromataris and Rychkov 2006). These mutations shift 
the voltage dependence of the common gate to more positive potentials. Although, the 
common gating of ClC channels is still not well understood, it is likely that it involves 
significant structural rearrangements of the protein, because the temperature dependence of 
this type of gating is unusually high (Pusch, Ludewig et al. 1997; Bennetts, Roberts et al. 
2001). It also established that common gating involves changes in the interactions between 
the two subunits and possibly between the cytoplasmic domains. A recent study on ClC-0 
confirmed that large movements of the intracellular domains are linked with the common 
gating of the channel (Bykova, Zhang et al. 2006). By combining "Förster resonance 
energy transfer" with electrophysiological measurements, it has been discovered that the 
association of the cytoplasmic domains occurs when the common gate opens, and that 
separation leads to common gate closure. Although, these experiments revealed novel 
insight into the structural basis for common gating, they also raised the question how the 
cytoplasmic events in the C-terminus affect ion permeation in the transmembrane part. The 
candidate for coupling the C-terminal movement to the pore is the last transmembrane 
helix R. The position of R helix is unique, since it is partially integrated into the membrane 
and partially projects into the cytoplasmic space where it connects to the cytoplasmic 
domain. The tyrosine residue in the N-terminus of R helix is involved in coordinating a 
chloride ion in the central binding site of the selectivity filter. It appears likely that the 
movement in the cytoplasmic domains during common gating affects ion permeation of the 
channel by altering the position of the R-helix. However, to reach a detailed understanding 
of this process, the structural analysis of cytoplasmic domains in the context of full length 
ClC proteins is required.  
 
1.3.1.1 Nucleotide binding to the CBS domains  
 
A number of experiments during the last decade revealed that CBS domains can bind 
adenosine-containing ligands like ATP, AMP and S-adenosylmethionine, which led to the 
hypothesis that CBS domains function as sensors of intracellular metabolites. The most 
extensively studied CBS domains are those of the γ subunit of the AMP-activated protein 
kinase (AMPK) (Scott, Hawley et al. 2004; Rudolph, Amodeo et al. 2007; Townley and 
Shapiro 2007). The γ subunit contains four repeats of the CBS motifs and can 
competitively bind AMP or ATP. In this way, the CBS domains of AMPK act as sensors of 
the cellular energy state. When ATP is depleted due to cellular stress, the kinase is 
activated by AMP and switches on the catabolic pathways that generate ATP. Different 
effects of AMP and ATP probably arise from the charge difference between the mono- and 
triphosphate groups of AMP and ATP that are recognized in the critical regulatory region 
and transmitted to the catalytic α subunit of AMPK by a still unknown mechanism.  
 1 Introduction 
 17 
 The CBS domains of ClC proteins have also been suggested to constitute binding 
modules for nucleotides that regulate function. ATP binding has been reported for ClC-1 
(Bennetts, Rychkov et al. 2005; Bennetts, Parker et al. 2007; Tseng, Bennetts et al. 2007), 
ClC-2 (Scott, Hawley et al. 2004) and ClC-5 (Meyer, Savaresi et al. 2007). However, it is 
still unclear whether nucleotide binding is a universal property of all ClC CBS domains 
and, if so, to which extent it modulates the function of ClC proteins. For example, it 
appears that CBS domains of the channels ClC-0 and ClC-Ka lack nucleotide dependence 
as neither binding assays nor co-crystallization experiments have shown specific 
interaction of the protein with nucleotides (Meyer and Dutzler 2006; Markovic and Dutzler 
2007). 
 The first direct evidence for nucleotide binding to ClC proteins comes from the 
structural and biochemical analysis of the ClC-5 cytoplasmic domain (Meyer, Savaresi et 
al. 2007). The co-crystallization experiments revealed specific binding of ATP, ADP and 
AMP in the cleft between the two CBS subdomains of ClC-5 (Figure 1.10). From an 
inspection of the binding pocket the amino acids important for the binding have been 
detected and a novel conformation of the bound nucleotide was observed. Similar 
conformation of bound ATP was later found in the equivalent domains of AMPK 
(Townley and Shapiro 2007). The determined affinities of the nucleotides ATP, ADP and 
AMP binding to the domain of ClC-5 are very similar in the range of 100 µM.  
 
     A 
 
        
B 
      
 
Figure 1.10. Binding of ATP to the ClC-5 cytoplasmic domain.  
(A) Ribbon representation of the ClC-5 domain. The two CBS subdomains are colored in green and blue, 
respectively, residues of the ubiquitin ligase recognition site are colored in red. The bound ATP molecule is 
shown as CPK model. (B) Structure of the nucleotide binding site. Protein main chain is shown as Cα trace 
and colored in yellow with selected residues near the bound ATP molecule shown as sticks. Dashed lines 
denote hydrogen bonds between protein and nucleotide. The protein residues in contact with protein are 
labeled. The tyrosine residue 617 makes stacking interaction with the base, the aspartate 727 coordinates the 
ribose and the serine 618 the phosphate group. Mutation of Y617 and D727 abolishes nucleotide binding. 
Figures derived from (Meyer, Savaresi et al. 2007) 
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 Although the nucleotide binding is abolished by mutating the amino acids that 
coordinate the ligand, these mutations did not alter the current phenotype of the ClC-5 
transporter when studied in heterologous expression systems. Surprisingly, changes in 
current rectification were observed when such mutations were studied in the background of 
the uncoupled ClC-5 gating glutamate mutant, which might hint at a regulatory role of 
nucleotides under currently unknown circumstances. Recently, the intracellular regulation 
of ClC-5 by adenine nucleotides was directly studied by inside-out patch experiments 
(Zifarelli and Pusch 2009). The obtained results suggest that nucleotides increase the 
probability of ClC-5 to be in an active, transporting state.  
In contrast to the observations in ClC-5, for the muscle channel ClC-1 it has been 
proposed that ATP has an inhibitory effect (Bennetts, Rychkov et al. 2005). Detailed 
electrophysiological analyses have demonstrated that physiological concentrations of ATP  
in combination with low intracellular pH might inhibit ClC-1 channel by shifting the open 
probability curve of the common gate towards more depolarizing potentials (Tseng, 
Bennetts et al. 2007). This would mean that in the presence of ATP and low pH the 
channel is in the closed state. It is proposed that this mechanism plays an important role in 
opposing muscle fatigue. Intensive exercise is associated with muscle acidification which 
has been observed to lead to reduced chloride conduction (Pedersen, de Paoli et al. 2005). 
Due to reduced Cl¯ shunting current on the surface membrane of skeletal muscles partially 
inactivated Na+ channels are still able to initiate action potential. Therefore, the regulation 
of ClC-1 is important for the maintenance of excitability in working muscle.  
 
 
 
 
Figure 1.11. Effect of 1 mM ATP on ClC-1 at pH 
6.2. Po-V curves of the common (left) and fast gate 
(right). Solid and open lines were obtained in 0 and 
1 mM ATP, respectively. ATP shifts the open 
probability of the common gate by 130 mV towards 
more positive potentials, but does not influence the 
fast gate. Figure derived from (Tseng, Bennetts et al. 
2007). 
 
 
The regulation of the ClC-1 common gating is thought to result from a direct 
interaction between ATP and the cytoplasmic domains, although a structural evidence for 
the binding is still missing. The residues responsible for the nucleotide binding in ClC-5 
are not conserved in ClC-1, but some similarities exist (Figure 1.12). However, the binding 
hypothesis is supported by the two single-point mutations in the ClC-1 cytoplasmic 
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domain, H847A and L848A, known to suppress the inhibitory ATP effect (Zhang, Tseng et 
al. 2008).  
 
 
 
 
 
 
 
 
 
Figure 1.12. Sequence alignment of the 
cytoplasmic domains of ClC-1, ClC-0 
and ClC-5. Residues in ClC-5 involved 
in ATP binding are highlighted in violet. 
The residues H847 and H848 of ClC-1 
are labeled with a red star. Figure derived 
from (Meyer, Savaresi et al. 2007). 
 
   After the structural and functional analyses of ligand binding to the CBS domains 
of several proteins, the effects these ligands exert on their targets and the molecular 
mechanisms underlying the regulation are still ambiguous. Currently, there are two 
different types of regulatory mechanisms proposed (Lucas, Encinar et al. 2009). In the first 
type, denoted as “static”, the nucleoside position of the ligand induces essentially no 
change in the protein structure. Instead, the electrostatic potential at the binding site is 
thought to be the most significant property of adenosine nucleotide binding. This “static” 
type of regulation would be involved in processes in which regulation by the cellular 
energy state would be advantageous like, for instance, in AMPK. The second type of 
mechanism, denoted as “dynamic”, would involve dramatic conformational changes in the 
protein upon ligand binding. This dynamic type of regulation has recently been observed 
for the cytosolic domain of the magnesium transporter MgtE (Hattori, Iwase et al. 2009) 
and for the CBS domain of protein MJ0100 from Methanocaldococcus jannaschii (Lucas, 
Encinar et al. 2009). The cytosolic domains of MgtE have been proposed to regulate the 
gating of the ion-conduction pore by sensing the intracellular Mg2+ concentration. Crystal 
structures of the cytoplasmic domains in the presence and absence of Mg2+ demonstrate a 
substantial conformational change in the CBS domain dimer upon ion binding (Figure 
1.13). This conformational change is transmitted to the ion conduction pore via the plug 
helix that connects the transmembrane with the cytosolic component. The structural study 
on the CBS domain of MJ0100 in complex with S-adenosylmethionine and S-methyl-5’-
thioadenosine revealed different conformations of the head-to-head dimer depending on 
the number of ligands bound to the protein (Lucas, Encinar et al. 2009). Four detected 
conformers differed in the angle adopted between the two CBS domains suggesting an 
open-to-closed conformational change.  
** 
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Figure 1.13. Cytoplasmic domains of MgtE transporter act as ion sensors. 
Structure of the cytoplasmic domains in the absence (A) and presence (B) of magnesium ions (PDB entries: 
2YVZ and 2YVY, respectively). The protein chains are shown as ribbon, with the N-domains colored in gray 
and CBS domains colored in red. The α2 helices of CBS1 building the interface are colored in yellow, the 
Mg2+ ions are presented as green spheres. In the Mg2+ bound structure the N-domains are removed for clarity. 
Binding of ions influences closing of the CBS dimer. The closing of the ion conduction pore is triggered by 
the movement of the plug helices (indicated by the black arrows).  
 
 It is currently unclear which type of mechanism would be relevant for the ClC 
proteins ClC-5 and ClC-1 that were identified to interact with nucleotides. The static type 
of regulation is unlikely due to the fact that both ClC-5 and ClC-1 do not discriminate 
between ATP, ADP and AMP. Moreover, the binding affinities determined for ClC-5 and 
the inhibitory effect of the physiological concentrations of ATP on ClC-1 would suggest 
that the ligands permanently occupy the protein. It could thus be argued that the 
nucleotides have rather a structural than regulatory role and that most probably CBS 
domains in ClC proteins do not act as sensors of the cellular energy state. The dynamic 
type of regulation is more likely, but structural information on CBS domains or full-length 
ClC proteins in the presence and absence of ligands is necessary to confirm this 
speculation. The results that support the dynamic type of regulation include the observed 
structural rearrangements associated with the common gating of ClC-0 and that were also 
suggested for ClC-1. As nucleotide binding is only shown for certain ClCs it is also 
possible that other factors (like for example pH in the case of ClC-1) can act as regulators 
of transport.  
 
 
1.4 Prokaryotic ClC homologs as model proteins 
 
Prokaryotic ClC homologs have served as invaluable model system to shed light on both 
the structure and function of ClC family members. In addition to providing a high-
resolution molecular view of the family, the functional investigation of prokaryotic ClC 
proteins has led to the discovery that many ClCs are chloride-proton antiporters and not 
chloride channels. It is thus attractive to assume that additional features of the ClC family 
that concern concerted regulatory mechanisms could be uncovered by examining 
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prokaryotic proteins. This goal is facilitated by the recent availability of sequenced 
prokaryotic genomes that aid the discovery of proteins which have the desired features. A 
feature that makes prokaryotic proteins attractive targets is their easier overexpression and 
purification when compared to their eukaryotic counterparts. The prokaryotic expression 
systems, particularly E. coli, are inexpensive, robust, easy to handle and thus suited for 
broad screening approaches. The availability of milligram quantities of the prokaryotic 
ClCs in an active form makes them readily accessible for both structural and functional 
studies.  
The newly discovered homologs may prove to be more suitable as model proteins 
to study certain aspects of ClC function than the structurally characterized EcClC and 
StClC. Several of them share additional structural features with eukaryotic ClCs and some 
proteins could potentially function as channels. Sequence analysis of known prokaryotic 
ClC homologs shows that less than a half of these prokaryotic proteins contain the 
“intracellular glutamate” (Gluint) found in transporters, while the other half contains a 
hydrophobic residue at this position (Matulef and Maduke 2007). A number of prokaryotic 
ClCs contain cytoplasmic CBS domains and they are, therefore, very interesting targets for 
studies on concerted regulatory mechanisms. Many remaining questions are to be 
addressed on the new prokaryotic ClC homologs: What is the structure and function of the 
cytoplasmic domains in the prokaryotic ClC homologs? Are there endogenous ligands that 
bind to these domains? Do any of the prokaryotic ClCs that lack Gluint function as channels 
rather than transporters? How are the prokaryotic ClCs regulated in their physiological 
context? Do the prokaryotic homologs have any accessory subunits, such as the two known 
for mammalian ClCs? Addressing these questions on prokaryotic homologs may reveal 
novel features that are relevant for the entire family of chloride channels and transporters. 
However, one has also to be aware that certain regulatory and pharmacological properties 
will be unique to eukaryotic proteins and that the understanding of such processes will 
require structural investigation of eukaryotic proteins.  
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1.5 Aim of this thesis  
 
While currently all structural information on the ClC family only exists for the isolated 
transmembrane catalytic domains and the cytoplasmic regulatory domains, there are no 
structures of full length proteins that include both components available. Therefore, the 
main goal of this thesis was to establish the overexpression and purification of prokaryotic 
ClC proteins containing cytoplasmic domain that would serve as model systems for 
structural and functional studies. An additional aim of the thesis was to reveal the 
oligomeric assembly of cytoplasmic domains in prokaryotic and eukaryotic ClC proteins 
which is of fundamental importance for investigating regulatory mechanisms governed by 
these cytoplasmic components. 
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2 Results 
 
2.1 Expression and biochemical characterization of prokaryotic ClC 
homologs 
 
2.1.1 Homology search 
 
The members of the ClC family of chloride channels and transporters are widely 
represented in prokaryotes. Over a thousand of sequenced prokaryotic genomes offer, 
therefore, an enormous source of ClC homologs that could be potentially used for 
structural studies.  
 The sequence identity between the prokaryotic and eukaryotic ClCs is relatively 
low (15 – 25 %). However, several stretches of the ClC sequence are invariant and serve as 
a good criterion for classification. The highly conserved regions include residues of 
functional importance that form the ion translocation pore with its specific binding sites. 
One interesting structural feature of prokaryotic ClC family members is that some 
of them contain cytoplasmic CBS domains and some do not. Regarding functional 
differences, it is known that the ClC homolog from E. coli, EcClC, functions as 
chloride/proton antiporter, while ClC homologs that function as chloride channels have so 
far not been identified and functionally characterized.   
 The prokaryotic ClC homologs I have chosen for cloning had the following 
characteristics:  
1) They contain cytoplasmic CBS domain. 
2) They either contain a valine, leucine or isoleucine instead of the glutamate at 
the position determined to be responsible for the proton translocation in ClC 
transporters on the intracellular side (Accardi, Walden et al. 2005). In that way 
only potential prokaryotic ClC channels were selected. 
3) They are relatively small in size as compact proteins are more promising for 
crystallization  
4) They are found in easily available, non-pathogenic microorganisms 
 
The protein sequence of the chloride channel ClC-0 from Torpedo marmorata was 
used as a query for blast searches (blastp). The Blossum62 matrix was applied for scoring 
of the alignments. Table 2.1.1 presents 27 homologs that were identified during the search 
and subsequently cloned. By pairwise sequence alignment implemented in ClustalW, the  
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Strain with the strain code 
 
Homolog 
name 
Gene Identity to 
ClC-0 [%] 
Length 
[aa] 
Mw 
[kD] 
Archaeoglobus fulgidus  
 DSM 4304 
AfClC AF_1415 19 589 63.4 
Caldivirga maquilingensis IC-167     
DSM 13494 
CmClC Cmaq_0176 18 586 63.2 
Chlorobium limicola       
 DSM 245 
ClClC Clim_1107 
 
19 470 50.2 
Chlorobium tepidum TLS 
DSM 12025 
CtClC CT1391 
 
16 629 68.7 
Desulfuromonas acetoxidans 
DSM 684 
DaClC Dace_0926 
 
17 606 65 
Halobacterium sp. NRC-1 HaClC VNG1544G 
 
15 792 81.7 
Haloferax volcanii 
DSM 3757 
HvClC HVO_A0171 15 656 67.6 
Hydrogenobaculum sp. Y04AAS1 HyClC HY04AAS1_0583 
 
19 462 49.6 
Hyperthermus butylicus   
DSM 5456 
HbClC Hbut_0425 
 
16 563 60.1 
Metallosphaera sedula     
DSM 5348 
MsClC Msed_0357 
 
15 588 63.6 
Methanococcoides burtonii  
DSM 6242 
MbClC Mbur_1352 
 
14 577 62.2 
Methanoculleus marisnigri JR1 
DSM 1498 
MmClC Memar_1622 
 
13 754 79.7 
Methanosaeta thermophila PT 
DSM 6194 
MtClC Mthe_1465 
 
16 580 62.2 
Methanosarcina acetivorans C2A 
DSM 2834 
MaClC MA3609 
 
17 607 65.9 
Methanosarcina barkeri 
DSM 804 
Mb1ClC Mbar_A2221 
 
16 590 63.7 
Methanosarcina barkeri 
DSM 804 
Mb2ClC Mbar_A1823 
 
16 593 64.4 
Methanosarcina mazei Go1 
DSM 7222 
MmzClC MM_0498 
 
19 589 63.4 
Pelobacter carbinolicus   
 DSM 2380 
PcClC Pcar_1620 
 
14 606 64.7 
Pelodictyon luteolum       
DSM 273 
PlClC Plut_0919 
 
15 624 67.8 
Picrophilus torridus        
 DSM 9790 
PtClC PTO1156 
 
14 590 65.4 
Prosthecochloris vibrioformis 
DSM 265 
PvClC Cvib_0969 
 
15 624 68 
Ralstonia metallidurans CH34     
DSM 2839 
Rm1ClC Rmet_0455 
 
13 560 57.8 
Ralstonia metallidurans CH34     
DSM 2839 
Rm2ClC Rmet_0584 
 
14 637 66.8 
Rhodopseudomonas palustris 
CGA009   
RpClC RPA1465 
 
14 604 64 
Streptomyces coelicolor A3(2) 
DSM 40783 
ScClC SCO6320 
 
16 589 60 
Syntrophobacter fumaroxidans 
MPOB     DSM 10017 
SfClC Sfum_2352 
 
15 612 66.3 
Thermoplasma volcanium GSS1 
DSM 4299 
TvClC TVN0094 
 
15 592 64.2 
 
Table 2.1.1. Prokaryotic ClC homologs. 
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Table 2.1.1. Prokaryotic ClC homologs. 
List of 27 ClC homologs selected for cloning. The homologs were identified using blastp with Blosum62 
matrix searching with ClC-0. Identity to ClC-0 was determined applying pairwais sequence alignment 
implemented in ClustalW. 
 
identity to ClC-0 was determined. The percentage of identical residues between ClC-0 and 
the prokaryotic homologs is relatively low, in the range between 13 to 19 %.  
The size of the selected ClC proteins with cytoplasmic domains varies from 560 to 
792 residues (on average 591 residues). The shortest human ClC proteins are ClC-K 
channels with 687 amino acid residues, which indicates that most of the selected 
prokaryotic ClCs are more compact proteins due to the shorter loops connecting 
transmembrane helices. 
In searching for putative prokaryotic ClC channels, two proteins that do not contain 
a cytoplasmic domain were identified: ClClC and HyClC. This was an interesting 
observation, since all other prokaryotic ClCs lacking cytoplasmic domains are putative 
transporters, based on the conservation of the intracellular glutamate. Therefore, the two 
homologs were included in the screen. Figure 2.1.1 summarizes the conservation of the 
residues constituting the selectivity filter of EcClC in the chosen set of ClC homologs. The 
structure of the selectivity filter is presented in Figure 2.1.1A. The gating glutamate (E148 
in EcClC) is strictly conserved in all ClCs and the surrounding stretch of sequence is 
highly homologous (Figure 2.1.1C). This is not the case for the residues of the central ion 
binding site, S107 and Y445 in EcClC. While the tyrosine residue is conserved in most of 
the selected proteins, the serine is not found in any of them. In more than half of the 
proteins, the serine residue is substituted by a histidine, and in the rest of the proteins this 
region is not homologous. As described before, all selected homologs have a hydrophobic 
residue (mostly valine) at the position of the intracellular glutamate that acts as a proton 
donor in ClC transporters. Structural information in combination with functional analysis 
will be the only way to uncover the role of specific residues in the ion binding in this novel 
set of ClC proteins. 
From the multiple sequence alignment a phylogram connecting the 27 ClC 
homologs with EcClC and ClC-0 was generated (Fig. 2.1.1.B). In phylograms, the distance 
of one group from the other groups indicates the degree of relationship; i.e. closely related 
groups are located on branches close to one another. Selected ClC homologs cluster into 
five different groups. By analyzing the microbial origin of each ClC homolog, it is 
apparent that the biggest group (blue in Figure 2.1.1B) encompasses proteins coming from 
thermophilic archaea and δ/ε proteobacteria. Four ClC proteins are from green sulfur 
bacteria (Chlorobi - green) and five from methanogenic archaea (orange). Two homologs 
are from halophilic archaea and one from an actinomycete (purple). Another group 
contains proteins from β- and α- proteobacteria (red). This classification is potentially  
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Figure 2.1.1.  Conservation of the residues building the EcClC selectivity filter in the selected prokaryotic ClC homologs. 
A) Structure of the EcClC selectivity filter in the closed conformation. The protein backbone is shown as ribbon, with selected residues as sticks. The 
chloride ions are represented as green spheres. The residues building the chloride binding sites are labeled, together with the helices they belong to. The 
putative proton translocation pathway is labeled with the red dotted line connecting the intracellular glutamate E202 (H+ donor) and the extracellular 
glutamate E148 (H+ acceptor).  
B) Phylogram of the ClC homologs created with the multiple sequence alignment in ClustalW. Selected ClC homologs cluster into five different groups 
based on their sequence similarity i.e. prokaryotic organism they come from. Blue: thermophilic archaea and δ/ε proteobacteria; Green: green sulfur 
bacteria; Orange: methanogenic archaea; Purple: halophilic archaea and actinomycetes; Red: β and α proteobacteria; ClC-O from Torpedo marmorata; 
EcClC: γ proteobacteria. 
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C) Sequence alignment between selected prokaryotic ClCs, ClC-0 and EcClC (ClustalW). Five sequence regions containing the residues of the selectivity 
filter are presented. Sequences with high homology are colored in red, identical residues are labeled with a star. The numbering of the critical residues 
corresponds to EcClC. The gating glutamate is strictly conserved. A serine residue in the selectivity filter (S107 in EcClC) is not conserved and the 
intracellular glutamate (E202 in EcClC) is substituted with hydrophobic valine, isoleucine or leucine residues.   
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interesting for correlating the expression and biochemical behavior with the microbial 
origin of the selected proteins.   
 
 
2.1.2 Cloning of prokaryotic ClC homologs 
 
Selected microbes were purchased from the DSMZ microbial collection as dried cell 
pellets or as growing cultures. The genomic DNA was subsequently isolated by standard 
procedure resulting in sufficient starting material for amplification. The genes of interest 
were amplified by the polymerase chain reaction (PCR), using primers that contained 
specific sequences for subsequent cloning into expression vectors. The choice of the DNA 
polymerase had the biggest influence on successful amplification (Pfusion®, KOD® and a 
mixture of polymerases present in the Master Mix® were used). 
For cloning of prokaryotic ClC homologs a new strategy termed fragment exchange 
(FX) cloning was applied. This type of cloning circumvents the problem of internal 
cleavage sites for certain restriction enzymes and facilitates high throughput efforts. As for 
the Gateway® cloning system, the genes of interest and the target vector are mixed in one 
tube to which the restriction enzyme is added. The enzyme catalyzing the reaction is very 
specific resulting in a low frequency of cleavage site in the genes of interest that could 
interfere with the procedure.  
 
      
 
Figure 2.1.2. FX Cloning 
Fragment exchange (FX) cloning requires the addition of short DNA sequences on both sides of the gene of 
interest (blue). They differ in sequence to guarantee directional cloning. The target vector contains the CcdB 
marker (grey) flanked by the corresponding short DNA recognition sequences. After the ligation reaction 3 
bp are left on the plasmid introducing an additional amino acid on both sides (5’ serine, 3’ alanine). CcdB 
(grey) is a toxic protein to E. coli that prevents growth of clones that do not contain the insert.  
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Another beneficial feature for high throughput cloning is the integration of the 
selection marker CcdB in the original plasmid (Figure 2.1.2). CcdB is a cytotoxic protein 
that inactivates DNA gyrase and that is integrated into the plasmid under the control of a 
consecutive promoter (Bernard, Gabant et al. 1994). The cassette is eliminated after a 
successful ligation with the insert. In that way, religations with the CcdB cassette and 
uncut vectors are eliminated since bacteria containing such vectors fail to grow.  
 All 27 homologs were cloned into pBXC3GH vector to generate C-terminal fusions 
with the green fluorescent protein (GFP) and His10 tag at the end. The GFP part in these 
fusion proteins can be used as a folding indicator, for detection and quantification of the 
proteins. Only promising candidates were subsequently cloned into pBXC3H vector which 
results in a C-terminal fusion with a His10 tag used for affinity purification (Figure 2.1.3).  
 
 
 
 
 
 
Figure 2.1.3. Expression constructs for prokaryotic ClC homologs 
Initially, fusion proteins containing C-terminal GFP (green) and His-tag separated from the protein (red) by 
3C protease cleavage site were generated by FX cloning (top). Expressing proteins were subsequently cloned 
into a vector containing a C-terminal 3C site and a His-tag only to aid purification (bottom). The FX cloning 
method introduces an additional amino acid on both termini (N- serine, C- alanine). 
 
2.1.3 Expression tests 
 
The first hurdle towards membrane protein structure determination is the overexpression of 
target proteins at high levels needed for crystallization. The expressed membrane proteins 
must have suitable biochemical properties like proper folding, catalytic activity and broad 
detergent stability to be suitable for structural analysis. When screening broadly for 
microbial homologs of a certain membrane protein family, the chance for identifying 
candidates that satisfy the above mentioned criteria is increased. Nevertheless, it is 
advantageous to be able to initially investigate a large number of constructs in parallel in 
small volumes to identify the most promising ones for scale-up closer characterization.  
 Several parameters can influence the amount of well folded membrane protein such 
as the expression strain, induction temperature, growth medium and promoter strength 
(Wang, Safferling et al. 2003). Analysis and optimization of expression conditions for a 
large number of homologs can be laborious when applying standard methods like Western 
blot or activity assays. Moreover, due to the hydrophobic nature of membrane proteins, 
their transfer to the blotting membrane can be inefficient, thus making Western blotting 
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less suitable for quantitative purposes. Since simple activity assays are often not available 
for certain families of membrane proteins, e.g. ion channels and transporters, the successful 
overexpression is often not straightforward.  
 The use of the green fluorescent protein (GFP) as a folding indicator has 
revolutionized expression screening of membrane proteins in bacterial systems (Drew, von 
Heijne et al. 2001; Kawate and Gouaux 2006; Hammon, Palanivelu et al. 2009). When 
fused to the C-terminus of a membrane protein, GFP moiety folds properly and becomes 
fluorescent only if a membrane protein is also properly folded and stably inserted into the 
membrane (Drew, Lerch et al. 2006). C-terminal GFP fusions allow over-expressed 
membrane proteins to be monitored in intact cells by measuring in cell fluorescence 
(Hammon, Palanivelu et al. 2009). Since GFP does not unfold under standard SDS-PAGE 
conditions, membrane protein–GFP fusions can also be visualized directly by in-gel 
fluorescence (Drew, Lerch et al. 2006). In addition, the GFP moiety greatly facilitates 
purification and characterization of the membrane protein-GFP fusions (Kawate and 
Gouaux 2006). 
 While GFP fluorescence reveals the well folded population of a membrane protein, 
it does not quantify the total expression level i.e. the amount of produced protein that 
includes misfolded and aggregated protein. Recently, an elegant method was developed 
that allows detection of well folded and aggregated proteins simultaneously (Geertsma, 
Groeneveld et al. 2008). The method combines in-gel fluorescence and anti His-tag 
Western blot analysis to follow differential migration of folded and aggregated GFP fusion 
proteins during SDS-PAGE (Figure 2.1.4). Determination of the ratio of both species 
accelerates the optimization of the functional overexpression of membrane proteins.  
 
 
Figure 2.1.4. GFP as expression and folding indicator 
Green fluorescent protein (GFP) can be used as a folding indicator. C-terminally fused GFP folds properly 
and shows fluorescence only if the preceding protein is also folded. In contrast, if the preceding protein is 
aggregated, GFP is misfolded and lacks fluorescence. Since GFP keeps its conformation during SDS-PAGE 
analysis, it can be used to directly trace the folded fraction of the target protein within the gel (left). Since 
folded and unfolded GFP fused to SDS denatured protein have different migration behaviors, they can be 
separated and thus used to analyze the ratio of folded (right, lower band) to aggregated protein (right, upper 
band) expression levels.  
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2.1.3.1 Whole cell fluorescence-based expression screening of prokaryotic ClC 
homologs 
 
All prokaryotic ClC homologs were cloned as C-terminal fusions with GFP and His10-tag 
(Figure 2.1.3) under the control of the PBAD promoter. The PBAD (araBAD) promoter was 
chosen because it offers an expression strategy that allows a tight regulation with dose-
dependent induction, in that way combining gentle expression conditions with high 
expression yields. The inducer in this system is arabinose. In arabinose-free medium the 
AraC dimer binds two distant parts of the araBAD-operon and suppresses transcription 
through DNA loop formation. Upon arabinose binding, the AraC dimer rearranges and 
binds to adjacent regions in the araBAD-operon thus releasing the loop and activating 
transcription of the target gene (Schleif 2003). 
For expression screening the ligation mixtures were transformed into the E. coli 
strain MC1061 that is incapable of metabolizing arabinose due to a disrupted ara gene. 
In order to rapidly test for protein expression, all experiments were carried out in a 
high-throughput manner. The bacterial cultures were grown in 96 well plates with only 0.7 
ml culture medium. This allowed a simultaneous screening of different homologs and 
inducer concentrations. The expression medium in these studies was Terrific Broth (TB) 
and the induction temperature was 25°C.  
 
 
 
Figure 2.1.5. Whole cell fluorescence of 22 prokaryotic ClC homologs following induction with 10-2 % 
arabinose and overnight expression at 25°C. 
Tested ClC homologs can be divided into four groups based on the specific fluorescence intensity compared 
to the negative and positive control. Each homolog is represented with four independent colonies. Two 
homologs (yellow) show very low fluorescence, almost close to the background. Eight homologs (olive 
green) show low to intermediate fluorescence. Six homologs (sea green) show intermediate to high 
fluorescence. Six homologs (fluorescent green) show high to very high fluorescence and can be considered 
promising based on this experiment. Only three colonies (red) out of 88 do not contain an insert which 
illustrates the high efficiency of FX cloning. As a positive control E. coli transformed with the plasmid 
containing LacS protein from Streptococcus termophilus fused to GFP was used. As a negative control E. 
coli cells transformed with a vector without GFP were used. 
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The transformed bacterial cells were grown at 37°C to an OD600=0.5, cooled down 
to 25°C and induced with a range of arabinose concentrations. After overnight expression, 
the cells were pelleted, resuspended in PBS buffer and analyzed for fluorescence. The 
measured fluorescence is normalized by the total amount of bacteria and listed as specific 
fluorescence. Figure 2.1.5 presents a 96 well plate with 22 ClC homologs tested for whole 
cell fluorescence after induction with 10-2 % arabinose.   
When comparing specific fluorescence values of the 22 homologs tested in this 
experiment with the background fluorescence of the negative control, it can be concluded 
that all homologs express folded fusion proteins at different levels. The amounts of 
fluorescence vary up to ten fold between different homologs. Based on the specific 
fluorescence, all investigated proteins are classified into four groups. The first group 
contains two proteins, AfClC and PcClC, with very low fluorescence levels, less than two 
times over the background. The second group encompasses eight ClC homologs (DaClC, 
HaClC, MsClC, MtClC, Mb2ClC, RpClC, SfClC and TvClC) with low to intermediate 
fluorescence, two to four times higher than the background. In the third group we find six 
ClC homologs (HbClC, MbClC, MmClC, MaClC, Mb1ClC, ClClC) showing intermediate 
to high fluorescence levels, four to six times over the background. The fourth group is the 
most promising one with six proteins (CmClC, HvClC, MmzClC, PlClC, PvClC, and 
ScClC) that show high to very high fluorescence, in some cases more than ten times over 
the background. It is important to emphasize that the described classification is valid for 
the presented experimental condition. The induction with 10-2 % arabinose was chosen, 
since for all investigated concentrations it illustrates the differences in fluorescence 
between homologs best. Though, this inducer concentration is not optimal for all proteins 
to yield the highest amount of well folded fusion proteins.  
Whole cell fluorescence can be used to estimate the optimal inducer concentration 
for a given membrane protein-GFP fusion. The expression of all 27 cloned ClC homologs 
was investigated for four arabinose concentrations. Figure 2.1.6 shows the specific 
fluorescence of three ClC homologs at specified inducer concentrations. The increased 
arabinose concentration has a different influence on the amount of the fluorescent fusions 
in the presented proteins. For all three fusion proteins the lowest arabinose concentration 
(10-4 %) does not induce significant expression, as the fluorescence values are close to 
those of the negative control. Interestingly, the higher arabinose concentrations do not give 
similar results for all the homologs. In the case of the Rm1ClC homolog, it appears that 
increased inducer concentration does not have a negative effect on the yield of functional 
protein. The fluorescence is slowly and steadily increasing and all three expression 
conditions provide high amounts of properly folded fusion protein. For the ClClC 
homolog, 10-2 % arabinose in the medium induces the highest amount of fluorescent 
protein and can be considered optimal based on this experiment. For EcClC, the well 
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characterized homolog from E. coli, the optimal inducer concentration is 10-3 %, which is 
in agreement with previously published results (Geertsma, Groeneveld et al. 2008). 
 
    
 
Figure 2.1.6. Whole cell fluorescence of Rm1ClC, ClClC and EcClC at different inducer 
concentrations. 
Whole cell fluorescence can be used to estimate the optimal inducer concentration that gives the highest 
amount of well folded membrane protein. In the case of Rm1ClC, increasing arabinose concentrations lead to 
higher fluorescence. In the case of ClClC, an arabinose concentration of 10-2 % is optimal, since it gives the 
highest amount of fluorescent protein. The optimal inducer concentration for EcClC is 10-3 % arabinose. 
  
 
Expression screening of prokaryotic ClC homologs by measuring whole cell 
fluorescence has provided initial information on the expression levels and optimal inducer 
concentrations for each membrane protein. A set of candidate proteins with promising 
overexpression potential were identified in that way. Still, this simple GFP screen did not 
provide any information on the amount of misfolded membrane proteins produced. 
Measured fluorescence also did not reveal the integrity of the membrane protein-GFP 
fusion as degradation of the expressed target protein could also contribute to the 
fluorescence. In order to study these properties, the well expressed candidates were 
subsequently analyzed by in-gel fluorescence and anti-His Western blot. 
 
 
2.1.3.2 Expression screening of prokaryotic ClC homologs by in-gel fluorescence and 
Western blot 
 
After quantifying whole cell fluorescence, the same cultures were used to prepare samples 
for SDS-PAGE. For comparison, similar quantities of cells were analyzed in order to 
correlate the specific amounts of overexpressed proteins. Following the electrophoretic 
separation of proteins, the fluorescence in the SDS-PAGE gel was analyzed. The size of 
the target protein-GFP fusion was estimated from the position of the fluorescent band on 
the gel. In that way also degradation products were detected. The same gel was 
subsequently analyzed by Western blotting on a PVDF membrane. Due to the presence of 
a His10-tag at the C-terminus, the fusion proteins can be detected with appropriate 
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antibodies. The combination of in-gel fluorescence and anti His-tag Western blot analysis 
of the same gel provides complementary information on the amount of expressed proteins 
as described in Figure 2.1.4. 
  For ClC homologs that showed low to intermediate expression, the in gel 
fluorescence signals correlate well with the fluorescence observed in whole cells (Figure 
2.1.7). All presented ClC-GFP fusions migrate at the expected molecular weight 
confirming the integrity of the membrane protein part. In the case of the homolog TvClC a 
strong fluorescent degradation band is detected. In almost all samples only one band 
corresponding to the folded protein is detected by anti His-tag immunoblot. Only for 
TvClC a strong upper band of aggregated protein was identified.  
 
               
Figure 2.1.7. Analysis of expression using GFP folding assay. 
Five ClC homologs previously classified to have low to intermediate expression level were analyzed by in-
gel fluorescence (left panel) and anti-His immunoblot (right panel). Two clones for each homolog were 
tested. Arabinose concentrations used for induction are indicated (-3 and -2 for 10-3 % and 10-2 %, 
respectively). The upper fluorescent band in the marker corresponds to 75 kDa, the lower one to 25 kDa. 
Green triangles indicate well folded fluorescent protein, whereas red triangles indicate misfolded non-
fluorescent protein. Both analyses were performed using the same SDS-PAGE gel.  
 
 
Figure 2.1.8 shows the analysis of two ClC homologs from the same bacterium 
Ralstonia metallidurans, Rm1ClC and Rm2ClC. Already whole cell fluorescence 
experiments revealed substantial difference in expression levels between the two proteins, 
which is additionally confirmed by in-gel fluorescence. Since Rm1ClC was identified as 
one of the proteins with the highest overexpression potential, the quality control with anti 
His-tag Western blot analysis was of great importance. Only a negligible amount of 
aggregated fusion protein was detected even at the highest inducer concentration. These 
results make Rm1ClC very attractive for more detailed examinations.  
 
clone 
Ara 
Mb1ClC Mb2ClC RpClC RpClC SfClC TvClC LacS M 
2 4 4 2 3 4 2 2 4 4 
-2 -2 -2 -2 -3 -2 -2 -3 -2 -2 -2 -2 -3 
Mb1ClC Mb2ClC RpClC RpClC SfClC TvClC LacS M 
2 4 4 2 3 4 2 2 4 4 
-2 -2 -2 -2 -3 -2 -2 -3 -2 -2 -2 -2 -3 
In-gel GFP fluorescence Anti-His immunoblot 
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Figure 2.1.8. Analysis of the Ralstonia metallidurans ClC homologs by GFP folding assay. 
Rm1ClC and Rm2ClC were analyzed by in-gel fluorescence (left panel) and anti-His immunoblot (right 
panel). Two clones for each homolog were tested. Increasing arabinose concentration of 10-3, 10-2, 10-1 % 
(w/v) was used for induction (blue triangle). Green triangles indicate well folded fluorescent protein, whereas 
red triangles indicate misfolded non-fluorescent protein. Both analyses were performed with the same SDS-
PAGE gel. 
  
A few ClC homologs were classified as promising based on their whole cell 
fluorescence experiments, but did not show satisfying behavior in continuing assays. For 
example, although the HvClC homolog is expressed at high levels in the folded form, the 
amount of aggregated protein is also high (Figure 2.1.9). At all tested inducer 
concentrations, folded and misfolded protein are present in the similar amounts. This could 
indicate that the expression of HvClC does not overload the folding machinery of the cell, 
but rather that this membrane protein is lacking a specific factor from its natural 
environment.    
 
  
Figure 2.1.9. Analysis of the Haloferax volcanii ClC homolog by GFP folding assay. 
HvClC was analyzed by in-gel fluorescence (left panel) and anti-His immunoblot (right panel). Four 
independent colonies were tested for expression. Colony No. 2 shows a much higher expression level than 
the other three colonies for unknown reasons. Increasing arabinose concentration of 10-3, 10-2, 10-1 % (w/v) 
was used for induction (blue triangle). Green triangles indicate well folded fluorescent protein, whereas red 
triangles indicate misfolded non-fluorescent protein. Both analyses were performed using the same SDS-
PAGE gel. 
HvClC HvClC HvClC HvClC M 
1 2 3 4 
HvClC HvClC HvClC HvClC 
1 2 3 4 
Ara 
clone 
In-gel GFP fluorescence Anti-His immunoblot 
clone 
Ara 
In-gel GFP fluorescence Anti-His immunoblot 
Rm1ClC Rm1ClC Rm2ClC Rm2ClC M 
3 4 3 4 
Rm1ClC Rm1ClC Rm2ClC Rm2ClC M 
3 4 3 4 
75 kDa 
25 kDa 
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An interesting behavior was discovered for ScClC, where aggregated protein 
dominates at arabinose concentrations of 10-2 and 10-1 % (Figure 2.1.10). In the case of 
MmzClC homolog there is no correlation between the measured whole cell fluorescence 
values and the results of in-gel fluorescence. The reason for this observation might be 
membrane protein degradation after expression, which leaves the folded GFP moiety 
intact.  
 
             
 
Figure 2.1.10. Analysis of expression using GFP folding assay. 
MmzClC (represented with two clones) and ScClC (represented with three clones) were analyzed by in-gel 
fluorescence (left panel) and anti-His immunoblot (right panel). Arabinose concentration used for induction 
was 10-2 and 10-1 % (blue triangles). The upper fluorescent band in the marker corresponds to 75 kDa, the 
lower one to 25 kDa. Green triangles indicate well folded fluorescent protein, whereas red triangles indicate 
misfolded non-fluorescent protein. In the samples of MmzClC fluorescent degradation bands are noticeable. 
In the samples of ScClC the aggregated protein is expressed at high amounts. Both analyses were performed 
using the same SDS-PAGE gel. 
 
The extensive analysis of expression properties followed by quality control 
experiments have allowed for the classification of cloned prokaryotic ClC homologs and 
the selection of promising candidates for closer examination. Table 2.1.2 summarizes those 
results. Only one homolog, Rm1ClC, showed very high expression level, comparable with 
the expression level of EcClC that is overexpressed in its native host. Nine additional ClC 
proteins were selected for further characterization. Overall, the tendency for aggregation 
for this set of prokaryotic ClC proteins was low. Still, the optimal temperature and inducer 
concentration will have to be identified for each homolog.   
 Though it is interesting to correlate the microbial origin of the homolog with its 
expression behavior, it is difficult to draw conclusions. The homologs from thermophilic 
archaea and δ/ε proteobacteria (labeled blue in Table 2.1.2 and Figure 2.1B) generally 
express at low level and some of them show aggregation and degradation, combining in 
3 4 3 2 1 
MmzClC ScClC M 
3 4 3 2 1 
MmzClC ScClC M 
In-gel GFP fluorescence Anti-His immunoblot 
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that way many undesirable properties. From other four “phylogentic” groups at least two 
homologs showed satisfactory expression levels and were chosen for further studies.  
 
 
 
ClC homolog 
Expression level 
 
Whole cell GFP 
fluorescence 
Aggregation 
(upper) band  
 
Western blot 
Degradation 
bands 
In gel GFP 
fluorescence 
Selected for 
further 
examination 
AfClC very low - -  
MtClC low + +  
PtClC very low - -  
TvClC low + +  
MsClC low + +  
CmClC intermediate - +  
HyClC low - -  
MmClC intermediate + -  
HbClC intermediate - +  
DaClC very low - -  
PcClC intermediate - +  
SfClC low - -  
ClClC intermediate - - + 
CtClC intermediate - -  
PlClC high - + + 
PvClC high - - + 
MaClC intermediate - ++  
MmzClC high - ++ + 
Mb2ClC very low - -  
Mb1ClC intermediate - - + 
MbClC intermediate + - + 
HaClC low + -  
HvClC   high ++ - + 
ScClC high ++ - + 
Rm1ClC very high - - + 
Rm2ClC   low - -  
RpClC         intermediate - - + 
 
Table 2.1.2. Summary of expression screening of prokaryotic ClC homologs. 
The 27 ClC homologs are listed as in the phylogram obtained from a sequence alignment (Figure 2.1B/C). 
The expression levels determined by whole cell fluorescence measurements are shown. The presence of a 
prominent aggregation band on the Western blot is indicated as ++, moderate as + and no aggregation as - . 
Degradation bands visible on in-gel fluorescence are labeled as ++ when strong, + when moderate and – 
when absent. Homologs selected for further examination are indicated (+) 
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2.1.4 Extraction tests on selected membrane proteins  
 
For purification purposes, membrane proteins need to be solubilized. For this purpose, 
different types of detergents are used. The role of detergent is to keep the target protein in 
its functional, folded state in the absence of a membrane by mimicking the natural 
hydrophobic environment of the lipid bilayer (Prive 2007). The identification of a suited 
detergent for a particular membrane protein is a challenging step. Apart from being able to 
extract the protein from the membrane, the detergent must stabilize the protein in solution 
during the course of experiment. So far, the most successful detergents for the 
crystallization of membrane proteins have been nonionic detergents (mild detergents) 
including glucosides, maltosides, polyoxyethylenes and the zwitterionic amine oxides.  
 For initial extraction tests of ClC homologs from the membrane the mild detergent 
dodecyl-β-D-maltoside (DDM) was chosen. The experiments were performed on a small 
scale level from whole cell lysate without prior isolation of the membrane fraction. After 
expression of the protein, the cells were broken and the membrane proteins were 
solubilized by addition of 1 % DDM (w/v) and incubation for 1 h on ice. To remove the 
insoluble cell debris and aggregated (unsolubilized) membrane proteins, the samples were 
centrifuged at high velocity. The amount of extracted membrane proteins in the 
supernatant was subsequently compared with the total amount of expressed protein before 
centrifugation.  
 The expression of ClC proteins fused to GFP has been advantageous also in these 
analyses. The fusion proteins have been investigated by in-gel fluorescence and by 
measuring GFP fluorescence in solution. Both procedures allowed quantification of 
fluorescent material that can be extracted from the membrane.  
 Figure 2.1.11 illustrates extraction tests on four ClC homologs by in-gel 
fluorescence. For each homolog three samples were analyzed: total material before 
centrifugation (T), pellet - unsolubilized fraction after centrifugation (P) and supernatant -
solubilized fraction after centrifugation (S). It is evident from the gel (Figure 2.1.11A) that 
the proteins ClClC and RpClC can be almost completely extracted from the membrane, as 
the fluorescent band in the pelleted sample is minor. The amount of fluorescent protein in 
the pellet of PvClC is higher than in the previous two homologs. In the case of HvClC, the 
fluorescent protein in the solubilized fraction is almost unnoticeable, which might mean 
that the protein is either not extractable or it rapidly precipitates after extraction. This result 
is not so surprising when considering the behavior of HvClC in the previously performed 
quality control assays. Figure 2.1.11B shows the quantification of solubilized fraction for 
each fusion protein applying densitometric analysis of the fluorescent bands. 
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      A) 
                                       
        B) 
 
          
   
Figure 2.1.11. Extraction of ClC homologs from the membrane with dodecyl-β-D-maltoside (DDM). 
After expression and cell lysis, samples were incubated with 1 % DDM followed by high-spin centrifugation. 
Total material before centrifugation (T), pellet (P) and supernatant (S) after centrifugation were analyzed by 
in-gel fluorescence.  
A) SDS-PAGE gel with fluorescent fusion proteins. The proteins ClClC, PvClC and RpClC are 
extractable with DDM as the fluorescent band in the solubilized fraction has a strong intensity 
compared to the starting sample. HvClC is not extractable from the membrane as most of the fusion 
protein is found in the pelleted sample. 
B) Quantification of extractability by densitometric analysis of the fluorescent bands. ClClC and 
RpClC are almost completely extracted from the membrane with DDM. 
 
 
Out of ten ClC homologs selected for closer examination, after expression tests six 
were extractable with DDM at a satisfying level (minimum 50 %). For the remaining four 
homologs HvClC, MbClC, Mb1ClC and ScClC the amount of extractable protein was too 
low to pursue with further experiments that are part of the precrystallization screening. It is 
necessary to mention that a more thorough expression optimization could have been 
performed in order to express these proteins in an improved condition, which could have 
led to a better detergent extractability. However, I limited the more extensive 
investigations only to the six homologs that were extractable with DDM at the first place: 
ClClC, MmzClC, PlClC, PvClC, Rm1ClC and RpClC. 
 
 
 
 
 
 
 
 
 
ClClC PvClC HvClC RpClC M 
T S P T S P T S P T S P 
75 kDa 
25 kDa 
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2.1.5 Test purification of prokaryotic ClC homologs 
 
In the standard purification procedure of membrane proteins for crystallization, two 
purification steps after extraction from the membrane are commonly used. The first step is 
immobilized metal affinity chromatography (IMAC) followed by size exclusion 
chromatography (SEC).  
 IMAC is a separation technique that is based on the coordination between 
imidazole groups and metal ions. Recombinant proteins fused with a histidine tag (His6 or 
His10-tag) bind to immobilized divalent ions like Ni2+, Co2+, Fe2+ and Zn2+. In this way 
target protein can be retained on Me2+ chelating matrix and purified from mixture of 
proteins in the cell lysate or solubilized membrane fraction. 
 SEC separates proteins based on their size and shape and therefore enables 
separation from impurities with very different molecular weight from the target protein. 
Additionally and more importantly, SEC serves as one of the most useful tools for 
separating high molecular aggregates and monitoring the monodispersity, stability and 
oligomeric state of a target protein. A monodisperse and folded protein generally gives a 
single symmetrical peak, while a polydisperse, unstable or unfolded protein typically gives 
multiple asymmetric peaks (Barth, Boyes et al. 1994). A monodisperse size exclusion 
profile is a good indicator of a membrane protein that is of suitable quality for further 
biochemical and crystallization studies (Kawate and Gouaux 2006). Testing many protein 
constructs for monodispersity in the precrystallization screening is thus the most reliable 
criterion for the selection of promising candidates.  
 The six selected ClC homologs were tested for monodispersity in the following 
way: Each ClC protein-GFP fusion was expressed in 500 ml TB medium using the 
conditions determined in the expression screening. The cells were harvested and broken 
and the membrane fraction was isolated by high-spin centrifugation. The membrane 
proteins were extracted from the membrane with DDM and the unsolubilized fraction was 
pelleted by high-spin centrifugation. The supernatant after centrifugation was used for 
protein purification with IMAC. In this experiment Ni-NTA agarose (Qiagen) was used for 
batch binding of fusion proteins. The affinity matrix with immobilized protein was washed 
with buffer containing low concentration of imidazole to remove non-specifically bound 
proteins. Subsequently, the bound fusion protein was eluted from the resin with the higher 
imidazole concentration. After IMAC purification, the GFP fusion proteins were subjected 
to size exclusion chromatography on a Superdex 200 column (S200 GE Healthcare). The 
calibration of the column with known protein standards provides the relationship between 
protein molecular weight and the retention volume. In the case of membrane proteins that 
are surrounded by a detergent micelle, though, the apparent molecular weight is higher 
than expected because of the contribution of the detergent. 
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 Figure 2.1.12 shows size exclusion profiles for the homologs Rm1ClC, RpClC and 
ClClC on S200. The protein was detected by measuring its absorbance at 280 nm. The 
lower histograms show the measured fluorescence in the fractions eluted from the S200 
column.  
 
 
 
 
Figure 2.1.12. Size exclusion chromatography (SEC) of Rm1ClC, RpClC and ClClC in DDM. 
Purified GFP fusions of ClC homologs were analyzed by SEC on S200 column. The chromatograms present 
absorbance at 280 nm during the separation, the histograms present fluorescence values in each eluted 
fraction. The blue arrow is indicating the void volume (7 ml). For all three homologs the fluorescent proteins 
have elution volume that corresponds to well folded proteins. In the case of Rm1ClC and RpClC the elution 
peaks are monodisperse. In the case of ClClC, there are higher molecular aggregates at the void volume and 
the elution peak contains two populations with different oligomeric state.  
 
 
The elution profiles for all three homologs looked very encouraging. Rm1ClC-GFP 
shows a symmetric peak with an elution volume of 11.2 ml, which corresponds to a 
molecular weight of a dimeric protein. Based on the absorbance in the second fraction, it 
appears that there is a certain amount of aggregated protein that elutes at the void volume 
of the column, but as the fluorescence in that fraction is negligible, the absorbance is 
probably due to impurities.  
 RpClC-GFP elutes at 11.6 ml, corresponding to the approximate molecular weight 
of a dimer. The difference in the elution volumes between the Rm1ClC-GFP and RpClC-
GFP fusions, that have a similar molecular weight, might result from slight differences in 
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the shape of the two molecules. The elution peak of RpClC contains a second smaller peak 
at lower elution volumes (fraction four).  
 The size exclusion profile of ClClC indicates that the solubilized protein is not 
monodisperse. While the largest amount of the fluorescent protein is eluted at 12.2 ml, 
there is a second peak eluting at a lower volume, which indicates the presence of a higher 
oligomeric state. The two populations could represent the dimeric and a monomeric 
species of the protein, based on the estimate of the elution volumes. In addition, higher 
molecular aggregates of ClClC eluting at the void volume were found.   
 Figure 2.1.13 represents size exclusion profiles for the homologs MmzClC, PlClC 
and PvClC. It is apparent that none of the three proteins is monodisperse. High amounts of 
aggregated proteins eluting in the void volume and degradation products in the form of the 
free GFP were detected by following the absorbance at 280 nm and by measuring the 
fluorescence of the collected fractions. MmzClC shows a severe degradation that was 
already observed during expression studies by in gel fluorescence. The fluorescence values 
for this protein are very low comparing to the other tested homologs. It is possible that the 
fusion protein is degrading during purification leaving the soluble GFP intact, and causing 
the membrane protein to aggregate.  
 The similar behavior of PlClC and PvClC might be correlated with the microbial 
origin of these two proteins, which come from closely related bacteria (Figure 2.1.1B). The 
highest amounts of both proteins were found as high molecular aggregates. However, there 
is a small amount that elutes at 11.6 ml and 11.8 ml, respectively, that might correspond to 
properly folded protein. It is possible that additional expression optimization and the 
choice of a different detergent could improve the biochemical behavior of PlClC and 
PvClC, but those experiments have not been performed during the course of this project.  
 In summary, three ClC homologs (MmzClC, PlClC and PvClC) were characterized 
as polydisperse and not suitable for further biochemical and crystallization studies. The 
proteins ClClC and RpClC required additional examinations to be properly classified. The 
Rm1ClC homolog showed the most promising behavior in the performed test for 
monodispersity in detergent solution. 
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Figure 2.1.13. Size exclusion chromatography (SEC) of MmzClC, PlClC and PvClC in DDM. 
Purified GFP fusions of ClC homologs were analyzed by SEC on S200 column. The chromatograms present 
absorbance at 280 nm during the separation, the histograms present fluorescence values in each eluted 
fraction. The blue arrow is indicating the void volume (7 ml). All three homologs are polydisperse and their 
chromatograms show strong aggregation peaks. In the case of MmzClC the fluorescence due to degradation 
to free GFP is higher than from the fusion. In the case of PlClC and PvClC, most of the protein is in the 
aggregated state and elutes in the void volume.  
 
 
2.1.6 Further biochemical analyses of RpClC and ClClC 
 
After testing for monodispersity by size exclusion chromatography, three ClC homologs 
were selected as promising and subjected to more extensive examinations. In this chapter, 
follow-up experiments on RpClC and ClClC are presented.  
 The expression and purification of RpClC-GFP fusion was carried as described 
before, starting from the culture volume of 1 l. Following IMAC purification, the eluted 
and concentrated protein was injected onto a S200 column equilibrated with buffer 
containing DDM (Figure 2.1.14). Interestingly, the size exclusion profile is very similar to 
the one already observed (Figure 2.1.12A). A "shoulder" in the fourth fraction is preceding 
the main elution peak coming at the volume of 11.7 ml. The protein from the peak fraction 
(No. 5) was reinjected on S200 after 24 h incubation at 4ºC (Figure 2.1.12B). The elution 
profile is changed, indicating that RpClC is not stable under the applied conditions. Two 
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protein populations can be observed, one eluting at the volume corresponding to the 
"shoulder" in the first SEC (10.2 ml), a second one eluting at the volume of the main peak 
in the first SEC (11.7 ml). The height of the 10.2 ml peak suggests that the protein has a 
tendency to form higher oligomers over time.  
 
    A 
   
 
 
 
    B 
    
 
 
 
C 
 
 
 
Figure 2.1.14. Test purification of RpClC-GFP fusion in DDM. 
A) Size exclusion chromatography of RpClC-GFP fusion purified with IMAC. The protein elutes at 11.7 ml 
(S200 column). The elution peak is not symmetrical due to a shoulder in the fourth fraction. The blue arrow 
indicates the void volume (7 ml). 
B) Size exclusion profile of RpClC-GFP eluted in fraction 5 (A) after reinjection onto S200 after 24 h. The 
protein shows two peaks.   
C) SDS-PAGE analysis (top - in gel fluorescence, bottom - coomassie stained gel) of the SEC fractions 1-7 
from figure A. The sample labeled 3C presents RpClC-GFP fusion incubated for 3 h with 3C protease. The 
protease cleavage turned out not to be complete.  
 
 
For crystallization experiments the GFP-His10 part needs to be removed from the 
target protein. Therefore, RpClC-GFP fusion was digested by 3C protease, which cleaves 
at a specific site at the C-terminus of the membrane protein (Figure 2.1.12B, lane 3C). The 
3C protease is very efficient in cutting of the His-tag from both soluble and membrane 
proteins at different buffer compositions and temperatures. However, in the case of RpClC 
fusion, the cutting efficiency was very low. The reason for this might be the inaccessibility 
of the cleavage site for the protease due to a special folding of the protein. This finding 
together with the results from size exclusion chromatography suggested that RpClC was 
not suitable for crystallization.  
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  A   ClClC-GFP      DDM 
 
 B    ClClC-GFP     DM      
 
   C   ClClC       DM      
 
 
 
 
 
 
Figure 2.1.15. Test purifications of ClClC in DDM and DM. 
A) Size exclusion chromatography of ClClC-GFP fusion in DDM. The protein is polydisperse with two 
populations eluting at 11.5 ml and 12.2 ml (S200 column). The blue arrow indicates the void volume (7 ml). 
After reinjection of fractions 5 and 6 independently on S200, the dominating component has the lower 
elution volume corresponding to the higher molecular weight. 
B) Size exclusion profile of ClClC-GFP fusion in DM. The fluorescent fusion elutes at the volume of 12.6 
ml. The protein is not monodisperse, because of the presence of aggregated protein eluting at the void 
volume.   
C) Size exclusion profile of ClClC protein purified with IMAC and cleaved with the 3C protease to remove 
GFP-His10 part (top). The ClClC protein elutes at 13.1 ml. The SDS-PAGE (bottom) of SEC fractions shows 
that the highest amount of the protein is eluted in the peak fractions.  
 
 
 The ClClC-GFP fusion has shown a polydisperse distribution in the previous SEC 
analysis. Besides the presence of aggregated protein, the protein eluted at higher volumes 
also appeared to exist in different oligomeric states, most probably in a monomer dimer 
equilibrium. After reinjection of fractions containing one of the two species on a S200 
column, the fraction with the higher molecular weight was dominating (Figure 2.1.15A). In 
contrast to the elution in DDM, the size exclusion profile of ClClC-GFP in β-D-decyl-
maltoside (DM) looks different (Figure 2.1.15B). Besides a certain amount of aggregated 
protein, a peak at 12.6 ml (corresponding to the higher elution volume in DDM) appears to 
be monodisperse.  
 The cleavage of the GFP from the ClClC-GFP fusion protein after IMAC 
purification was successful and the cleaved membrane protein was analyzed by SEC in 
DM (Figure 2.1.15C). The elution profile is very similar to the profile of the fusion protein, 
except for a shift in the elution volume to 13.1 ml due to the lack of GFP moiety. This 
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elution volume probably corresponds to a monomeric protein, which is not the native 
dimeric state for ClC proteins. It is conceivable that the harsher detergent DM shifts the 
equilibrium towards the monomeric state, while in DDM both oligomeric states are 
coexisiting. More sophisticated techniques such as multi angle static light scattering or 
analytical ultracentrifugation are necessary to determine the oligomeric state of ClClC with 
certainty. It might also be possible to stabilize the dimer by different detergents or by the 
addition of lipids during purification and thus make the protein a more promising candidate 
for crystallization screening.  
       
 
2.1.7 Summary 
 
To identify promising candidates for structural analysis 27 prokaryotic homologs of ClC 
chloride channels and transporters were cloned as C-terminal GFP fusion proteins under 
the control of pBAD promoter. Expression tests were performed by whole cell 
fluorescence measurements. Additionally, a combination of in-gel fluorescence and 
Western blot analysis allowed to judge the quality of expressed proteins at an early stage. 
Based on the expression level, ten ClC homologs were selected for closer examination. In 
extraction tests with DDM, six proteins showed a satisfying behavior and were further 
analyzed by size exclusion chromatography. During this procedure, three proteins 
(MmzClC, PlClC and PvClC) showed severe aggregation, which made them unsuitable for 
crystallization screening. Two proteins, ClClC and RpClC, showed initially promising 
SEC profile, but closer examination revealed that they are not stable in a set of chosen 
detergents. Overall, only one protein, Rm1ClC, was identified as highly expressed, 
monodisperse and stable. The work on Rm1ClC is presented in the following chapters.  
 
 
2.1.8 Material and methods 
 
Preparation of genomic DNA (gDNA). The genomic DNA was isolated from the 
dried cell pellets using a GenEluteTM Bacterial Genomic DNA Kit (Sigma). Briefly, 
bacteria were lysed with lysozyme in a chaotropic salt-containing solution. Proteins were 
removed from DNA by digestion with proteinase K and incubation at 55ºC. DNA is bound 
to the silica-based membrane and the remaining lysate is removed by centrifugation. After 
washing to remove contaminants, the DNA is eluted with buffer into a collection tube.  
 
PCR. For amplification of ClC genes different polymerases were used to obtain a 
full set of amplified products. The reaction mixtures were adjusted according to the 
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accompanying manuals for Phusion polymerase (FINNZYMES), KOD polymerase 
(Novagen) and thermoprime Mastermix (ABgene). Reactions were supplemented with 20 - 
50 µg of genomic DNA, 25 µM forward and reverse primer and 3% DMSO. To avoid 
amplification of nonspecific sequence a touchdown PCR protocol was applied. The starting 
annealing temperature of 58.5 ºC was decreased in each of the first 15 cycles for 0.5 
degree. In the following 15 cycles the annealing temperature was kept constant at 50ºC. 
Denaturation and elongation temperatures were chosen according to the protocol of the 
polymerase. The PCR was finished by a final elongation step for 5 minutes at the optimal 
polymerase temperature. The PCR products were separated by agarose gel electrophoresis 
and the expected DNA bands excised and purified with High Pure PCR Product 
Purification Kit (Roche).  
 
Ligation. For ligation, the linearized plasmid was mixed with a digested insert at a 
molar ratio of 1:5, supplemented with reaction buffer and 400 U of T4 DNA ligase (NEB), 
adjusted to a final volume with water and incubated for 1 h at room temperature.  
 
Transformation of E. coli. 60 µl of chemically competent E. coli cells MC1061 
were thawed on ice and incubated for 20 minutes with DNA. A heat shock at 42ºC for 1 
min was followed by incubation on ice for another 5 min. After addition of 0.9 ml of LB 
medium, the cells were grown for 1 h at 37ºC. An aliquot of cell suspension was plated on 
LB agar plates supplemented with the appropriate antibiotic and incubated at 37ºC 
overnight until colonies became visible.  
 
Protein expression and whole cell fluorescence measurements. Expression of 
prokaryotic homologs was carried out in 96 well plates (2.2 ml deep, round bottom, 
Thermo Scientific) closed with gas permeable seals (Thermo Scientific). Precultures and 
expression cultures were grown in 0.7 ml medium. After transformation 4 colonies were 
picked for each construct and grown as precultures overnight at 37ºC in LB medium. For 
expression, the preculture was diluted 100 times with the TB medium (12 g peptone, 24 g 
tryptone, 4 ml glycerol, 2.31 g KH2PO4, 12.54 g K2HPO4 and 100 mg ampicilin per liter). 
The cultures were grown at 37ºC under vigorous shaking to an OD600=0.5, cooled down to 
25ºC and induced with the following arabinose concentrations: 10-4, 10-3, 10-2 and 10-1 % 
(w/v). After overnight expression, the plates with the cultures were centrifuged and the cell 
pellets resuspended in 100 µl of PBS buffer. 50 µl of cell suspension was transferred to 
black 96 well plates (Nunc)) and the whole cell fluorescence was recorded in a Tecan 
GENios Microplate Reader with the Magelan Software (λabsorption=485 nm, λemission=535 
nm). To correct for the different cell densities between cultures, the OD600 of 10 times 
diluted cultures were measured in MaxiSorp 96 well plates (Nunc). Specific fluorescence 
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was calculated by dividing the measured fluorescence value with the measured OD600 
value.  
 
In-gel GFP fluorescence detection and Western blot (from (Geertsma, 
Groeneveld et al. 2008)). Whole cell expression samples equivalent to ~ 1 mg of total 
protein were resuspended in 400 µl ice-cold lysis buffer (50 mM K-phosphate pH 7.2, 1 
mM MgSO4, 10 % (w/v) glycerol, 1 mM PMSF and 20 µg/ml DNase). After addition of 
glass beads (300 mg, 0.1 mm diameter), the samples were broken with a Fast prep device 
(Bio101) two times at 20 s at force position 6 interrupted by 5 min cooling step on ice 
between the runs. 20 µg of total protein samples, corresponding to 2 µg of total membrane 
protein, were analyzed by SDS-PAGE. In-gel fluorescence was visualized with an LAS-
3000 imaging system (Fujifilm) and analyzed with the AIDA software (Raytest). 
Immediately after fluorescence visualization, gels were submitted to semidry 
electroblotting. The standard transfer buffer contained additional 0.1 % SDS to ensure 
better transfer of membrane proteins. For immunodetection of His10-tagged proteins a 
mouse monoclonal anti His-tag antibody-HRP conjugate was used according to the 
manufacturer’s instructions (Roche).  
 
Isolation of membrane vesicles. Cells were harvested and lysed with an 
Emulsiflex C3 high pressure homogenizer (Avestin) in 50 mM K-phosphate pH 7.4, 150 
mM NaCl, 5 % glycerol with addition of 1 mg/ml lysozyme, 20 µg/ml DNase, 1µg/ml 
leupeptin, 1 µg/ml pepstatin and 1 mM phenylmethyl sulphonil fluoride (PMSF) with at 
least two passages at 700 bar. The lysate was cleared by low-spin centrifugation (30 min, 
11,000 x g, +4ºC). The membranes were pelleted from the supernatant by high-spin 
centrifugation (1.5 h, 100,000 x g, +4ºC), flash frozen in liquid nitrogen and stored at -
80ºC. 
 
Extraction of membrane proteins from the membrane. For the small scale 
extraction tests, membrane proteins were extracted from the cell lysate. The samples were 
prepared as described for in-gel fluorescence experiments. After lysis, aliquots of 100 µl 
were solubilized for 1 h at 4ºC in the presence of 1 % DDM (w/v). For analysis, a small 
aliquot (20 µl) was taken before ultracentrifugation, the remaining sample was centrifuged 
at 335,000 x g for 15 min at 4ºC in a TLA 100.1 rotor. The pellet after centrifugation was 
resuspended in 5 M urea. Three samples: total protein, pellet and supernatant after 
centrifugation were separated by SDS-PAGE and analyzed by in-gel fluorescence and 
Western blot.  
 Extraction of membrane proteins from previously isolated membrane vesicles was 
carried out by mixing 10 ml of solubilization buffer (50 mM K-phosphate pH 7.4, 150 mM 
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NaCl, 5 % glycerol, 1 % DDM (w/v)) with membranes (10 ml buffer per 1g of 
membranes). The suspension was incubated for 1.5 h with gentle stirring at 4ºC. To 
remove unsolubilized membrane fractions, the sample was centrifuged at 100,000 x g for 
30 min at + 4ºC in Ti70 or Ti80 rotor (Beckman). 
 
Purification of prokaryotic ClC proteins. The supernatant after 
ultracentrifugation was incubated in batch with equilibrated Ni-NTA agarose (Qiagen) for 
1 h. The resin was transferred to a column and washed with 50 mM K-phosphate pH 7.4, 
150 mM NaCl, 5 % glycerol, 0.04 % DDM (buffer A) until OD280 baseline was reached. 
To remove nonspecifically bound proteins the resin was washed with buffer A 
supplemented with 50 mM imidazole. The protein was eluted with buffer A containing 300 
mM imidazole. For cleaving of the His-tag HRV 3C protease (GE Healthcare) was added 
at the ratio 1 mg of protease for 10 mg of protein. After 1-2 h incubation the protein 
solution was concentrated to less than 500 µl with an Amicon Ultra Centrifugal filter 
device (MWCO = 50 kDa, Milipore). The concentrated protein was injected onto a gel 
filtration column (Superdex 200 10/300 GL, Äkta Prime system, GE Healthcare) 
equilibrated with running buffer (10 mM K-phosphate, 150 mM NaCl, 0.04 % DDM). Size 
exclusion profile was recorded as absorption at 280 nm. All steps were carried out at 4ºC. 
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2.2 Rm1ClC - a ClC homolog from Ralstonia metallidurans 
 
2.2.1 Biochemical characterization of Rm1ClC full length protein  
 
In the expression and biochemical screening of prokaryotic ClC proteins, the homolog 
from the bacterium Ralstonia metallidurans, Rm1ClC, showed the most promising 
behavior. This protein was expressed at high level ~ 2 mg of protein per liter of culture, 
which is a satisfying amount for getting enough protein for crystallization trials. Besides 
the high expression it was nearly completely solubilized upon addition of DDM and DM. 
Size exclusion profiles in DDM and DM confirmed its monodispersity and long-term 
stability in detergent solution.   
 All tests for precrystallization screening were performed on a small scale with 
membrane protein–GFP fusion, where GFP fluorescence had many advantages for the 
detection of the protein. However, for large scale expression, purification and 
crystallization the presence of C-terminal GFP is not necessarily beneficial, since the GFP 
part needs to be cleaved from the membrane protein by limited proteolysis and one more 
IMAC purification step is required to remove the GFP-His tag part. Therefore, Rm1ClC 
was cloned into the pBXC3H vector resulting in a C-terminal fusion with a 3C cleavage 
site and a His10 tag (Figure 2.1.3). The expression level and biochemical behavior of the 
Rm1ClC-His construct were similar to the Rm1ClC-GFP fusion. 
 
 
2.2.1.1 Large scale expression and purification of Rm1ClC for crystallization 
 
In order to obtain enough protein for crystallization trials, Rm1ClC was expressed and 
purified on a large scale (10 l culture in TB medium). Protein expression was induced with 
10-3 % arabinose at 25°C overnight. Protein purification was performed as described in the 
Material and methods chapter. Briefly, Rm1ClC was extracted from the membrane vesicles 
by DDM or DM and then purified by IMAC. The initial purifications were carried out by 
using Ni-NTA agarose (Qiagen) as the affinity matrix. Subsequent use of TALON affinity 
resin (Clontech) proved to be advantageous, because the eluted protein was of higher 
purity, due to the less non-specific binding to the Co2+ chelating resin. 
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Figure 2.2.1. SDS-PAGE analysis of 
Rm1ClC IMAC purification. 
After batch binding to TALON affinity resin, 
a wash with low imidazole concentration was 
performed followed by elution of the protein 
with 300 mM imidazole. The non-specifically 
bound proteins elute with 20 mM imidazole, 
while Rm1ClC is still bound to the resin. In 
the elution fraction Rm1ClC is the major 
protein band (black arrow), but the minor 
impurities are still present.  
 
 
 
After elution from the affinity resin, the His10-tag was removed by digestion with 
3C protease. The protein was concentrated and subjected to size exclusion chromatography 
on a S200 column. Different maltosides were used to assess stability of Rm1ClC and 
subsequently perform crystallization trials in these detergents. Rm1ClC proved to be stable 
in all four tested detergents: β-D-dodecyl-maltoside (DDM), β-D-decyl-maltoside (DM), β-
D-nonyl-maltoside (NM) and β-D-octyl-maltoside (OM). The protein was eluting at a 
volume corresponding to a dimer, it was monodisperse and stable after 24 h as confirmed 
by gel filtration (data not shown). Figure 2.2.2 displays the elution profiles of Rm1ClC in 
DDM, DM and OM. The corresponding SDS-PAGE analysis of eluted fractions confirms 
that the highest amount of the protein was eluted in the peak fractions.  
 
 
      DDM      DM 
 
 
  OM 
 
 
 
 
Figure 2.2.2. Rm1ClC purification in different maltoside detergents. 
Rm1ClC was purified by IMAC and after His-tag removal with the 3C protease additionally purified by size 
exclusion chromatography on a S200 column. Chromatograms of purifications in DDM, DM and OM are 
presented together with the corresponding analysis of the fractions by SDS-PAGE. The elution volume in all 
three detergents suggests a dimer of Rm1ClC protein. The blue arrow indicates the void volume (7 ml). 
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2.2.1.2 Crystallization of Rm1ClC  
 
Rm1ClC was broadly screened for crystallization in the four maltoside detergents DDM, 
DM, NM and OM and at two different temperatures (4°C and 20°C). Unfortunately, the 
crystallization screening did not provide any promising results. Precipitation of the protein 
in the crystallization drops was not observed even at the high precipitant concentrations, 
which might suggest that the protein is stable under many investigated conditions, but fails 
to crystallize.  
 
 
2.2.2 Expression and crystallization of the Rm1ClC transmembrane domain 
 
While Rm1ClC showed a very promising biochemical behavior, it failed to crystallize. 
Although the ultimate goal of the project was the structure determination of a full length 
ClC protein containing the transmembrane and cytoplasmic domains, I continued with the 
expression of the two isolated domains independently to overcome the crystallization 
bottleneck. This strategy would allow to determine the structures of the isolated 
components in case a flexible linker connecting the two domains prevented crystallization 
of the full length Rm1ClC. The structural information on the isolated domains would still 
be very useful for the design of biochemical and functional experiments.   
 The transmembrane domain of Rm1ClC (Rm1ClC_TM) contains some very 
interesting features (Figure 2.2.3A): The sequence identity between EcClC and 
Rm1ClC_TM is 24 % with a sequence similarity of 49 %. The residues building the ion 
selectivity filter are conserved, except for the serine residue (S107 in EcClC) that 
coordinates a chloride ion in the central binding site. The N-terminus of Rm1ClC is 19 
residues shorter than that of EcClC, leading to a severe truncation or even absence of the A 
helix preceding the first transmembrane helix. Some loops connecting transmembrane 
helices are shorter than those found in EcClC, like the ones between helices D and E, and 
N and O. The loop between helices F and G is, in contrast, three residues longer. Overall, 
the transmembrane domain of Rm1ClC appears to be very compact and consequently 
promising for crystallization.   
 Structural information on EcClC and several ClC cytoplasmic domains enabled the 
straightforward design of transmembrane domain constructs. In the designed constructs the 
length of the N- and C-terminus was varied. With respect to the C-terminus, five constructs 
were generated ending at different positions in the putative R helix and in the linker region 
between the transmembrane and the cytoplasmic domain (Figure 2.2.3C). The N-terminus 
of Rm1ClC was truncated by 4, 8 and 12 residues, with the shortest construct starting at the 
first transmembrane helix B (Figure 2.2.3B).  
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Figure 2.2.3. Sequence alignment between EcClC and Rm1ClC and design of Rm1ClC transmembrane 
domain constructs. 
(A) Sequence alignment between EcClC and Rm1ClC generated in ClustalW. The residues building the 
helices in EcClC are marked yellow and the helices are labeled from A to R. The identical residues are 
labeled with "*", the similar ones with ":". The N-terminus of Rm1ClC is significantly shorter than the one in 
EcClC. The long C-terminal part in Rm1ClC is a cytoplasmic CBS domain. (B) The truncations of N- and C-
termini of Rm1ClC were based on the sequence alignment and the known structure of EcClC. At the N-
terminus, 3 truncations lead to 4, 8 and 12 aa residues shorter proteins. The N-12 construct starts at the first 
putative transmembrane helix (marked green). (C) At the C-terminus, five truncations were constructed. Two 
of them (418 and 424) terminate within the R helix (marked green). Construct 430 ends at the last amino acid 
belonging to the R helix of EcClC. Construct 437 ends at the position equivalent to the EcClC construct used 
for crystallization. Construct 445 ends at the position corresponding to the native C-terminus of EcClC. Red 
arrows indicate the sites of tryptic digestion experimentally determined by a combination of limited 
proteolysis on Rm1ClC and mass spectrometry.  
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The goal of the design of constructs with different length was to identify the ones 
that give the highest crystal and diffraction quality. Since long and floppy termini can 
inhibit crystallization or influence crystal packing, it is generally helpful to find a minimal 
stable construct for crystallization that leads to improved diffraction.  
 
 
2.2.2.1 Cloning and expression of Rm1ClC transmembrane domain constructs 
 
For cloning of Rm1ClC transmembrane domain constructs FX cloning was applied. DNA 
fragments were cloned into the pBXC3GH vector to generate Rm1ClC_TM–GFP fusions. 
Test expression and quality control were investigated as described for previously cloned 
ClC homologs.  
 All truncated constructs were expressed at a similar or even higher level compared 
to the full length protein. Interestingly, when trying to express the transmembrane domain 
only as a His10 tagged protein (pBXC3H vector), the expression was almost undetectable 
by Western blot. For this reason, Rm1ClC_TM-GFP fusions were subsequently used for 
large scale expression and purification.  
 The quality control assay of overexpressed transmembrane domain constructs 
showed no presence of aggregated protein at all investigated inducer concentrations. All 
constructs were completely extractable with decyl-maltoside and monodisperse in size 
exclusion chromatography as illustrated in the SEC profile of the Rm1ClC transmembrane 
domain construct 445 (Rm1ClC_TM445) in Figure 2.2.4.  
  
 
                     A 
                                 
B 
 
 
Figure 2.2.4. Size exclusion chromatography of Rm1ClC_TM445-GFP fusion.  
Purified GFP fusion of Rm1ClC_TM445 was analyzed by SEC on a S200 column. The chromatogram (A) 
shows the absorbance at 280 nm during the run, the histogram (B) presents fluorescence values in each eluted 
fraction. The blue arrow is indicating the void volume (7 ml). The chromatogram shows a symmetric peak at 
11.9 ml, the volume corresponds to a well folded protein at the approximate size of a dimer. The fluorescence 
measurement confirms the monodispersity of Rm1ClC_TM445-GFP fusion. 
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2.2.2.2 Large scale expression and purification of Rm1ClC_TM constructs 
 
Large scale expression of the Rm1ClC transmembrane domain – GFP fusion was 
performed in the same way as described for the expression of the full-length protein. 
Bacteria were grown in 10 l cultures in TB medium and protein expression was induced 
with 10-3 % arabinose at 25°C overnight.  
 Protein purification was performed as described in the Material and methods 
chapter. Briefly, Rm1ClC_TM-GFP fusions were extracted from isolated membrane 
vesicles by DM and then purified by IMAC (Figure 2.2.5). TALON affinity resin 
(Clontech) was used in all experiments since it has been previously observed to be more 
efficient in yielding pure protein after elution.  
 
 
 
Figure 2.2.5. SDS-PAGE analysis of the Rm1ClC 
transmembrane domain purification. 
The Rm1ClC_TM430-GFP fusion was extracted in DM and 
purified with TALON affinity resin. After batch binding, the resin 
was washed with low imidazole concentrations to remove non-
specifically bound proteins (sample 1 – 0 mM, sample 2 – 20 mM 
imidazole) and the fusion protein was eluted with 300 mM 
imidazole (sample 3). To remove the GFP-His10 part, the protein 
was cleaved with the 3C protease for 1 h (samples 4 and 5). The 
GFP-His10 was subsequently separated from the Rm1ClC 
transmembrane domain by binding to Ni-NTA agarose (sample 6). 
Black triangle – Rm1ClC_TM430-GFP fusion; Red triangle – 
Rm1ClC_TM430; Green triangle – GFP-His10.  
 
 
 To cleave off the GFP-His10 part from the Rm1ClC transmembrane domain, the 
protein was digested with 3C protease followed by an additional IMAC purification in 
order to remove GFP-His10 and to obtain pure Rm1ClC transmembrane domain. Apart 
from GFP-His10, this step also removes some impurities, which were co-purified on the 
first metal affinity column. 
Size exclusion chromatography was used as an additional purification step and to 
investigate the homogeneity and stability of Rm1ClC_TM in different maltoside 
detergents. The Rm1ClC transmembrane domain was stable in all tested detergents: β-D-
decyl-maltoside (DM), β-D-nonyl-maltoside (NM) and β-D-octyl-maltoside (OM). The 
protein was eluting at the expected elution volume for a dimer, was monodisperse and 
stable after 24 h reinjection (data not shown). Figure 2.2.6 illustrates the elution profiles of 
Rm1ClC_TM430 in DM, NM and OM. The SDS-PAGE analysis after purification in DM 
confirms that the highest amount of the protein was eluted in the peak fractions. The eluted 
protein was also pure enough for crystallization.  
 
1     2     3     4     5     6     M 
50 kDa 
37 kDa 
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Figure 2.2.4 Size exclusion chromatography of 
Rm1ClC transmembrane domain in different 
maltoside detergents. 
After IMAC purification in DM and removal of GFP-
His10, the Rm1ClC_TM430 was purified by size exclusion 
chromatography on a S200 column equilibrated with 
different detergents (A – decyl-maltoside, DM; B – nonyl-
maltoside, NM; C – octyl-maltoside, OM). The exclusion 
profile in all three detergents indicates a monodisperse 
protein with the expected elution volume for a dimer (12.6 
ml). The blue arrow indicates the void volume (7 ml). The 
SDS-PAGE analysis of the fractions from SEC in DM (D) 
shows that the Rm1ClC transmembrane domain is mostly 
found as pure protein in the main elution peak. Fractions 
6, 7 and 8 were pooled and subsequently used for 
crystallization.  
 
 
2.2.2.3 Crystallization of Rm1ClC_TM constructs 
 
Rm1ClC_TM constructs were broadly screened for crystallization in three maltoside 
detergents (OM, NM and DM) and at two different temperatures (4°C and 20°C). The first 
trials, which were set up with the protein construct 430 in DM, showed crystals under 
many conditions at 4°C with PEG400 as precipitant. Refined screening for this and other 
constructs gave similar results with respect to the crystallization conditions. The change of 
detergent from DM to OM led to a narrowing of the crystallization conditions with respect 
to salt type and pH range. At this stage, the diffraction quality of different crystal forms 
was assayed. Table 2.2.1 summarizes crystallized Rm1ClC_TM constructs, their 
crystallization condition and X-ray diffraction properties.  
 The crystallization of six different Rm1ClC_TM constructs allowed to obtain 
crystals growing under similar conditions, most of which showed low resolution 
diffraction, extending in the best cases to resolution of 6 to 7 Å. 
 M       1      2       3      4       5       6       7       8        9      10    11 
37 kDa 
50 kDa 
12.8 ml 
12.8 ml 
 
12.6 ml 
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Crystallized Rm1ClC_TM 
construct 
Detergent Crystallization condition Diffraction properties Unit cell parameters 
(space group, unit cell axis in Å, unit 
cell angles different than 90°) 
418 NM 15 % PEG400, 0.5 M KCl, pH 6.5 Max to 6 Å P21 
82.1     202     87.4       β=104° 
424K_3C  
DM 
 
25% PEG400, 0.5M KCl, pH 5.5 
Anisotropic diffraction  
6 Å good direction 
7.5 Å bad direction 
 
P21 
87  208    87                 β =103° 
 NM 25% PEG400, 0.5M KCl, pH 8.4 Max to 7 Å  
 OM 25% PEG400, 0.5M KCl, pH 8.4 Max to 7 Å  
424K_LysC  
DM 
 
25% PEG400, 0.5M KCl, pH 5.5 
Anisotropic diffraction  
4.5 Å good direction 
6.5 Å bad direction 
 
P21 
84.94   207.1    87.25   β =103.2° 
 NM 25% PEG400, 0.5M KCl, pH 8.4 Max to 9 Å  
 OM 25% PEG400, 0.5M KCl (KBr or NaBr)  
pH 8.4 
Max to 9 Å  
430 DM 15-25% PEG 400, various salts 
broad pH range 
Max to 6.5 Å P2  
92.3   143.7  122.1        β = 99.8° 
 NM 24 % PEG400, 0.1 M Na,K-tartrate, pH 5.5 
20 % PEG400, 1 M NaCl, pH 8.4 
Max to 7.5 Å 
 
 OM 25% PEG 400, 0.5 M KCl, pH 9.4 Max to 7.5 Å 
 
437 DM 15-25% PEG 400, 0.5 M KCl 
pH 5.5, 6.5, 7.4 
Max to 7.6 Å 
 
P2 
119.3    110.8   125.2     β=104°  
N-8_424K_LyS DM 25 % PEG400, various salts 
pH 7.4, 8.4, 9.4 
Max to 8 Å  
 
Table 2.2.1. Summary of crystallized Rm1ClC transmembrane domain constructs. 
Six different RM1ClC_TM constructs were crystallized in three different detergents at 4ºC. The crystallization conditions for the best crystals for each construct are given. 
The precipitant in all crystallization condition was PEG400. The pH for crystallization varied from 4.5 to 9.5. Different salts in the reservoir solution contributed to crystal 
formation, but 0.5 M KCl was the most preferable one. All crystals diffracted to low resolution, in most of the cases to around 7 Å. The crystals of the construct 424K_LysC 
had the most promising diffraction properties. Although the diffraction was anisotropic, it reached in one direction resolution of 4.5 Å. For some of the crystals the full data 
sets were collected. The data was processed; the unit cell parameters are presented in the table. All analyzed crystals belong to a primitive monoclinic space group, with some 
difference in unit cell constants.  
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For some crystals data collection and crystallographic characterization were performed. All 
analyzed crystals were of primitive monoclinic space group (P2 or P21), but had different 
unit cell parameters and Matthews coefficients depending on the construct.  
The length of the N- and C-termini in different constructs did not play a very 
significant role for crystal quality (except in one case, see later), as for all tested constructs 
crystals diffracting to 7 Å were identified under certain crystallization conditions (Figure 
2.2.8A). Surprisingly, strong dependence of the diffraction quality on the detergent used 
for crystallization was also not observed. In crystallization of membrane proteins, the 
length of the hydrophobic chain of the detergent often plays a very important role for 
crystal quality. The optimal chain length depends on the membrane protein structure and 
has to be determined experimentally. Detergents with short acyl-chain are often favorable, 
since they cover less protein surface and therefore leave more places for crystal contacts. 
Many structures of membrane proteins were successfully determined by using octyl-
maltoside and octyl-glucoside for crystallization. Unfortunately, crystallization of 
Rm1ClC_TM in octyl-maltoside did not improve diffraction properties compared to its 
crystallization in decyl-maltoside. The transmembrane domain of Rm1ClC was previously 
described as being compact and thus promising for crystallization. However, this very 
compact architecture could also be disadvantageous particularly when hydrophilic loops 
between the transmembrane helices are too short to make well defined crystal contacts, 
which might be the case in Rm1ClC_TM.  
 The best diffraction was obtained with the construct 424K_LysC crystallized in 5 
mM DM, 25 % PEG400, 0.5 M KCl, pH 5.5. Other transmembrane domain constructs 
gave crystals under this or similar conditions of lower quality. Therefore, it was assumed 
that the length of the C-terminus in the 424K_LysC construct plays a central role for 
crystal packing. In this construct a lysine residue was introduced after the amino acid 424 
and before the recognition site for the 3C protease (Figure 2.2.7). In that way, it was 
possible to remove the residues of the 3C recognition site by digestion with the protease 
LysC, which cleaves after lysine residue. The complete digestion was also detectable on 
SDS-PAGE and later confirmed by mass spectrometry.  
 
 
 
Figure 2.2.7. Schematic representation of Rm1ClC transmembrane domain 424K_LysC construct. 
After the amino acid residue 424 and before the recognition site for the 3C protease (blue) a lysine residue is 
introduced by cloning (red). Following GFP-His10 removal by digestion with the 3C protease, digestion with 
LysC removed the remaining residues of the 3C recognition site. 
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The crystals of Rm1ClC_TM construct 424K_LysC diffracted anisotropically to different 
resolutions in different regions of reciprocal space. In the direction of poor diffraction the 
crystal diffracted to about 6.5 Ǻ, and in the direction of good diffraction to 4.5 Ǻ resolution 
(Figure 2.2.8B). Anisotropic diffraction usually occurs if the crystal packing is more 
ordered in one direction than in others. Frequently, the directional dependence coincides 
with the reciprocal cell axes a*, b*, and c*.  
   
A                                                                        B 
   
 
Figure 2.2.8. Diffraction images of Rm1ClC_TM crystals. 
A) Crystal of the construct 430 grown in 26 % PEG400, 0.15 M NaCl, pH 6.5 and OM detergent. Resolution 
rings are indicated. The crystal diffracted isotropically to 7.5 Ǻ. Many crystals from other TM constructs and 
crystallization conditions behaved in a similar way. 
B) Crystal of the construct 424K_LysC in 25 % PEG400, 0.5 M KCl, pH 5.5 and DM. The crystal diffracted 
anisotropically. In one direction the diffraction was observed to ~ 6.5 Ǻ, and in the other direction to ~ 4.5 Ǻ 
resolution. The diffraction image is from the dataset which was used for molecular replacement.  
 
 
The 424K_LysC data was processed. The crystal belongs to the space group P21 
with the following cell parameters: a = 84.94 Ǻ,   b = 207.1 Ǻ, c = 87.25 Ǻ, β =103.2°. The 
number of molecules in the asymmetric unit (AU) was estimated by calculating the 
Matthews coefficient (Matthews 1968), suggesting 4 molecules per AU and a solvent 
content of 72 % (Table 2.2.2).  
 
        
N molecules/AU Matthews Coeff % solvent 
 
 1 17.74 93.07 
2 8.87 86.14 
3 5.91 79.21 
4 4.43 72.28 
5 3.55 65.35 
6 2.96 58.42 
7 2.53 51.48 
8 2.22 44.55 
9 1.97 37.62 
10 1.77 30.69 
    
Table 2.2.2. Calculation of Matthews Probabilities 
and Solvent Content of 424K_LysC crystal. 
The Matthews coefficient and solvent content were 
calculated from the unit cell parameters and the 
molecular weight of the molecule in the unit cell 
(43881 Da) with the CCP4 program 
MATTEWS_COEF. The number of molecules in the 
AU with the corresponding Matthews coefficient and 
solvent content is presented. Four molecules in the 
AU would give a solvent content of 72%, which is in 
the expected range for membrane protein crystals.  
4.79 Ǻ 3.88 Ǻ 
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As expected, the completeness of the data was influenced by anisotropic diffraction 
being 95 % complete only to a resolution of 6 Ǻ. Table 2.2.3 illustrates data statistics after 
scaling.   
 
Resolution limit Redundancy Completeness (%) Rmerged (%) I/σ 
10.0 5.6 86.0 2.4 61.31      
8.0 6.6 99.4 3.2 48.64      
7.0 7 98.6 5.5 30.31      
6.0 6.5 95.6 15.0 12.98     
5.5 6.5 90.5 30.7 7.19     
5.0 6.1 87.4 38.5 5.91     
4.8 5.8 81.3 45.9 5.07     
4.6 5.5 79.3 57.0 4.20     
4.4 5.4 75.0 65.7 3.81     
4.2 5 69.9 112.9 2.25    
total 5.9 85.5 7.1 16.06      
 
Table 2.2.3. Statistics for the data from 424K_LysC crystal after scaling in XSCALE. 
 
 
2.2.2.4 Molecular replacement 
 
The dataset obtained from the crystal of the 424K_LysC construct was of sufficient quality 
for molecular replacement with the program Phaser. As search model the EcClC structure, 
encompassing residues 20-451, was used. Whereas an initial trial with the EcClC dimer as 
search model failed, another search with a single EcClC subunit as search model was 
successful. When searching with a single subunit, three out of four predicted copies in the 
asymmetric unit were identified. Two of them had a similar dimeric arrangement as 
observed in the EcClC structure. A careful analysis by superposition showed that the 
relationship between the monomers in the molecular replacement solution does not obey a 
perfect two fold symmetry as in EcClC but it is not clear whether this is due to the limited 
resolution of the data (Figure 2.2.10A). Potentially this is the reason why the molecular 
replacement with EcClC dimer as search model was unsuccessful. In a subsequent search 
the dimer identified in the first run was used as search model. After increasing the 
tolerance for clashes in the packing from 10 to 25, the second dimer was found. Two 
dimers interact via the intracellular side of the protein where also the overlaps between the 
two models were observed (Figure 2.2.10B). After removal of four residues from the N-
terminus and two residues in the loop between the H and I helices from the search model, a 
final search with the truncated model gave a strong solution with very good parameters 
(translation function Z-score (TFZ) of 18 and the refined log-likelihood gain (LLG) of 
394)  indicating a correct packing of the model The validity of the molecular replacement 
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solution was further examined by comparing self rotation functions calculated from the 
experimental data with the calculated rotation function from the obtained solution (Figure 
2.2.9). The projections of κ=180º sections look very similar indicating that the obtained 
molecular replacement solution is most probably correct.  
             A 
         
    B 
 
Figure 2.2.9. Self rotation functions for the experimental data of 424K_LysC crystal (A) and the 
molecular replacement solution (B). Shown is the kappa section at 180º.  
A 
 
 
B         
 
Figure 2.2.10. Molecular replacement solution from 424K_LysC construct. 
(A) Superposition of EcClC dimer with the dimer found in the crystal of 424K_LysC construct by molecular 
replacement. The chain A of one dimer is superimposed on chain B of the other dimer (Secondary-structure 
matching (SSM) in Coot). The subunits in the dimer obtained by molecular replacement (violet and green) 
are not related by a perfect 2 fold. (B) Arrangement of four molecules in the asymmetric unit of 424K_LysC 
crystal. The interaction between two dimers is formed with the intracellular loops.  
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The crystal packing of the molecular replacement solution revealed some interesting 
features (Figure 2.2.11). The crystal contacts in the direction of the three cell axes were not 
of the same extent. The strongest contacts are observed parallel to the x axis, where the 
interaction between the dimers in the asymmetric unit is also formed. In orientations 
parallel to y and z axes no direct contacts between the molecules are observed suggesting 
detergent mediated crystal contacts. The unequal crystal packing interactions might be the 
reason for the anisotropic diffraction of the crystal. Based on this observation it would be 
expected that the diffraction quality could be improved by crystallization in detergents with 
shorter aliphatic chains or by applying post-crystallization treatments like for example 
dehydration.  
 A   
    
B 
      
 
Figure 2.2.11. Crystal packing in the molecular replacement solution of the 424K_LysC construct. 
(A) A view along x axis. The crystal contacts between the asymmetric units are made by the extracellular 
loops 
(B) A view along z axis. The molecules are separated by large gaps, suggesting detergent mediated crystal 
contacts.  
 
 
2.2.2.5 Summary 
 
Although the biochemical properties of the Rm1ClC full length protein make the protein a 
promising candidate for structure determination, no crystallization was identified, despite 
the broad screening of conditions. In order to improve the chances for crystallization, the 
transmembrane domain of Rm1ClC was expressed independently. While the isolated 
transmembrane domain showed similar biochemical behavior and stability as the full 
length protein, it readily crystallized. Unfortunately, the crystals were not of sufficient 
quality for structure determination of Rm1ClC, a feature that is frequently observed for 
membrane proteins. To overcome this bottleneck in membrane protein crystallography the 
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production of monoclonal antibodies against Rm1ClC was launched and specific binders 
for future co-crystallization experiments were selected (Appendix 4.1).  
 
 
2.2.2.6 Material and methods 
 
Large scale expression and purification of the Rm1ClC full length protein and 
the transmembrane domain. For large scale expression 2 l baffled shake flasks were 
filled with 600 ml TB medium supplemented with 100 µg/ml ampicilin. Usually 9.6 l 
culture was used for production of the protein for crystallization, resulting in a yield of 
about 3 mg of purified protein. Cells were grown at 37ºC until an OD600 of 0.6 and 
subsequently cooled to 25ºC. Protein expression was induced with 0.001 % arabinose for 
14 - 15 hours at 25ºC. 
 Cells were harvested by centrifugation at 4000 rpm (rotor Sorvall H6000A) for 20 
min at 4ºC. The cell pellet was resuspended in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 
% glycerol (buffer B) with the addition of 1 mg/ml lysozyme, 20 µg/ml DNase, 1µg/ml 
leupeptin, 1 µg/ml pepstatin and 1 mM PMSF. The cells were lysed with an Emulsiflex C3 
high pressure homogenizer (Avestin) with at least two passages at 700 bar. The lysate was 
cleared by low-spin centrifugation at 11,500 × g for 40 min at 4ºC. Membranes were 
isolated by ultracentrifugation at 45,000 rpm for 1.5 h at 4ºC (Ti70 rotor, Beckman). For 
storage, membranes were homogenized in buffer B in 1/10 of the extraction volume, flash 
frozen in liquid nitrogen and stored at -80ºC. 
 All purification steps were carried out at 4ºC. Membranes were resuspended in 
buffer B (10 ml buffer/1 g membrane) and solubilized by addition of detergent (1 % for 
DDM, 1.25 % for DM) for 1.5 h. The unsolubilized membrane fraction was removed by 
centrifugation at 45,000 rpm for 30 min at 4ºC (Ti70 rotor, Beckman). The supernatant was 
supplemented with 3 mM imidazole to reduce nonspecific binding to the metal affinity 
resin.  
 The protein was purified by IMAC using TALON affinity resin (Clontech). All 
buffers used for purification contained detergent - 0.8 mM DDM or 5 mM DM. 10 ml of 
equilibrated resin was used for batch binding for 1h. Afterwards, the resin was transferred 
to a column and washed with the buffer B until baseline of OD280 was reached. To remove 
nonspecifically bound proteins the resin was washed with the buffer B supplemented with 
20 mM imidazole. The protein was eluted with the buffer B containing 300 mM imidazole. 
 To cleave off the His10-tag or remove the GFP-His10 part, the protein was digested 
for 2 h with HRV 3C protease (GE Healthcare) at a ratio of 1 mg of protease for 10 mg of 
fusion protein. During the digestion of Rm1ClC-TM-GFP fusions, the solution was 
dialyzed against buffer B containing detergent at a concentration of 1.2 × CMC to remove 
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imidazole. After digestion of Rm1ClC-TM-GFP fusions, the solution was incubated for 15 
min with 2 ml Ni-NTA agarose (Qiagen) to remove the GFP-His10 and the His-tagged 3C 
protease.  
 The cleaved protein was concentrated to a volume of ~ 400 µl using an Amicon 
Ultra Centrifugal filter device (MWCO = 50 kDa, Milipore). The concentrated sample was 
subjected to size exclusion chromatography on a Superdex S200 column (GE Healthcare) 
equilibrated in buffer containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl and a detergent at 
the following concentration: 0.8 mM DDM, 5 mM DM, 20 mM NM or 30 mM OM. In that 
way it was possible to exchange the detergent used for extraction and IMAC with the 
detergent needed for crystallization.  
 
Crystallization of Rm1ClC full length protein and transmembrane domain. 
The purified protein was concentrated to 10 mg/ml and used for crystallization. 
Crystallization screening was performed at the NCCR High-Throughput Nanoliter 
Crystallization Facility. All crystals were obtained by sitting drop vapor diffusion at 4ºC by 
mixing protein with the reservoir solution in 1:1 ratio. After screening, the crystallization 
conditions were scaled up to 2 µl drops and refined by hand (Cryschem-plates, Hampton 
Research). The crystals of Rm1ClC transmembrane domain were grown under conditions 
that contained 20 - 30 % PEG400 as precipitant, 50 mM to 1 M salt (e.g. NaCl, KCl, 
CaCl2, MgCl2, NH4Cl, K, Na-tartrate etc.) and a pH varying from 4.5 to 9.4. In some cases, 
the protein was supplemented with 0.5 mg/ml of E. coli polar lipids (Avanti Polar Lipids, 
Inc), which did not improve the crystal quality.  
 For cryoprotection, crystals were transferred into mother liquor containing an 
increasing amount of PEG400 to a final concentration of 35 %, flash frozen in liquid 
propane and stored in liquid nitrogen.  
 
Crystallography. Data was collected on frozen crystals on the X06SA beamline at 
the Swiss Light Source of the Paul Scherer Institute on a PILATUS detector (Dectris). The 
data were indexed, integrated and scaled with XDS (Kabsch 1993) and further analyzed 
and processed with CCP4 programs (Bailey 1994).  
 The dataset of the transmembrane domain crystal 424K_LysC was used for 
molecular replacement with the program PHASER (McCoy, Grosse-Kunstleve et al. 
2007). As a search model the structure of a single EcClC subunit (truncated model 20-451 
aa) was used. PHASER was run in the automated molecular replacement mode. The 
resolution was limited to 6 Å. In order to identify the right solution the default packing 
criterion was changed from 10 to 25. The coordinate files and electron density maps were 
visualized in the graphical program Coot (Emsley and Cowtan 2004). The self rotation 
function was calculated using the program polarrfn of the CCP4 package. 
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2.2.3 Crystallization and structure determination of the Rm1ClC cytoplasmic domain  
 
 
The main criterion for the selection of prokaryotic ClC homologs was the presence of 
cytoplasmic CBS domains. These prokaryotic proteins could thus serve as valuable models 
for providing structural and functional information on regulatory mechanisms conferred by 
these domains. Cytoplasmic domains of prokaryotic ClCs are usually of smaller size than 
their eukaryotic counterparts. The size difference is due to a shorter linker region between 
two CBS subdomains and a shorter C-peptide. In the selected set of ClC homologs the 
average length of the CBS domain, starting from the first amino acid after the R-helix was 
147 residues. The degree of conservation when compared to the eukaryotic domains, but 
also within the prokaryotic domains, is very low. Therefore, it is difficult to predict the role 
of CBS domains in prokaryotic ClC proteins based on the existing structural and functional 
information on eukaryotic cytoplasmic domains. To reveal whether prokaryotic 
cytoplasmic domains share some of the eukaryotic structural and regulatory features or 
whether they have some unique characteristics they need to be structurally and functionally 
investigated.  
 The cytoplasmic domains of ClC proteins can usually be expressed in isolation as 
soluble proteins, which facilitates their crystallization and structure determination. In 
addition, biochemical assays for identification of regulating ligands are performed easer on 
isolated cytoplasmic domains than on labile, detergent solubilized membrane proteins. The 
obtained results on soluble domains can be valuable for later purification, crystallization 
and biochemical characterization of the full length protein.  
 To gain an insight into the structure of the cytoplasmic domain of the ClC homolog 
from Ralstonia metallidurans, this protein component was cloned and expressed 
independently from its transmembrane part. The expression construct included residues 
436–560. Like the full length Rm1ClC, the cytoplasmic domain is very compact and with 
only 125 amino acids the smallest ClC CBS domain studied so far.  
 Figure 2.3.1 shows sequence alignments between the cytoplasmic domain of 
Rm1ClC with the domain of the human channel ClC-Ka (A) and the domain of the 
prokaryotic homolog PtClC (B), the structures of which have been previously determined. 
The level of sequence conservation is low. The Rm1ClC and ClC-Ka CBS domains share 
15 % of identical and 30 % of similar residues; with respect to the PtClC domain the 
sequence identity is 13 % and the similarity 25 %. The conserved residues are distributed 
over the whole domain. Interestingly, the homology between domains of the two 
prokaryotic ClC proteins is not higher than between the prokaryotic and the eukaryotic ClC 
protein. The CBS1 subdomain of Rm1ClC is slightly more similar to ClC-Ka and CBS2 to 
PtClC.  
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         A 
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Figure 2.3.1. Structure-based sequence alignment between Rm1ClC cytoplasmic domain and the 
cytoplasmic domain of ClC-Ka (A) and PtClC (B).  
Identical residues are highlighted in red, similar in yellow. Secondary structure of ClC-Ka and PtClC domain 
are indicated above the sequences. The R helix preceding the cytoplasmic domain is included in the 
alignment and colored in violet. The secondary structure elements of CBS1 subdomain are colored in blue 
and of CBS2 in green. The helix in the linker region is colored in grey. The first residues of the crystallized 
ClC-Ka and PtClC products are designated with a blue arrow, and for the Rm1ClC domain with a red arrow. 
The residues involved in the dimer interface of ClC-Ka domain are labeled with a star.  
 
 
2.2.3.1 Expression and purification of the Rm1ClC cytoplasmic domain 
 
The Rm1ClC cytoplasmic domain was overexpressed as a C-terminal His10-tag fusion 
under the control of the arabinose promoter. The standard purification protocol was applied 
including IMAC as the first purification step, followed by His tag removal with protease 
digestion and SEC as the final purification step. Expression and purification resulted in a 
yield of about 10 mg of purified Rm1ClC domain per liter of expression culture.  
 From the elution volume on Superdex 200 column it was difficult to estimate the 
oligomeric state of Rm1ClC CBS domain in solution, because both a monomer and a 
dimer would be consistent with the observed elution volume.   
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Figure 2.3.2. Purification of the Rm1ClC cytoplasmic domain. 
After IMAC purification and removal of the His tag with 3C protease, the concentrated protein was subjected 
to SEC on S200 column (A). The protein eluted as a single monodisperse peak at 15.4 ml. The peak is not 
symmetrical and shows tailing due to the large amount of protein loaded onto the column. The purification 
was analyzed by SDS-PAGE (B). Samples: E – protein eluted from the IMAC column, 3C – protein after 
protease cleavage, 8, 9, 10, 11 and 12 – peak fractions from the size exclusion chromatography. The cleavage 
of the His tag was not complete. The 3C protease co-migrates with Rm1ClC domain on a S200 column.  
 
 
2.2.3.2 Oligomeric state of the Rm1ClC cytoplasmic domain 
 
To gain an insight into the oligomeric organization of the Rm1ClC cytoplasmic domain its 
sedimentation behavior was investigated by analytical ultracentrifugation (AUC).  
This method allows to determine the properties of the protein in solution including 
molar mass, gross shape, and the heterogeneity of the sample. Two basic types of 
experiments are possible: sedimentation velocity and sedimentation equilibrium 
centrifugation. In sedimentation velocity experiments a high centrifugal force is applied 
and the time course of the sedimentation process is analyzed, allowing determination of the 
sedimentation coefficient S and the approximate estimation of the molecular weight 
(Schuck 2000). In sedimentation equilibrium the application of a low centrifugal force 
permits the diffusion to balance the sedimentation such that a time-invariant equilibrium 
gradient can be observed. Because the concentration distribution at equilibrium depends 
only on molecular mass, the exact molecular mass can be calculated with the known 
parameter S that was previously determined from sedimentation velocity experiments.  
The Rm1ClC domain was analyzed by sedimentation velocity experiments. The 
experiments were carried out at three different protein concentrations (35, 70 and 150 
mM), in TBS buffer at 4°C. The sedimentation profile that looked similar for all protein 
concentrations is presented in Figure 2.3.3. The measured sedimentation coefficient was 
1.1 S. Since the measured S depends on the buffer composition, temperature and protein 
15.4 ml 
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concentration, it is necessary to extrapolate it to the value in water at 20°C at infinite 
dilution - Sº20,W. The condition independent Sº20,W allows indirect estimation of molecular 
weight. From the calculated Sº20,W of 1.77, it can be concluded that the Rm1ClC 
cytoplasmic domain exists as a monomer in solution at all investigated concentrations.  
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Figure 2.3.3. Analytical ultracentrifugation of 
Rm1ClC cytoplasmic domain. The distribution of 
sedimentation coefficient as calculated from the 
sedimentation velocity experiment is plotted against 
the sedimentation coefficient S. Rm1ClC domain 
sediments at 1.1 S. The protein concentration in this 
experiment was 70 µM. 
 
 
A similar sedimentation behavior was found for the cytoplasmic domain of the 
prokaryotic ClC homolog PtClC, which was a monomer in solution while all investigated 
cytoplasmic domains of eukaryotic ClCs showed a dimeric organization in solution. These 
biophysical properties already hint at potential differences that might exist in the structure 
and function of prokaryotic and eukaryotic ClC proteins.  
 
 
2.2.3.3 Crystallization of the Rm1ClC cytoplasmic domain 
 
The purified Rm1ClC cytoplasmic domain was broadly screened for crystallization at 
different protein concentrations (5-10 mg/l) and at two different temperatures (4ºC and 
20ºC). The crystals were obtained in collaboration with Sara Savaresi. Interestingly, the 
protein crystallized at both 4ºC and 20ºC only in two conditions: 35-45 % PEG400, 200 
mM CaCl2, pH 7.4 or 9.4. The crystals had a cubic shape with a size of around 20 µm only. 
At a synchrotron source these small crystals showed very high diffraction to a resolution of 
1.6 - 1.7 Ǻ (Figure 2.3.4).  
The Rm1ClC domain crystals were of the space group P21212 with a small unit cell 
(a = 40.5 Ǻ, b = 88.2 Ǻ, c = 39.1 Ǻ and α=β=γ= 90º). The Matthews coefficient suggests 
one molecule in the asymmetric unit and a solvent content of 49 %.  
Initially the structure determination of the Rm1ClC cytoplasmic domain was 
attempted by molecular replacement. The known structures of three CBS domains of 
eukaryotic ClC proteins (ClC-0, ClC-5 and ClC-Ka) and one structure of the prokaryotic 
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homolog PtClC provide different possible search models. Because of the similar size to the 
Rm1ClC domain and the similar crystallization characteristics (1 molecule in AU, structure 
determined at 1.8 Ǻ) the structure of the PtClC domain appeared to be the most promising 
search model. 
 
 
   
 
 
 
 
 
 
 
Figure 2.3.4. Diffraction image of Rm1ClC 
cytoplasmic domain crystal.  
Crystals grown in 200 mM CaCl2, 40 % PEG, pH 9.4 
diffracted to 1.7 Ǻ. Resolution rings are indicated. 
The data was collected on a frozen crystal on the 
X06SA beamline at the SLS on a PILATUS detector. 
 
 
 
Unfortunately, all molecular replacement trials failed. The reason for this failure, which 
was previously also encountered for the structure determination of other ClC cytoplasmic 
domains, might be the large variation in the mutual arrangement of the two CBS 
subdomains. Independent searches with either of the two subdomains (CBS1 or CBS2) of 
different proteins as search models were also unsuccessful. Therefore, the structure 
determination was pursued by experimental phasing.  
 
 
2.2.3.4 Structure determination of the Rm1ClC domain 
 
Experimental phases can either be determined by isomorphous replacement or anomalous 
scattering methods that rely on information that can be derived from small differences 
within a dataset (for anomalous scattering) or between diffraction datasets (for 
isomorphous replacement). In both methods, the first step is the location of the heavy 
atoms or anomalous scatterers, generally termed the substructure, in the crystallographic 
asymmetric unit.   
 In order to determine the structure by either isomorphous replacement or 
anomalous scattering, the crystals of the Rm1ClC cytoplasmic domain were derivatized 
with different heavy-atoms and ions. Crystals were soaked in solutions containing low mM 
amounts of different salts of heavy atoms like Pt, Hg, Pb, Au, Eu, W and higher 
concentrations of the halides I- and Br-. Initial trials to solve the structure by single or 
multiple isomorphous replacement were unsuccessful. Although, the binding of mercury 
1.73 Ǻ 
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and iodide was detected by manual inspection of difference Patterson maps (Figure 2.3.5), 
the derivatized crystals were not isomorphous with the native crystals, which prevented 
structure determination. The frequently occurring problem of non-isomorphism is avoided 
when using anomalous dispersion methods like single (SAD) and multiple wavelength 
anomalous dispersion (MAD). 
 The structure of the Rm1ClC cytoplasmic domain was determined by SAD using 
the anomalous scattering of mercury in the crystals derivatized by mercury (II)-chloride. 
The data was collected at the L-III X-ray absorption edge of mercury for maximizing 
anomalous differences. The data was collected with high redundancy and an attenuated 
beam was used. The high redundancy increases precision of the data and attenuated beam 
reduces radiation damage, both improving the quality of the anomalous signal.  
 
A                                                     B 
          
 
Figure 2.3.5. Isomorphous difference Patterson maps of Rm1ClC domain crystals derivatized with 
HgCl2 (A) and CaI2 (B). Peaks of the mercury and iodide sites are found in the Harker plane u [1/2] w. 
Contour level starts at 3σ in steps of 1σ. 
 
 After scaling and merging of the data (Friedel pairs were treated as independent 
reflections) the magnitude of the anomalous contribution was analyzed by plotting the 
anomalous difference (|F+-F-|/σ) against resolution (Figure 2.3.6). As a cut off for phase 
determination a resolution of 2.2 Ǻ was chosen, where the anomalous difference was 1.3 
times over the background.  
 
u u 
w w 
 2 Results 
 71 
 
 
Figure 2.3.6. Dependence of anomalous signal on the resolution in the SAD data set of Hg-derivatized 
Rm1ClC domain crystals. The anomalous difference (d") over the standard deviation of the error of the 
measurement (σ) is plotted against the resolution. The anomalous signal is detectable to 1.9 Ǻ resolution.  
 
The anomalous difference Patterson map calculated from a Hg-SAD dataset shows 
strong peaks at Harker sections indicating the binding of mercury to the protein (Figure 
2.3.7). Since the Rm1ClC domain contains only one cysteine, one Hg atom in the 
asymmetric unit was expected, which was easily identified by Patterson interpretation. The 
mercury coordinates and initial phases were calculated using the program SHELXD 
(Schneider and Sheldrick 2002).  
 
 
      
 
 
 
 
 
 
 
Figure 2.3.6. Anomalous difference Patterson 
map of the Rm1ClC domain crystal derivatized 
with HgCl2. The data was collected at the L-III X-
ray absorption edge of mercury. Strong peaks of the 
mercury sites are found in the Harker plane u [1/2] 
w. Contour level starts at 3σ in steps of 1σ. 
 
 
Initial SAD phases were improved by 20 cycles of density modification and solvent 
flipping implemented in SHELXE (Sheldrick 2002). During this procedure the correct 
hand of the mercury coordinates was determined. The experimental electron density map 
obtained from SHELXE was of very good quality and allowed model building of the 
largest part of the protein (Figure 2.3.7).  
 
 
 
u 
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Figure 2.3.7. Electron density maps of the Rm1ClC cytoplasmic domain.  
(A) and (C) Experimental density obtained from SHELXE and used for model building; (B) and (D) 2Fo-Fc 
electron density after completed refinement. The density was calculated at 2.2 Ǻ and 1.6 Ǻ, respectively and 
contoured at 1.5 σ. The electron density is superimposed on the refined model of the Rm1ClC domain. The 
figures A and B represent the section of the electron density in the interface between the two CBS 
subdomains that was very well defined already in the experimental map. In the linker region (residues 501-
505) the electron density in the experimental map was missing (C), but after several rounds of refinement the 
difference map allowed model building in this region too (D).   
 
 
An initial model was built automatically with the program ARP/wARP (Langer, 
Cohen et al. 2008). From 134 residues, 79 residues were correctly placed in that way. The 
initial model was manually corrected and partially completed using the graphical program 
Coot (Emsley and Cowtan 2004). The corrected model was still missing 13 residues in the 
linker region between the CBS1 and CBS2 subdomain, because the electron density in this 
region of the experimental map was not observed. After several runs of refinement, the 
density for the linker region was observed in 2Fo-Fc maps, which allowed building of the 
missing residues. The final model consists of a total of 130 amino acids including the 
residues 436–560 of Rm1ClC, a methionine and a serine introduced at the N-terminus by 
FX cloning and three residues of the 3C protease cleavage site at the C-terminus.  
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 Native Hg 
Data collection  
Space group  
Cell dimensions 
     a, b, c (Ǻ) 
     α, β, γ (º)                                    
Resolution (Ǻ)* 
Wavelength (Ǻ) 
Rmerge (%) 
Rmrgd-F (%) 
I/σI 
Completeness (%) 
Redundancy 
 
Refinement 
Resolution (Ǻ) 
No. reflections 
Rwork/Rfree (%) 
No.atoms 
     Protein 
     Ion 
     Water 
Average B-factors 
     Protein 
     Ion 
     Water 
R.m.s. deviations 
     Bond lengths (Ǻ) 
     Bond angles (%) 
 
 
P21212 
 
40.51    88.18    39.13 
90.0, 90.0, 90.0 
50-1.6 (1.7-1.6) 
1.0707 
5.6 (48.9) 
6.4 (50.6) 
19.61 (3.12) 
96.8 (86.4) 
6.4 
 
 
19.74 -1.6 
19086 
16.5 / 20.4 
 
965 
1 
121 
Isotropic  Anisotropic 
22.38       57 
21.63       - 
36.61       - 
 
0.006 
1.002 
 
P21212 
 
41.41    87.81    39.02    
90.0, 90.0, 90.0 
50-1.8 (1.9-1.8) 
1.006 
13.4 (68.9) 
7.4 (30.2) 
16.75 (4.26) 
97.6 (90.1) 
11 
     * Values in the parenthesis are for the highest resolution shell. 
      Rmerge = Σ|I(h,i)-I(h)| / Σ(I(h,i) , where I(h,i) is the mean intensity of the reflection  
Rwork = Σ||Fo|-|Fc|| / Σ|Fo|, where Fo and Fc are the observed and calculated structure factor 
amplitudes, respectively. 
Rfree was calculated using a randomly selected 5 % sample of the reflection data omitted from the 
refinement.  
Table 2.3.1. Data collection and model refinement statistics.  
 
Refinement was carried out against the native dataset to the resolution of 1.6 Ǻ 
with the program PHENIX.refine (Adams, Grosse-Kunstleve et al. 2002). The first 
refinement steps included restrained refinement of atomic positions, occupancies and 
stereochemistry, isotropic refinement of atomic displacement parameters (B factors) and 
bulk solvent correction. In the following steps, water molecules were included and TLS 
refinement was performed by dividing the molecule into two groups that move as rigid 
bodies. Between the refinement steps, the model was manually adjusted to fit better into 
the calculated difference map (2Fo-Fc). The last refinement step consisted of the 
anisotropic refinement of B factors of protein atoms as well as of the isotropic refinement 
of water molecules and ions.  The final model, containing 965 protein atoms, 121 water 
molecules and 1 chloride ion, agreed with the crystallographic data with Rwork of 16.5 % 
and Rfree of 20.4 % and did not show outliers in Ramachandran plot.   
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2.2.3.5 Structure of the Rm1ClC cytoplasmic domain 
 
The structure of the Rm1ClC cytoplasmic domain is presented in Figure 2.3.8. The overall 
organization resembles the equivalent structures of the cytoplasmic domains of ClC-0, 
ClC-5, ClC-Ka and PtClC. The domain consists of two subdomains, CBS1 and CBS2, 
which are connected by a short linker. The two subdomains are related by a pseudo-two-
fold arrangement and tightly interact via an interface formed by a pair of β strands.  
 The secondary structure elements in the CBS motifs of Rm1ClC are slightly 
different than found in eukaryotic ClC members (β1, α1, β2, β3, α2). In both CBS1 and 
CBS2 the short β1 strands are absent, hence giving the motive α1, β1', β2', α2 (Figure 
2.3.8.D). The absence of β1 strands has already been observed in the CBS subdomains of 
PtClC, suggesting that this could be a general feature of the cytoplasmic domains in 
prokaryotic ClC proteins.  
 
A                                                                           B                
 
    C 
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Figure 2.3.8. Structure of the cytoplasmic domain of Rm1ClC. 
(A) Ribbon representation of the Rm1ClC domain. The CBS1 subdomain is colored in blue, the CBS2 in red. 
The N-terminal region connecting the CBS1 with the R helix is colored in green and the linker region 
between to CBS subdomain in gray. The model in (A) is rotated by 180º around the pseudo-two-fold axis to 
give the model orientation in (B). 
(C) Schematic representation of Rm1ClC domain in the same orientation as in (A).  
(D) Sequence of the Rm1ClC CBS domain with its secondary structure elements indicated. The R helix is 
colored in yellow, the elements belonging to CBS1 in blue, the helix in the linker region in grey and the 
elements of CBS2 in red. The red arrow is indicating the first residue used for cloning and crystallization.  
 
CBS1 CBS2 
N-terminus 
C-terminus 
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180º 
N 
C 
CBS1 CBS2 
 2 Results 
 75 
 The N-terminal region that connects CBS1 with the transmembrane domain is 19 
residues long and consists of a short helix (αN) followed by a long coil that wraps around 
the protein. The linker connecting the two CBS subdomains consists of 22 residues and 
tightly interacts with the residues from both subdomains. This is probably the reason for its 
defined electron density, which was not the case for the longer linkers found in the 
eukaryotic CBS domains. The N-terminal coil and the linker are located at about the same 
height on the opposite sides of the cytoplasmic domain surface and encircle the β sheets of 
the two CBS subdomains in different directions. The Rm1ClC CBS domain does not 
contain a C-peptide as the last amino acid is part of the CBS2 α2 helix.  
Besides its small size and compactness, another interesting feature found in the 
Rm1ClC domain structure is a very symmetric shape with respect to the secondary 
structure elements in CBS1 and CBS2 (Figure 2.3.9). The pseudo-two-fold arrangement 
extends from the two β sheets to other parts of the subdomains. The reason for this 
symmetry is the same length of the corresponding α helices and β strands in the two 
subdomains. The structural conservation between the two subdomains is also illustrated by 
the low rmsd value of 1.07 Ǻ obtained when superimposing the Cα positions of both 
subdomains. This feature was not observed to this extent in other crystallized ClC CBS 
domains.  
 
           A                                                              B   
        
 
Figure 2.3.9. Pseudo-two-fold symmetry of the Rm1ClC cytoplasmic domain. (A) A view from the 
bottom, (B) a view from the top. The helices are colored in red, the strands in yellow, the loops and coils in 
green. The black dot indicates the centre of symmetry.  
 
 The overall structure of the Rm1ClC domain was compared to the other ClC 
cytoplasmic domains by superimposing their main chains. Using the SSM (secondary 
structure match) algorithm (Krissinel and Henrick 2004), the highest similarity was found 
with the domain of PtClC with a root mean square deviation (rmsd) of 2.28 Ǻ. 
Superposition with the ClC-0, ClC-5 and ClC-Ka gave rmsd values of 2.49, 2.51 and 2.78 
Ǻ, respectively.  
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Figure 2.3.10. Structural comparison of ClC cytoplasmic domain. 
The structure of the cytoplasmic domain of Rm1ClC (red) is superimposed with the cytoplasmic domains of 
ClC-0 (A, blue); ClC-5 (B, magenta); ClC-Ka (C, green) and PtClC (D, orange). The superposition was 
generated by a least-square fit of the respective CBS2 subdomains. The angle between CBS1 and CBS2 is 
similar to the one of ClC-0 and ClC-5, but different than found for ClC-Ka and PtClC. 
 
  
 When superimposing the cytoplasmic domains by a least-square fit of the CBS2 
subdomains, differences in the arrangement between CBS1 and CBS2 can be observed 
(Figure 2.3.10). The angle between the β sheets in the Rm1ClC domain is similar as found 
in the domains of ClC-0 and ClC-5, while it is smaller than the equivalent angle in the 
ClC-Ka domain and bigger than in the PtClC domain. The cleft in the interface of the two 
CBS subdomains is the place where nucleotide binding was detected in the ClC-5 domain. 
Although the overall size of the cleft in Rm1ClC appears similar to ClC-5 when comparing 
the main chain atoms only, it is much smaller when including side chains. The residues 
found in this region are not conserved between the two proteins and the interactions with 
nucleotide binding would not be possible in Rm1ClC for sterical reasons. However, it is 
still possible that other ligands bind to this region of Rm1ClC, whose identification will 
require extensive biochemical screening.  
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2.2.3.6 Ion binding to the Rm1ClC cytoplasmic domain 
 
Besides water molecules, a putative single chloride ion was detected in the electron density 
of the Rm1ClC cytoplasmic domain structure. The binding of ions to the CBS domains of 
other protein families has been previously observed (Biemans-Oldehinkel, Mahmood et al. 
2006; Hattori, Iwase et al. 2009) In order to systematically investigate ion binding to the 
Rm1ClC domain, the crystals were soaked in solutions containing different anions and 
cations.  
 Initially, the binding of halides was tested. The crystals were incubated in solutions 
containing Br- and I- and data allowing the calculation of anomalous or isomorphous 
differences were collected. Interestingly, the binding of both bromide and iodide was 
detected at the same position where the putative chloride ion was bound in the native 
crystals (Figure 2.3.11A and B).  Two arginine residues (R516 and R518) surround the 
halide ion and provide with their positively charged side chains a suitable chemical 
environment for anion coordination. To quantify the affinity of chloride binding to the 
isolated Rm1ClC cytoplasmic domain, biochemical experiments like isothermal titration 
calorimetry or equilibrium dialysis need to be performed. It will be also important to reveal 
whether this binding site also exists in the context of the full length Rm1ClC protein.  
 
   A                    
 
    B 
       
   C         
 
    D 
  
Figure 2.3.11. Ion binding to the Rm1ClC cytoplasmic domain.  
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Figure 2.3.11. Ion binding to the Rm1ClC cytoplasmic domain.  
Crystals of the Rm1ClC domain were soaked in solutions containing different ions and the ion binding was 
crystallographically detected by calculating difference maps. (A) Electron density of bromide found in the 
anomalous difference map of a crystal soaked in 100 mM NaBr. The map is contoured at 3 σ. (B) Electron 
density of iodide found in the isomorphous difference map of a crystal soaked in 400 mM CaI2. The map is 
contoured at 8 σ. (C) Electron density of Zn2+ ions found in anomalous difference map of a crystal soaked in 
100 mM ZnCl2. The map is contoured at 4 σ. (D) Closer view on the residues in the region of bound Zn2+ 
ions.  
 
 The binding of different cations to the Rm1ClC domain was tested in a similar way. 
By soaking the crystal in solution containing the ion the specific binding of two Zn2+ ions 
was detected (Figure 2.3.11.C and D). One of them is located exactly in the middle of the 
cleft between the two CBS subdomains. The ion is coordinated by interaction with the side 
chains of two arginines (R467 and R531) and one asparagine (N530). The second Zn2+ ion 
binds at the end of the helix α1 of CBS2 and it is coordinated by a histidine residue 
(H527). Since the ions were found in crystals grown at pH 9.4, it would be clearly 
interesting to study the pH dependence of binding in order to see whether the Zn2+ ion 
would also be bound at physiological pH.  
 Rm1ClC originates from a bacterium that grows in heavy metal polluted water (von 
Rozycki, Nies et al. 2005). This microorganism can survive millimolar concentrations of 
Zn2+, Cd2+, Co2+, Pb2+, Hg2+, Ni2+ and Cr3+. The identification of Zn2+ ions bound to the 
cytoplasmic domain of Rm1ClC thus opens the question on the potential physiological 
importance of heavy metal binding. Heavy metals might play a role of ligands for the 
cytoplasmic domain of this ClC protein and in this way influence ion transport. Future 
experiments will include investigations on the binding of other heavy metals by 
crystallography and biochemical and functional assays.  
 
 
2.2.3.7 Possible dimeric arrangement of the Rm1ClC cytoplasmic domain 
 
The asymmetric unit of Rm1ClC domain crystals contains only a single subunit. By 
sedimentation analysis it was also shown that this domain exists as a monomer in solution. 
Both results suggest that there are no strong interactions between the isolated cytoplasmic 
domains. The question whether the cytoplasmic domains interact in the context of the full 
length dimer is difficult to answer in the absence of a full-length protein structure, but it is 
still possible that the relative high concentration of the domains in the full length protein 
allows weak interactions to be formed. Possible interaction modes for an Rm1ClC domain 
dimer can be observed in the crystal by analyzing the contacts between symmetry related 
molecules and by analogy to the observed dimeric arrangement of eukaryotic ClC 
cytoplasmic domains.  
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 Since the crystals of the Rm1ClC domain were of the space group p21212, only one 
2-fold relationship was found along the z axis. Figure 2.3.12A shows this arrangement. 
The interaction is formed between the CBS2 subdomains. The interacting residues are 
from the helices α1 and α2 and the combined molecular surface buried in the interface is 
1022 Ǻ2, as calculated in the PISA program (Krissinel and Henrick 2007). Five hydrogen 
bonds between interacting residues stabilize the interaction. In this dimeric assembly both 
the N- and the C-termini of the domain, and the bound chloride ions are located close to 
the interface while five residues make the connection to the predicted R-helix.  
  
A 
 
 
 
 
B 
 
C 
               
 
Figure 2.3.12. Two-fold relationship in the crystal of the Rm1ClC domain.  
(A) Dimer related by crystallographic symmetry viewed from the side (top) and from the top (bottom). 
(B) Close-up of A. Residues in the interface are represented as sticks, the N-terminus is colored in blue, the 
C-terminus in red and the bound chloride ions are represented as magenta spheres. 
(C) Dimer of the Rm1ClC domain created by superposition on the TM0892 dimer (PDB entry 1VR9). 
Helices α2 are colored in red, helices α1 in orange. The positively charged residues from the CBS1 are 
colored in blue.  
   
The observed dimeric arrangement in the crystal of the Rm1ClC domain looks 
similar to the head-to-head dimer of a CBS protein from Thermatoga maritima TM0892. 
y x 
z 
90º 
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The interaction in the TM0892 dimer is mainly formed by the residues in the helices α1 
and α2 of the CBS2 subdomain, with the minor contacts between the residues from the α2 
of the CBS1 subdomains. This interface has a combined surface of 1420 Ǻ2, and is quite 
hydrophobic. A hypothetical dimer of the Rm1ClC based on the superimposition of CBS2 
subdomains of TM0892 and Rm1ClC (Figure 2.3.12C) contains several clashes between 
the residues in the helices of CBS2. It would also place positively charged residues in the 
α2 of the CBS1 into proximity that might lead to repulsions and therefore favor more open 
structural arrangement as found in the crystal. In order to test whether the interaction of 
Rm1ClC domain found in the crystal exists in the context of the full length protein, the 
residues in the interface will ultimately have to be mutated to cysteine and the cross-
linking analysis will have to be performed. 
The dimeric arrangement observed in the crystals of the cytoplasmic domain of 
ClC-Ka has been shown to be also conserved in ClC-5 and ClC-0 (see next chapter). As 
the investigated domains of prokaryotic ClC homologs did not show a similar organization, 
it would be interesting to reveal whether the observed interactions would be structurally 
feasible. In order to answer this question, a dimer of the Rm1ClC cytoplasmic domain was 
constructed that resembles the interaction in ClC-Ka (Figure 2.3.13). 
 
          
Figure 2.3.13. Hypothetical dimeric arrangement of the Rm1ClC domain based on the structure of 
eukaryotic homologs. The dimer of Rm1ClC domain is colored in red, with the loops connecting β strands 
in CBS2 in yellow. The ClC-Ka domain dimer is colored in blue. The relationship between the two views is 
represented.  
 
  
The domain of Rm1ClC was superimposed on the dimer of the ClC-Ka domain by 
a least-square fit of the region of CBS2 that contains the interaction interface. The resulting 
Rm1ClC oligomer looks different from its eukaryotic counterpart. While the ClC-Ka dimer 
has a V-shape, the Rm1ClC dimer is more compact due to the smaller inclination between 
the two CBS subdomains. Several clashes between the side chains in the interface are 
90º 
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observed, with the most prominent ones between the loops connecting two β strands in 
CBS2. Like other potential interactions described before, this hypothetical arrangement 
thus needs to be investigated by a combination of mutagenesis and cysteine cross-linking.  
 
  
2.2.3.8 Summary 
 
The expression of isolated cytoplasmic domain of the Rm1ClC protein allowed its 
crystallization, structure determination and biochemical characterization. Several important 
features of this domain were revealed including the elucidation of its detailed molecular 
architecture, the monomeric state in solution and binding of ions to specific sites of the 
domain. The obtained structural information on the Rm1ClC domain now enables the 
design of detailed structural and functional experiments that would lead to the better 
understanding of the role of cytoplasmic domains in prokaryotic ClC proteins.  
  
 
2.2.3.9 Material and methods 
 
Expression and purification of the Rm1ClC cytoplasmic domain. The 
cytoplasmic domain of Rm1ClC encompassing residues 436-560 was constructed by FX 
cloning into pBXC3C vector and transformed into E. coli MC1061 cells. Expression 
cultures were grown in TB medium supplemented with 100 µg/ml ampicilin. Cells were 
grown at 37ºC until an OD600 of 0.6 and subsequently cooled to 25ºC. Protein expression 
was induced with 0.002 % arabinose for 14 - 15 hours at 25ºC. 
 Cells were harvested by centrifugation at 4000 rpm (rotor Sorvall H6000A) for 20 
min at 4ºC. The cell pellet was resuspended in the buffer containing 50 mM Tris-HCl pH 
7.4 and 150 mM NaCl (buffer C) with addition of 1 mg/ml lysozyme, 20 µg/ml DNase, 
1µg/ml leupeptin, 1 µg/ml pepstatin and 1 mM PMSF. The cells were lysed with an 
Emulsiflex C3 high pressure homogenizer (Avestin) with at least two passages at 700 bar. 
The lysate was cleared by low-spin centrifugation at 11,500 × g for 40 min at 4ºC and the 
supernatant was used for protein purification. 
 All purification steps were carried out at 4ºC. The protein was purified by affinity 
chromatography on Ni-NTA agarose (Qiagen). After binding of the protein the resin was 
washed with buffer C until baseline of OD280 was reached. To remove non-specifically 
bound proteins, the resin was washed with the buffer C supplemented with 50 mM 
imidazole. The protein was eluted with buffer C containing 300 mM imidazole. 
 To cleave off the His10-tag the protein was digested for 2 h with 3C protease at the 
ratio 1 mg of protease for 10 mg of fusion protein. During digestion the solution was 
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dialyzed against the buffer C. After cleavage, the solution was incubated for 15 min with 
Ni-NTA agarose (Qiagen) to remove the His-tagged 3C protease. The cleaved protein was 
concentrated using an Amicon Ultra Centrifugal filter device (MWCO = 5 kDa, Milipore) 
to a volume of ~ 400 µl. The concentrated sample was subjected to size exclusion 
chromatography on Superdex S200 column (GE Healthcare) equilibrated in buffer 
containing 10 mM Tris-HCl pH 7.4 and 150 mM NaCl. 
 
Analytical ultracentrifugation. Sedimentation velocity experiments were 
performed on a Beckmann model XL-I analytical ultracentrifuge with a 50-Ti rotor at 4ºC. 
Double-sector counterpieces were filled with 400 µl of protein samples and 420 µl of the 
buffer used for SEC. Data was acquired at 280 nm in continuous scan mode in 0.003 cm 
intervals at a rotor speed of 40,000 rpm. Sedimentation analysis of the Rm1ClC 
cytoplasmic domain was performed at protein concentration of 35, 70 and 150 µM. Data 
analysis was performed with the c(S) module of Sedfit (Schuck 2000; Schuck, Perugini et 
al. 2002). The buffer parameters, partial-specific volume of the protein and the corrected 
sedimentation coefficient Sº20,W were calculated by using Sednterp. For data used in this 
analysis the root-mean-square deviation of all the fits was between 0.008 and 0.01.  
 
Crystallization of the Rm1ClC cytoplasmic domain. Crystals of the Rm1ClC 
domain were obtained at 4 ºC and 20 ºC by the sitting drop vapor diffusion method. 
Purified protein with the concentration 5-10 mg/ml was mixed in a 1:1 ratio with the 
reservoir solution containing 40-50 % PEG400, 200 mM CaCl2, 50 mM Glycine pH 9.4 or 
50 mM HEPES pH 7.4. Crystals grew after 4-7 days in the space group p21212.  
 Heavy metal derivatives were obtained by soaking native crystals for 3h in mother 
liquor containing 1 mM HgCl2, 400 mM CaI2, 100 KBr or 100 mM ZnCl2.  
 As the crystals grew in such a high concentration of PEG400, the additional 
cryoprotection was not needed. Directly from the crystallization drops, the crystals were 
flash-frozen in liquid propane and stored in liquid nitrogen.  
 
Crystallography. Data were collected on frozen crystals on the X06SA beamline 
at the Swiss Light Source of the Paul Scherer Institute on a PILATUS detector (Dectris). 
The data were indexed, integrated and scaled with XDS (Kabsch 1993) and further 
analyzed and processed with CCP4 programs (Bailey 1994).  
 The structure of the Rm1ClC cytoplasmic domain was determined by the SAD 
method using the anomalous contribution of mercury in a crystal derivatized by HgCl2. 
The Hg site was identified with SHELXC and D (Schneider and Sheldrick 2002). The 
determination of the correct hand of the substructure and density modification was 
performed with SHELXE (Sheldrick 2002). The initial model was built automatically with 
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ARP/wARP (Langer, Cohen et al. 2008). The model was completed by manual building of 
the missing residues in Coot (Emsley and Cowtan 2004). The model was refined against 
the native data set to a resolution of 1.6 Ǻ with the program PHENIX.refine (Adams, 
Grosse-Kunstleve et al. 2002). 
 The specific binding of bromide and zinc ions to the Rm1ClC cytoplasmic domain 
was detected in anomalous difference electron density maps and binding of iodide in 
isomorphous difference electron density maps.  
 The superposition of the Rm1ClC domain with other CBS domains was done in 
Coot by using either SSM (Krissinel and Henrick 2004) or LSQ algorithm.   
 
 
2.3 Structure of the dimeric assembly of the cytoplasmic domains in 
eukaryotic ClC proteins  
 
Similar to the previously discussed prokaryotic homologs eukaryotic ClC chloride 
channels and transporters have a conserved molecular architecture consisting of a catalytic 
membrane domain and a regulatory cytoplasmic domain. They function as dimers of two 
identical subunits. The structural arrangement of the membrane domains within the dimer 
has been revealed by the structure determination of two bacterial homologs (Dutzler, 
Campbell et al. 2002). Due to the lack of cytoplasmic domains in these homologs, no 
structural information on these domains could have been obtained. The later work on 
isolated cytoplasmic domains of eukaryotic proteins ClC-0 and ClC-5 led to the structural 
and biochemical characterization of the intracellular components of ClC proteins (Meyer 
and Dutzler 2006; Meyer, Savaresi et al. 2007). Both ClC-0 and ClC-5 domains have a 
typical CBS fold and are found as dimers in solution. Dimeric assembly for ClC 
cytoplasmic domains is expected as it extends the symmetry of the transmembrane part. 
However, the structures of the ClC-0 and the ClC-5 CBS domain have not provided a clear 
answer on the dimeric arrangement of cytoplasmic domains in ClC proteins. While the 
ClC-0 domain crystallized as a monomer, the ClC-5 domain showed a dimeric relationship 
not previously observed for CBS domain-containing proteins (see Introduction 1.3).   
 Cytoplasmic domains are attributed to have a regulatory role in ion transport of ClC 
proteins, but the exact mechanisms of regulation are currently not known. In the case of the 
channel ClC-1 and the transporter ClC-5 the regulation likely depends on the binding of 
nucleotides, which might implicate conformational differences between the bound and 
unbound state of the cytoplasmic domains. In the channel ClC-0 the process of slow gating 
is regulated by the movements in the cytoplasmic domains. The recent results showed that 
the closure of the slow gate coincides with the dissociation of cytoplasmic domains and a 
distance change of 20 Ǻ (Bykova, Zhang et al. 2006). It is, therefore, understandable that 
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structural information on the interaction between the cytoplasmic domains in the context of 
dimeric ClC proteins is necessary to explain these functional properties. Whereas the most 
convincing answers to these important questions will ultimately be obtained from the 
structures of full-length proteins with different conformations of the cytoplasmic domains, 
the characterization of cytoplasmic domains in isolation provides important information on 
their dimeric assembly and may provide an initial structural basis for the regulatory 
processes. This is illustrated by the work on the cytoplasmic domain of the human kidney 
channel ClC-Ka presented in the following publication. 
 
2.3.1 The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals 
a conserved interaction interface 
 
Aim of this study: The main objective of this study was to determine the dimeric 
arrangement of the cytoplasmic domains in eukaryotic ClC proteins that was left 
ambiguous from the previous investigations. The dimeric assembly of the ClC-Ka domain 
found in the crystal was shown to be preserved in solution by the combination of 
mutagenesis, chemical cross-linking and analytical ultracentrifugation experiments. The 
conservation of the observed interaction within the ClC family was also investigated in 
complementary experiments on the cytoplasmic domain of ClC-0. Finally, the dimeric 
arrangement was confirmed in the context of the full length ClC proteins.  
 
 
 
         
       
 
Figure 2.4.1. Dimeric arrangement of the ClC-Ka CBS domain.  
The protein chains are shown as ribbon, with the N-terminus colored in blue and the C-terminus colored in 
red. The relationship between the two views is indicated. The V-shaped dimer is formed by the interaction 
between the CBS2 subdomains. 
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The cytoplasmic domains of ClC chloride chan-
nels and transporters are ubiquitously found in
eukaryotic family members and have been sug-
gested to be involved in the regulation of ion
transport. All cytoplasmic ClC domains share
a conserved scaffold that contains a pair of
CBS motifs. Here we describe the structure of
the cytoplasmic component of the human chlo-
ride channel ClC-Ka at 1.6 A˚ resolution. The
structure reveals a dimeric organization of the
domain that is unusual for CBSmotif containing
proteins. Using a biochemical approach com-
biningmutagenesis, crosslinking, andanalytical
ultracentrifugation, we demonstrate that the
interaction interface is preserved in solution
and that the distantly related channel ClC-0
likely exhibits a similar structural organization.
Our results reveal a conserved interaction inter-
face that relates thecytoplasmicdomainsofClC
proteins and establish a structural relationship
that is likely general for this important family of
transport proteins.
INTRODUCTION
The ClC chloride channels and transporters constitute
a large family of membrane proteins that is involved in
diverse physiological processes ranging from electrical
signaling to epithelial transport and the acidification of
intracellular organelles (Jentsch et al., 2005). All eukaryotic
family members share a conserved molecular architecture
that consists of a complex transmembrane transport
domain that is followed by a cytoplasmic domain (Dutzler,
2006; Dutzler et al., 2002). This cytoplasmic component
contains a pair of CBS motifs, small protein domains that
were named after the enzyme cystathionine b-synthetase
(Bateman, 1997). CBS motifs usually occur as tightly inter-
acting pairs and are found to constitute regulatory
domains in different protein families such as kinases,
membrane transporters, and enzymes (Biemans-Oldehin-
kel et al., 2006; Ignoul and Eggermont, 2005). For example,
in the AMP-dependent protein kinase, a regulatory domainStructure 15,composed of four consecutive CBS motifs binds adeno-
sine nucleotides and is suggested to regulate the catalytic
activity of the enzyme in response to changing nucleotide
concentrations (Scott et al., 2004; Townley and Shapiro,
2007). Although their role in certain enzymes is well estab-
lished, the regulatory role within the ClC family is less clear.
Different experiments, however, have suggested that
in the ClC family, these domains play a key role in the
regulation of transport in response to intracellular signals
(Bennetts et al., 2005; Maduke et al., 1998; Meyer et al.,
2007).
We have previously reported the structures of the
cytoplasmic domains of the voltage-dependent chloride
channel ClC-0 from Torpedo marmorata and of the human
transporter ClC-5 (Meyer and Dutzler, 2006; Meyer et al.,
2007). Both domain structures allowed the structural
characterization of the cytoplasmic components of ClC
proteins. The structure of the cytoplasmic domain of
ClC-5 additionally revealed insight into its specific interac-
tion with nucleotides, and therefore established the basis
of nucleotide recognition by certain ClC family members
(Meyer et al., 2007). Two questions that could not be clar-
ified in the previous structures concerned the oligomeric
organization of the cytoplasmic domains and whether
the specific interaction with nucleotides extends to other
members of the family. In order to clarify these two ques-
tions and to gain insight into the structural organization of
other ClC family members, we have investigated the cyto-
plasmic domain of the human ClC channel ClC-Ka. The
two highly homologous channels ClC-Ka and ClC-Kb
are distantly related to the muscle-type ClC channels
ClC-0, ClC-1, and ClC-2 (Jentsch et al., 2002). Both chan-
nels are expressed in epithelia of the kidney and the inner
ear, with mutations causing hereditary renal diseases and
deafness (Jentsch et al., 2002). The ClC-K channels have
unique regulatory properties and were identified to tightly
interact with their b subunit Barttin, a putative transmem-
brane protein (Estevez et al., 2001).
Here we present the structure of the cytoplasmic
domain of the human channel ClC-Ka at 1.6 A˚ resolution.
The crystal structure revealed an interaction mode be-
tween two protein chains in a homodimeric molecule
that is distinct from interactions seen in CBS motif con-
taining domains from other protein families. A similar orga-
nization, however, was previously found in crystals of the
cytoplasmic domain of the human transporter ClC-5. The715–725, June 2007 ª2007 Elsevier Ltd All rights reserved 715
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Structure of the Cytoplasmic Domain of ClC-KaFigure 1. Structure of the Cytoplasmic Domain of ClC-Ka
(A) Structure-based sequence alignment of the cytoplasmic domains of the ClC channels ClC-Ka, ClC-1, ClC-0, and the ClC transporter ClC-5. Iden-
tical residues are colored in red, similar residues in violet. Residues of the linker of ClC-Ka that lack electron density are colored in gray. Secondary
structure and numbering (ClC-Ka) are indicated above and below the sequences, respectively. The linker regions and the C peptides of all regions
except ClC-Ka have been omitted (XXX). Residues involved in the observed dimer interface of ClC-Ka are highlighted in green, residues involved in
a putative head-to-tail interface are highlighted in gray. The R helix preceding the domain is included in the alignment. The first residue of the crys-
tallized product is highlighted (#). ‘‘c’’ marks the residue in ClC-Ka and ClC-0 used for crosslinking. The residues mutated for analytical ultracentri-
fugation studies in ClC-Ka and ClC-0 are indicated by ‘‘k’’ and ‘‘0,’’ respectively; h,H. sapiens; t, T. marmorata; hClC-Ka, GenBank accession number
P51800; hClC-1, GenBank accession number M97820; tClC-0, GenBank accession number X56758; hClC-5, GenBank accession number
116734718.
(B) Stereo view of a Ca trace of the ClC-Ka domain. Selected residues are labeled according to their position in the hClC-Ka sequence.716 Structure 15, 715–725, June 2007 ª2007 Elsevier Ltd All rights reserved
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Structure of the Cytoplasmic Domain of ClC-Kahigh resolution of the data allowed a detailed interpreta-
tion of the extended interface, which buries a number of
residues that are conserved among different members of
the ClC family. In an attempt to probe whether the interac-
tion interface found in the crystal is preserved in solution,
we disrupted dimerization by site-directed mutagenesis
and introduced specific crosslinks. Both experimental
strategies strongly suggest that the crystal structure is
representative of the interactions in solution. We subse-
quently extended our investigations to the cytoplasmic
domain of the channel ClC-0. The same approach allowed
us to demonstrate that ClC-0, whose oligomerization was
not revealed in its crystal structure, shows a similar struc-
tural organization. Finally, we extended the crosslinking
approach to full-length ClC-0, demonstrating that the
same disulfide bond that covalently links the two interact-
ing subunits can also be formed in the context of the trans-
membrane protein. Both features, the structural similarity
found in the dimeric structures of the cytoplasmic do-
mains of ClC-Ka and ClC-5 as well as the similar biochem-
ical behavior of the ClC-Ka and the ClC-0 domain, point at
a conserved interaction that is common to eukaryotic ClC
family members and that is likely preserved in the full-
length proteins where the domains are attached to the
transmembrane pore. Our data clarify the previously
ambiguous oligomeric structure of the cytoplasmic com-
ponents of ClC channels and transporters, and reveal
important insights into the structural organization of the
family.
RESULTS
The Structure of the ClC-Ka Domain
To gain insight into the structure of the cytoplasmic
domain of the human channel ClC-Ka, we have cloned
and expressed a fragment of the protein encompassing
residues 533–687 (Figure 1A). The construct includes the
entire domain followed by a protease cleavage site and
a hexahistidine tag that was cleaved off during purifica-
tion. This protein construct allowed us to grow crystals
of space group P21 diffracting to a resolution of 1.6 A˚.
The crystal structure was determined by the multiple iso-
morphous replacement method; it contains two protein
chains, 238 water molecules, one I ion, and three Cl
ions in the asymmetric unit (Table 1). The two protein
chains have similar conformations and are related by
2-fold noncrystallographic symmetry. Their structure is
well defined in the electron density, with the exception of
ten residues of the linker connecting the two CBS domains
and ten residues of the N terminus that are disordered.
Figure 1B shows the structure of the ClC-Ka domain.
The overall organization resembles the equivalent struc-
tures of ClC-0 and ClC-5. Similar to structurally homolo-Structure 15, 7gous protein domains, the two CBS subdomains (CBS1
and CBS2) are related by a pseudo-two-fold arrangement
and tightly interact via an interface formed by a pair of
b strands (Figure 1C). The N terminus preceding CBS1 is
similar in length and structure to the equivalent region of
the channel ClC-0, whereas it is elongated by five residues
in the nucleotide binding domain of the transporter ClC-5
(Figure 1A). The short linker region connecting the two
CBS subdomains, in contrast, differs from the respective
regions of both ClC-0 and ClC-5. Apart from 11 disordered
residues following CBS1, the linker forms a short helix (aL)
followed by a loop, both interacting with residues of CBS1
(Figures 1A and 1C). To investigate whether the cytoplas-
mic domain of ClC-Ka binds nucleotides, we collected
data from crystals that were grown in the presence of
5 mM ATP (Table 1). An Fo  Fc difference electron density
calculated after refinement of the model failed to show any
evidence of ATP binding (data not shown). A similar
approach revealed the specific interaction of nucleotides
with the cytoplasmic domain of ClC-5 (Meyer et al.,
2007). When comparing the structure of the nucleotide
binding region of ClC-5 with the equivalent structures of
ClC-0 and ClC-Ka, it is evident that the shorter N-terminal
loop as well as differences in residues in the binding site
would probably interfere with nucleotide binding.
Oligomeric Assembly of the ClC-Ka Domain
Analytical ultracentrifugation experiments of the ClC-Ka C
terminus revealed a dimeric organization in solution. A
similar sedimentation behavior was previously found for
cytoplasmic domains of ClC-0 and ClC-5, thus pointing
at a specific interaction of two cytoplasmic domains in
the dimeric ClC proteins (Meyer and Dutzler, 2006; Meyer
et al., 2007). In accordance with their assembly in solution,
a pair of interacting proteins each containing two CBS
motifs was found in the asymmetric unit of the ClC-Ka
domain crystals (Figure 1D). The high resolution of our
data allows a detailed analysis of the protein-protein inter-
face (Figure 2). This structural arrangement mainly
involves residues on the surface of CBS2 in each chain
of the homodimeric protein. The interactions lead to a
V-shaped oligomeric structure which puts the two CBS2
subdomains in close proximity with few mutual in-
teractions between the remote CBS1 counterparts (Fig-
ures 1D and 2B). The dimer buries 1530 A˚2 of the
combined molecular surface and includes more than 25
well-defined water molecules, some of which form a
continuous chain bridging a narrow tunnel on one end of
the interaction interface (Figures 2A and 2C). Apart from
H-bonding interactions between protein residues, which
in several cases are mediated by buried water molecules,
the bulk of the interactions are hydrophobic. Several
residues contributing to this interface are conserved(C) Ribbon representation of the ClC-Ka domain. The two CBS subdomains are colored in orange and cyan, respectively. Secondary structure
elements are indicated.
(D) Ca representation of the ClC-Ka domain dimer in two orientations. The relationship between the two views is indicated. The individual subdomains
are labeled and colored in orange and cyan, respectively.
Figures 1, 2, and 5 were prepared with DINO (http://www.dino3d.org).15–725, June 2007 ª2007 Elsevier Ltd All rights reserved 717
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Structure of the Cytoplasmic Domain of ClC-KaTable 1. Data Collection and Model Refinement Statistics
Data Collection
SeMet Native MeHg HgCl KI ClC-Ka ClC-Ka/ATP
Synchrotron Home Home Home Home Synchrotron Synchrotron
Space group P21 P21 P21 P21 P21 P21 P21
Cell dimensions a = 35.5,
b = 82.0,
c = 60.4
a = 35.2,
b = 83.1,
c = 59.8
a = 35.2,
b = 81.6,
c = 59.9
a = 35.4,
b = 83.6,
c = 59.4
a = 35.2,
b = 82.9,
c = 59.5
a = 35.3,
b = 83.4,
c = 58.9
a = 35.3,
b = 82.5,
c = 59.9
b 93.5 92.4 92.4 91.5 92.5 92.0 92.7
Wavelength (A˚) 0.979 1.542 1.542 1.542 1.542 1.0 1.0
Resolution (A˚) 50–3.0 50.0–2.6 50–2.8 15–3.5 15–3.0 50–1.6 50–1.8
Rsym 11.0 (22.2) 3.9 (12.4) 9.9 (37.3) 14.0 (27.6) 10.3 (27.6) 5.5 (27.8) 6.5 (24.3)
I/sI 10.7 (3.3) 18.2 (6.0) 8.4 (2.6) 7.2 (3.7) 10.0 (4.6) 16.9 (2.8) 17.8 (4.5)
Completeness (%) 93.4 (82.8) 95.5 (82.1) 89.8 (86.4) 90.0 (80.3) 99.3 (98.9) 96.9 (79.0) 98.0 (93.2)
Mosaicity () 1.08 0.84 1.01 1.56 1.24 0.44 0.54
Refinement
Resolution (A˚) Reflections Rwork/Rfree Atoms Average B factor Rmsd Bonds (A˚) Rmsd Angles (
)
ClC-Ka 15–1.6 43,605 20.0/21.8 2,573 30.0 0.004 1.1
ClC-Ka/ATP 15–1.8 31,140 20.0/22.7 2,573 32.9 0.004 1.2
Native was used as a native data set for phasing and initial stages of refinement. Rsym = SjIi  <Ii>j/SjIij, where Ii is the scaled
intensity of the ith measurement and <Ii> is the mean intensity for that reflection. Values for the highest resolution shell are given
in parentheses. Rwork = SjjFoj  jFcjj/SjFoj, where Fo and Fc are the observed and calculated structure factor amplitudes, respec-
tively. Rfree was calculated using a randomly selected 10% sample of the reflection data omitted from refinement.between different family members, thus suggesting that
this interaction is general also for other ClC channels
and transporters (Figures 1A and 2C). Indeed, a similar
dimerization mode has previously been identified in the
structure of the cytoplasmic domain of the transporter
ClC-5, whereas no two-fold relationship was found in
the crystals of the corresponding domain of ClC-0 (Meyer
and Dutzler, 2006; Meyer et al., 2007). The oligomeric
arrangement is unusual for CBS motif containing proteins,
which, although frequently found to dimerize, usually
interact via an extended interface formed by the four
helices a1 and a2 of the two CBS subdomains, in either
a ‘‘head-to-tail’’ or ‘‘head-to-head’’ arrangement (Miller
et al., 2004; Rudolph et al., 2007; Townley and Shapiro,
2007). The common head-to-tail arrangement, in which
the a helices of the subdomain CBS1 from one chain
form a four-helix bundle with the equivalent regions in
the subdomain CBS2 of the interacting protein, motivated
the postulation of a similar interaction mode in ClC-0
(Meyer and Dutzler, 2006).
Probing the Dimer Interface by Mutagenesis
To clarify whether the assembly in the crystals corre-
sponds to the dimer found in solution, we mutated residues
of the dimer interface to either stabilize the oligomeric
structure by crosslinking or alternatively to disrupt dimer-
ization. From the structure, we identified the residue Leu
650 to be located at the periphery of the interaction inter-
face in proximity to the two-fold axis (Figures 2B and 2C).718 Structure 15, 715–725, June 2007 ª2007 Elsevier Ltd All rigThe mutation L650C leads to the formation of an intersubu-
nit disulfide bond bridging the introduced cysteine resi-
dues under oxidizing conditions (Figures 3A and 3B). The
tight structural constraints to form this short covalent
bond are fulfilled in the observed dimer, whereas they
would be incompatible with a head-to-tail or head-to-
head arrangement of the two protein chains.
In a complementary approach, we introduced muta-
tions in residues buried in the dimer interface, aiming to
interfere with dimerization. Several mutants involving the
conserved leucine residues (Leu 651, Leu 647, Leu 633,
and Leu 635) that form the hydrophobic part of the interac-
tion interface failed to express soluble protein, probably
due to the fact that mutations of the bulky side chains
that also contribute to the hydrophobic core of each pro-
tein chain interfere with folding (Figure 2C). Similarly,
mutations of other interface residues (such as Thr 634,
Thr 639, Thr 659, and Ile 589) did not express soluble
protein either (Figure 2C). Mutants involving the interface
residue F636, whose side chain is not buried in the protein
and instead projects toward the dimer interface, in con-
trast, did not show any sign of precipitation. The mutant
F636D expressed soluble protein with a yield similar to
WT. An increase in the gel-filtration elution volume of this
mutant already hinted at a smaller molecular weight. The
subsequent quantification by analytical ultracentrifugation
confirmed that this mutation prevents oligomerization of
the domains and that the protein thus sediments as
a monomer (Figure 3C). While the mutation of a residuehts reserved
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Structure of the Cytoplasmic Domain of ClC-KaFigure 2. Structure of the Dimer Interface
(A) 2Fo  Fc electron density of the dimer interface. The density (calculated at 1.6 A˚ and contoured at 1s) is shown superimposed on selected residues
of the interface. Protein residues are shown as sticks, ordered water molecules as spheres.
(B) Stereo view of the ClC-Ka dimer. The protein is shown as a Ca trace; the molecular surface of one subunit was calculated with MSMS and is shown
superimposed (Sanner et al., 1996). The surface of the dimer interface is colored according to the conservation of the underlying residues: green,
strictly conserved; orange, homologous.
(C) Interaction interface. The view and the color code is similar to that in (B). Residues contacting the dimer interface are shown as sticks, buried water
molecules as red spheres. The surface shows the interaction interface of one subunit.involved in the observed dimer interface interferes with
oligomerization, a mutation that affects a residue that
would be involved in a head-to-tail or head-to-head inter-
face did not have any detectable influence on dimer
formation. The mutant A597D expresses soluble protein
that elutes with a volume similar to WT in gel-filtration
experiments and also shows similar sedimentation prop-
erties as WT (Figure 3C).
The conclusive correlation between structure and
biochemical behavior, as shown for the mutation L650C
that stabilizes the dimer by forming an intersubunit disul-
fide bond and the mutation F636D that prevents dimeriza-
tion, strongly suggests that the interface found in the
crystal structure is preserved in solution and is therefore
not an artifact of crystallization.
Conservation of the Dimer Interface in ClC-0
The strong conservation of residues in the interface and
the similarity of the dimeric structures of the domainsStructure 15, 7from ClC-Ka and ClC-5 motivated us to probe whether
the same intermolecular interactions found in ClC-Ka
would also be preserved in ClC-0. Although the ClC-0
domain robustly dimerizes in solution, its crystal structure
did not reveal its oligomeric organization (Meyer and
Dutzler, 2006). In analogy to the mutational analysis of
the ClC-Ka domain, we mutated equivalent residues in
ClC-0. The residue Leu 741 in ClC-0 is the structural equiv-
alent of the ClC-Ka residue Leu 650. As for the ClC-Ka do-
main, the mutation L741C forms an intersubunit crosslink
in the ClC-0 domain (Figures 4A and 4B), thus suggesting
that also in ClC-0, this residue is close to the symmetry
axis relating two protein chains. Mutations in two positions
in the putative dimer interface of the ClC-0 domain ex-
press soluble protein and were therefore subjected to
sedimentation studies. Mutations of the residues Phe
724 and Val 727, the structural equivalents of the ClC-Ka
residues Leu 633 and Phe 636, to arginine both severely
weaken the stability of the ClC-0 domain dimer, shifting15–725, June 2007 ª2007 Elsevier Ltd All rights reserved 719
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Structure of the Cytoplasmic Domain of ClC-KaFigure 3. Crosslinking and Analytical Ul-
tracentrifugation Experiments of ClC-Ka
Domain Mutants
(A) SDS-PAGE of the purified ClC-Ka domain
and the domain mutant L650C under oxidizing
(ox.) and reducing (red.) conditions. The molec-
ular weight of protein standards and the posi-
tions of the monomeric and dimeric proteins
are indicated. A model of the crosslinked
mutant is shown.
(B) ESI mass spectrometry experiments of the
ClC-Ka domain and the mutant L650C. The
samples were prepared under oxidizing condi-
tions. The His6 tag was not cleaved off during
the experiment. The measurement was within
4 Da of the predicted molecular mass.
(C) Distribution of the sedimentation coefficient
(c[S]) as calculated from sedimentation veloc-
ity experiments for the WT ClC-Ka domain
and the domain mutants F636D and A597D.
The oligomeric state (m, monomer; d, dimer)
is indicated. A view along the two-fold axis
shows the position of the residue Phe 636 in
the dimer interface.the dissociation constant to larger values (Figures 4C
and 4D). The mutations K567A and A766R, involving
residues that would be part of a possible head-to-tail
interface, in contrast, do not have a strong effect on
oligomerization in solution, consistent with the assump-
tion that the ClC-0 dimer shares the same interaction inter-
face found in the crystals of the domains of ClC-Ka and
ClC-5. Finally, we probed whether a similar crosslink as
found for the mutant L741C in the ClC-0 domain could
also be formed in the context of the full-length protein.
We have expressed full-length ClC-0 and the point mu-
tant L741C as hexahistidine fusion proteins in Xenopus
laevis oocytes and have investigated the formation of a
covalent crosslink of the protein in the membrane under
oxidizing conditions following detection by SDS-PAGE
and western blot using an anti-His6 antibody (Figure 4E).
Also in this case, the mutant L741C allows the formation
of a selective crosslink between two protein chains, indi-
cating that the dimeric structure of the isolated domains
in solution is preserved in the full-length transmembrane
protein.720 Structure 15, 715–725, June 2007 ª2007 Elsevier Ltd All rigDISCUSSION
Ion transport proteins frequently contain cytoplasmic reg-
ulatory units that are attached to the transmembrane cat-
alytic domains and that regulate ion transport in response
to cellular signals. Such cytoplasmic units are ubiquitously
found in eukaryotic members of the ClC family of Cl
channels and transporters. Although their detailed role in
most family members is to date still unknown, increasing
experimental evidence points to an involvement in trans-
port regulation, in certain cases in response to the interac-
tion with adenosine nucleotides (Bennetts et al., 2005;
Meyer et al., 2007; Vanoye and George, 2002). Two recent
crystal structures of the cytoplasmic domains of ClC-0 and
ClC-5 revealed the structural organization of these do-
mains from two representative family members (Meyer
and Dutzler, 2006; Meyer et al., 2007). However, the olig-
omeric assembly that relates these putative regulatory
components to the dimeric transmembrane pore re-
mained ambiguous. This ambiguity could now be clarified
by the structure of the equivalent region of the channelhts reserved
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Structure of the Cytoplasmic Domain of ClC-KaFigure 4. Oligomerization in the Channel ClC-0
(A) SDS-PAGE of the purified ClC-0 domain and the domain mutant L741C under oxidizing (ox.) and reducing (red.) conditions. The molecular weight
of protein standards and the positions of the monomeric (m) and dimeric (d) proteins are indicated.
(B) ESI mass spectrometry experiments of the ClC-0 domain and the mutant L741C. The samples were prepared under oxidizing conditions. The His6
tag was not cleaved off during the experiment. The measurement was within 7 Da of the predicted molecular mass.
(C) Distribution of the sedimentation coefficient (c[S]) as calculated from sedimentation velocity experiments of the WT ClC-0 domain and of mutants
at different protein concentrations. The oligomeric state (m, monomer; d, dimer) is indicated.
(D) Dimer affinity. The fraction of dimeric protein (calculated from the integration of the respective peaks in [C]) is plotted against the protein concen-
tration. Kd was calculated by a fit of the data to the equation fdimer = 1/(c/Kd + 1), where fdimer is the fraction of the dimeric protein and c is the protein
concentration. The respective Kds are: WT = 21 mM (—), K567A = 15 mM (-$$-), A766R = 28 mM (-$-), F724R = 87 mM (- - -), V727R = 103 mM ($$$).
(E) Crosslinking of the full-length ClC-0 and the mutant L741C. The protein was expressed as a His6 fusion protein in X. laevis oocytes, and crosslinked
in its membrane environment under oxidizing conditions. The membrane fraction was separated by SDS-PAGE and detected by western blot using an
anti-His6 antibody. The oligomeric states (m, monomer; d, dimer) are indicated. The position of the respective molecular weight markers is indicated
on the left (ox., oxidation by incubation in 100 mM sodium tetrathionate at 4C for 30 min; red., subsequent reduction of the sample after oxidation).ClC-Ka in conjunction with biochemical data. The cyto-
plasmic domain of the channel ClC-Ka is a homodimer
of two structurally similar CBS motif containing proteins.Structure 15, 7Each subunit exhibits an organization that is common to
proteins with a similar fold. Unlike its counterpart in the
transporter ClC-5, the ClC-Ka domain does not interact15–725, June 2007 ª2007 Elsevier Ltd All rights reserved 721
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Structure of the Cytoplasmic Domain of ClC-Kawith adenosine nucleotides. As the equivalent structure of
the channel ClC-0 has no affinity for nucleotides either, it
remains an important question whether there might be
yet undiscovered ligands that bind to the cytoplasmic
domains of certain ClC family members and thereby influ-
ence the functional behavior of these transport proteins.
As ClC-K channels were found to interact with their auxil-
iary b subunit Barttin, which itself is a putative transmem-
brane protein, another unresolved question concerns
a possible interaction between the large cytoplasmic
component of Barttin and the cytoplasmic domain of
ClC-Ka (Estevez et al., 2001; Scholl et al., 2006). As the
functional behavior of ClC-K channels are to date only
poorly characterized, it is not a surprise that we currently
lack detailed information on the functional role of their
cytoplasmic components.
Apart from its high-resolution structure, the main impor-
tant feature discovered in this study concerns the oligo-
meric organization of the ClC-Ka domain, which is likely
general for other members of the family. The structure
reveals a conserved interaction interface that relates two
protein chains by a two-fold symmetric arrangement.
The intermolecular interactions are predominantly formed
between residues of the CBS2 motifs and bury more than
1500 A˚2 of the combined molecular surface. When includ-
ing coordinated water molecules, most of which are found
in a narrow tunnel crossing the interface, the contact sur-
face increases to 2000 A˚2. Several observations suggest
that the intermolecular interactions are preserved among
ClC proteins, as follows. (1) The dimeric relationship in
the ClC-Ka domain is very similar to an assembly found
in the previously determined ClC-5 domain structure
(Meyer et al., 2007). The 2-fold related CBS2 subdomains
of the respective dimers superimpose with a root-mean-
square deviation (rmsd) of only 1.4 A˚, and several residues
contributing to the interface are conserved in sequence
and structure (Figures 1A and 5A). (2) Biochemical exper-
iments from this study show strong evidence that the olig-
omeric structure of the ClC-Ka domain represents its
structure in solution, and similar experiments in ClC-0
strongly suggest that a pair of cytoplasmic domains of
this distantly related channel share the same interaction
interface. (3) Crosslinking experiments on full-length
ClC-0 in its membrane environment indicate that the
observed assembly is also preserved in the context of
the transmembrane channel.
The dimeric structures of the cytoplasmic ClC domains
are unusual and do not resemble common interaction
modes found in other proteins that share a similar fold
(Miller et al., 2004; Rudolph et al., 2007; Townley and
Shapiro, 2007). These head-to-head or head-to-tail
dimers, which we summarize as ‘‘conventional inter-
faces,’’ usually interact via a flat surface formed by the
two a helices of each CBS subdomain. Conventional inter-
faces usually bury a larger surface between 3300 and
4300 A˚2 and confer a disk-like appearance to the protein
assembly (Figure 5B). Two predominant features distin-
guish cytoplasmic ClC domains from other CBS motif
containing proteins, as follows. (1) The chemical features722 Structure 15, 715–725, June 2007 ª2007 Elsevier Ltd All riof the interface defined in the ClC family are not preserved
in proteins that oligomerize as ‘‘conventional dimers’’ and
vice versa. The respective interfaces thus exhibit a greater
degree of sequence conservation and larger hydrophobic
patches. (2) The helices of proteins forming conventional
dimers are positioned to allow a snug fit upon dimeriza-
tion, resulting in extensive interactions between both sub-
domains. Although the individual CBS motifs are generally
similar in structure, a difference in their arrangement with
respect to each other prevents the formation of an equally
large interface for the respective ClC domains. For exam-
ple, in the case of the cytoplasmic domain of the channel
ClC-Ka, this conformational difference is most pro-
nounced (Figure 5B). A partial structure including both
CBS motifs superimposes with an rmsd of more than
4.6 A˚ with the respective regions of the conventional di-
mer, forming protein TM0935 from Thermotoga maritima
(whereas the individual CBS motifs of the two proteins
would superimpose with an rmsd of only 1.8 A˚ and 1.2 A˚,
respectively) (Miller et al., 2004). A similar oligomerization
of the ClC-Ka domain would therefore only bury about
1800 A˚2 of the common molecular surface as compared
to more than 4300 A˚2 in the case of TM0935.
The considerably smaller interaction interface found in
the structures of the cytoplasmic domains of ClC proteins
might reflect the necessity to undergo conformational
changes upon transport regulation (Pusch et al., 1997).
Such a conformational change has recently been ob-
served in the channel ClC-0. Using Forster resonance
energy transfer spectroscopy, the authors of the study
described a distance increase between the two C termini
in the dimeric channel of more than 20 A˚ upon common
gate closure, a regulatory mechanism which affects
both subunits of the homodimeric protein (Bykova et al.,
2006; Miller, 1982). Although the structure of the ClC-0 do-
main was previously determined, its oligomeric organiza-
tion was not revealed by the crystal structure (Meyer and
Dutzler, 2006). When generating a dimeric assembly of
the ClC-0 domain using the ClC-Ka domain structure as
a template, the resulting dimer shows an interesting
feature: despite an overall fit, a dimeric organization as
seen in ClC-Ka or ClC-5 appears to be prevented by the
local conformation of the protein at the beginning of
strand b1. This region contains a sequence stretch that
is conserved in ClC-5 and most other ClC proteins
(although not in ClC-Ka). The conserved SPF motif (involv-
ing the residues Ser 722, Pro 723, and Phe 724 in ClC-0)
is well defined in the equivalent region of the transporter
ClC-5 but differs in its conformation with respect to
ClC-0 (Figure 5C). We have shown that a mutation of
Phe 724 destabilizes dimerization in the ClC-0 domain,
thereby underlining its role in the interaction interface
(Figures 4C and 4D). It thus remains to be shown
whether this conformational difference in ClC-0 could
represent an alternative conformation that would lead
to a change in the dimeric assembly as seen during
common gating.
In this study, we have described the dimeric structure of
the cytoplasmic domain of the human channel ClC-Ka,ghts reserved
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Structure of the Cytoplasmic Domain of ClC-KaFigure 5. Structural Comparison of ClC
Cytoplasmic Domains
(A) Stereo view of a superposition of the ClC-
Ka domain dimer (red) and the ClC-5 domain
dimer (green). The superposition was gener-
ated by a least-square fit of the two CBS2
subdomains of the respective dimer. The
structures are shown as Ca traces.
(B) Stereo view of a Ca trace of the head-to-tail
dimer of the protein TM0935 from T. maritima
(cyan). The structure of a Ca trace of a single
subunit of the cytoplasmic domain from ClC-
Ka is shown superimposed (red). The superpo-
sition was generated by a least-square fit of the
respective CBS2 subdomain of ClC-Ka on the
CBS2 subdomain of a single subunit of
TM0935.
(C) Superposition of the cytoplasmic domains
from ClC-0 (orange) and ClC-5 (green). A
section of a single subunit around b strand 1
of CBS2 close to the dimer interface is shown.
The view is approximately along the dimer axis.
Selected residues including the conserved
SPF motif (Ser 722, Pro 723, and Phe 724 in
ClC-0) are shown as sticks.
(D) Possible relationship in the full-length ClC
protein. Ca trace of the EcClC dimer and the
dimeric structure of the cytoplasmic domain
of ClC-Ka are shown. The subunits are colored
in blue and green, respectively. Bound ions in
the EcClC structure are shown as red spheres.
The exact relationship between the two com-
ponents is currently unknown.and have shown evidence that the observed intermolecu-
lar interaction is conserved within members of the ClC
family. It is very likely that this quaternary arrangement is
preserved in the context of the full-length proteins (Figures
4D and 5D). The next challenging step is to relate these
cytoplasmic components to the transmembrane pore
and reveal how changes in the domain conformation are
transmitted to influence the catalytic unit. With the current
study, we provide a structural framework for future inves-
tigations which may shed light on these poorly understood
mechanisms.Structure 15, 71EXPERIMENTAL PROCEDURES
Protein Preparation
For expression in Escherichia coli, the cytoplasmic domain of the
channel ClC-Ka from Homo sapiens (GenBank accession number
P51800) encompassing residues 533–687 was cloned into the
pET28-b+ vector (Novagen) with a C-terminal recognition site for Pres-
cission protease (GE Healthcare) and a hexahistidine tag. E. coli BL21
(DE3) cells transformed with the expression construct were grown at
37C in Luria broth medium containing 50 mg/l kanamycin to an
OD600 of 1.5. Expression was induced by addition of 0.5 mM
isopropyl-D-thiogalactopyranoside (IPTG) at 20C overnight. Cells5–725, June 2007 ª2007 Elsevier Ltd All rights reserved 723
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Structure of the Cytoplasmic Domain of ClC-Kawere harvested and lysed by sonication in 50 mM Tris-HCl (pH 7.5),
200 mM NaCl, 5 mM b-mercaptoethanol, 1 mg/ml lysozyme, 20 mg/ml
DNase, 1 mg/ml leupeptin, 1 mg/ml pepstatin, and 1 mM phenylmethyl
sulfonyl fluoride (PMSF). The lysate was cleared by centrifugation and
the protein was purified by affinity chromatography on a nickel chelat-
ing Sepharose column (GE Healthcare). The pure protein was cleaved
with Prescission protease (GE Healthcare) to remove the hexahistidine
tag and dialyzed into TBS buffer (10 mM Tris-HCl [pH 7.5], 200 mM
NaCl, 5 mM b-mercaptoethanol). After concentration, the protein
was subjected to gel filtration on a Superdex 200 column (GE Health-
care). For preparation of selenomethionine-labeled protein, the
bacterial culture was grown in minimal medium containing 50 mg/l
Se methionine. The cytoplasmic domain of ClC-0 from T. marmorata
was cloned into the pET28-b+ vector (Novagen) with a C-terminal rec-
ognition site for Prescission protease (GE Healthcare) and a hexahisti-
dine tag and was expressed and purified as previously described
(Meyer and Dutzler, 2006). Mutations were inserted with the Quik-
Change method (Stratagene) and confirmed by sequencing. Mutant
proteins were purified following the same protocol as for WT. For
crosslinking studies, the respective disulfide bridges formed spon-
taneously upon exposure to air and were reduced by addition of
250 mM b-mercaptoethanol. The proteins were analyzed by SDS-PAGE,
and molecular masses were confirmed by electrospray ionization
(ESI) mass spectrometry.
Crystallization and Crystal Preparation
Crystals of the ClC-Ka cytoplasmic domain were obtained at 4C by
the sitting drop vapor diffusion method. Purified protein with a concen-
tration of 5–10 mg/ml was mixed in a 1:1 ratio with reservoir solution
containing 100 mM MgCl2, 50 mM Tris-HCl (pH 8.5), and 20% PEG
4000 and was equilibrated against the reservoir. The reservoir solution
of crystals used for the high-resolution data sets and for cocrystalliza-
tion with ATP contained 100 mM KI instead of MgCl2. Crystals grew
after 2 days in space group P21 (a = 35.3 A˚, b = 83.4 A˚, c = 58.9 A˚,
a = 90, b = 92.5, g = 90) with two copies of the ClC-Ka domain in
the asymmetric unit. Heavy-metal derivatives were obtained by soak-
ing native crystals for 6 hr in mother liquor containing 1 mM methyl
mercury chloride, 1 mM Hg(II) chloride, or 300 mM KI. For cryoprotec-
tion, the crystals were successively transferred into mother liquor
containing increasing concentrations of ethylene glycol to a final
concentration of 25%, flash-frozen in liquid propane, and stored in
liquid nitrogen.
Crystallography
Data were collected on a Mar225 CCD detector (Marresearch) at the
X06SA beamline at the Swiss Light Source of the Paul Scherrer Insti-
tute and on a Mar345 imaging plate on an in-house rotating anode
(Nonius) (Table 1). The data were indexed and integrated with DENZO
and SCALEPACK and further processed with CCP4 programs (CCP4,
1994; Otwinowski and Minor, 1997). The structure of the human ClC-
Ka domain was determined by the multiple isomorphous replacement
method making use of three heavy-atom derivatives. Initial low-resolu-
tion phases were determined by the single anomalous dispersion
method from a data set from a crystal of Se methionylated protein
collected at the anomalous absorption edge of Se. The four Se sites
in the asymmetric unit were identified with the program SHELXC
and -D (Schneider and Sheldrick, 2002). The sites were refined and
low-resolution phases were calculated in SHARP (de La Fortelle and
Bricogne, 1997). These low-resolution phases allowed the identifica-
tion of heavy-atom positions in three derivatives by difference-Fourier
techniques. The heavy-atom positions were refined in SHARP, and
phases were initially improved in Solomon and subsequently by two-
fold noncrystallographic symmetry (NCS) averaging in DM (Abrahams
and Leslie, 1996; Cowtan, 1994; de La Fortelle and Bricogne, 1997). An
initial model was built into electron density of a data set at 2.6 A˚ in O
and refined in CNS using strict NCS constraints (Brunger et al.,
1998; Jones et al., 1991). The structure was subsequently refined in
a data set collected to 1.6 A˚ using CNS. Initial NCS constraints were724 Structure 15, 715–725, June 2007 ª2007 Elsevier Ltd All rsubsequently loosened, and restrained individual B factors were re-
fined using CNS (Brunger et al., 1998). The same set of reflections
(10%) was set aside for calculation of Rfree throughout the refinement.
The final model contains 2283 protein atoms, 286 water molecules,
one I ion, and three Cl ions with good geometry. All four ions bind
at the periphery of the protein and probably do not have any functional
significance. This model was used for refinement in a data set at 1.8 A˚
from a crystal grown in the presence of 5 mM ATP. The structure of the
protein in these crystals is virtually identical to the structure in the ab-
sence of ATP, and no residual density for bound ATP could be identi-
fied (Table 1). The interaction interfaces between subunits were calcu-
lated in CNS (Brunger et al., 1998).
Analytical Ultracentrifugation
Sedimentation velocity experiments were performed with a Beckman
model XL-I analytical ultracentrifuge with an An 50-Ti rotor at 4C. Dou-
ble-sector centerpieces were filled with 400 ml of protein samples and
420 ml of TBS buffer. Data were acquired at 280 nm in continuous-scan
mode in 0.003 cm intervals at a rotor speed of 40,000 rpm. Sedimen-
tation analysis of the ClC-Ka cytoplasmic domain and its mutants
F636D and A597D was performed at protein concentrations of
15 mM. For the ClC-0 cytoplasmic domain, WT protein and the domain
mutants P724R, V727R, K567A, and A766R were used at concentra-
tions of 17.5, 35, 70, and 140 mM. Data analysis was performed with
the c(S) module of Sedfit (Schuck et al., 2002). The buffer parameters,
partial-specific volume of the protein, and the corrected sedimentation
coefficients S20W were calculated by using Sednterp (Laue et al.,
1992). The S20W values for the WT ClC-Ka domain (2.34 S) and for
the mutant F636D (1.81 S) are consistent with a dimeric and a mono-
meric molecular assembly, respectively. Also in the case of the
ClC-0 domain, the S20W values for the WT ClC-0 domain at 140 mM
protein concentration (4.26 S) and for the mutant V727R at 17.5 mM
protein concentration (2.46 S) match the expected values for a dimer
and a monomer, respectively. For data used in this analysis, the root-
mean-square deviations of all the fits were between 0.005 and 0.01.
Expression of ClC-0 in X. laevis Oocytes and Western
Blot Analysis
ClC-0 from T. marmorata was cloned into the pTLN vector as a C-
terminal hexahistidine fusion protein for expression in X. laevis. Muta-
tion L741C was introduced with the QuikChange method (Stratagene)
and confirmed by DNA sequencing. After the linearization of plasmid
DNA by MluI, capped cRNA was transcribed with the mMessage
mMachine kit (Ambion) and purified with the RNeasy kit (QIAGEN).
For expression, 20 ng of RNA was injected into the defolliculated
oocytes. The oocytes were kept at 17C in Barth’s solution for
3 days after injection. Oocytes were homogenized in lysis buffer
containing 5 mM Tris-HCl (pH 6.9), 250 mM sucrose, 0.5 mM EDTA,
1 mg/ml leupeptin, 1 mg/ml pepstatin, and 1 mM PMSF. The lysate
was centrifuged two times at 100 3 g at 4C to remove large cellular
debris. For oxidative crosslinking, the supernatant containing the
membrane fraction was treated with 100 mM sodium tetrathionate
for 30 min at 4C and then separated on an 8% SDS-polyacrylamide
gel. Western blot analysis with anti-His6-peroxidase monoclonal anti-
body was performed according to the manufacturer’s instructions
(Roche Applied Science). Proteins were detected with Immobilon
western chemiluminescent HRP substrate (Millipore) and BioMax
XAR photographic film (Kodak).
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3 General Discussion and Outlook 
 
 
The cytoplasmic domains in eukaryotic ClC proteins have been recognized to be intimately 
involved in regulatory processes. One of these processes is the regulation of ClCs in 
response to nucleotide binding that has been shown to have opposite effects on ion 
transport in different ClC proteins. While in the muscle channel ClC-1 intracellular ATP 
has an inhibitory effect (Tseng, Bennetts et al. 2007), in the human transporter ClC-5 ATP 
increases the probabilty for an active, open state (Zifarelli and Pusch 2009). Although the 
chemistry of nucleotide binding has been revealed from the crystal structure of the ClC-5 
domain (Meyer, Savaresi et al. 2007), structural differences i.e. conformational changes 
expected to happen in the intracellular domains upon ligand binding are still not known. A 
probably related mechanism of regulation is the process of common gating in ClC channels 
that has been recently associated with the movements in the cytoplasmic domains (Bykova, 
Zhang et al. 2006). It has been demonstrated that the closure of the common gate in ClC-0 
coincides with the separation of the cytoplasmic domains by a distance up to 20 Å. In order 
to fully understand the described regulatory phenomena a structural basis for the 
organization of cytoplasmic domains in the context of full length ClC proteins is ultimately 
required.  
 It has been anticipated that the cytoplasmic domains in ClC proteins extend the 
two-fold symmetry of the transmembrane domains and that the interaction between them is 
important for the structure and function of these dimeric proteins. However, the previous 
structural and biochemical studies on the cytoplasmic domains of ClC-0 and ClC-5 have 
left their mode of dimerization ambiguous (Meyer and Dutzler 2006; Meyer, Savaresi et al. 
2007). In this work the dimeric organization of the cytoplasmic domains in eukaryotic ClC 
proteins has been clarified through the examination of the domain of the human channel 
ClC-Ka (Markovic and Dutzler 2007). The structural and biochemical analyses of the ClC-
Ka domain confirmed a novel mode of dimerization not found in other CBS domain 
containing proteins. This study has also suggested that the dimeric interaction is conserved 
in the eukaryotic family members and likely preserved in the context of the full-length 
proteins. Therefore, the structure of the ClC-Ka domain dimer serves as an initial structural 
basis for comprehending possible domain movements asociated with the common gating in 
ClC-0 and it allows the design of future functional experiments.  
 The interaction in the ClC-Ka domain dimer is formed mainly through the CBS2 
subdomains and leads to a V-shaped dimer with the combined surface of the interface of 
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around 1500 Ǻ2. This considerably smaller interface and a different arrangement of 
subunits than found in other CBS domain dimers might indicate the necessity to undergo 
conformational changes during the regulation of ion transport. Although mainly composed 
of hydrophobic residues, the interface contains a number of water molecules which build a 
tunnel in the lower part of the contact area. This finding could suggest a dissociation of the 
dimer in this part of the interface during the domain movement. Other interesting features 
of the ClC cytoplasmic domains discovered in this work are different affinities of the 
interaction found for the ClC-Ka and the ClC-0 domain by sedimentation analysis. While 
the ClC-Ka domain showed dimeric behavior independent of the tested protein 
concentrations, the ClC-0 domain dissociates at low protein concentration indicating lower 
affinity. This would mean that while the general dimeric arrangement of the cytoplasmic 
domains is conserved within eukaryotic ClC proteins, it might be energetically tuned in 
each specific protein depending on the regulatory function it needs to fulfill. The weaker 
interaction in the ClC-0 dimer agrees with the movements happening during the common 
gate closure while the stable dimer of the ClC-Ka cytoplasmic domain may be important 
for the unique function of this channel. ClC-K channels are the only ClCs that contain a 
valine residue instead of the gating glutamate, which implies that they do not contain a 
protopore gate that closes the individual pores. In case the tight interaction between the 
cytoplasmic domains also stabilizes the open state of the common gate (which has not yet 
been confirmed to exist in ClC-K channels), the channels may be constitutively open. Such 
non-gated, ohmic “leak” channels are suited to support the transepithelial transport over a 
large range of membrane potentials, which is the function of ClC-K channels in the 
epithelia of kidney and inner ear. The fact that ClC-K channels have a regulatory subunit 
Barttin, that has been implicated to modulate gating and conduction in heterologous 
expression systems (Scholl, Hebeisen et al. 2006), could also mean that ion transport in the 
ClC-K channels is not regulated by common mechanisms found in other ClC channels, but 
instead by the interaction with the accessory subunit. The ultimate goal in explaining the 
molecular basis for the regulatory role of the β-subunit Barttin is structure determination of 
the ClC-K channel – Barttin complex.  
 Although the structure of the ClC-Ka domain has made an important advance 
towards revealing structural relationship between the cytoplasmic domains in eukaryotic 
ClCs, the question of how the domains would be positioned with respect to the catalytic 
membrane domains and the pore remains unclear. In the hypothetical arrangement of the 
full-length protein shown in Figure 3.1, the CBS2 subdomains of the dimer are positioned 
in proximity to the membrane domain. Since the N-terminus wraps around CBS2, the 
connection with the last helix of the transmembrane part could be easily established. This 
hypothesis is supported by split channel experiments that showed that functional ClC-0 and 
ClC-1 channels could be reconstituted upon co-expression of the part containing the 
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transmembrane domain and the CBS1 subdomain and the part comprising CBS2 (Schmidt-
Rose and Jentsch 1997; Maduke, Williams et al. 1998). These results have suggested that 
CBS2 is closer to the membrane and thus necessary to form the interaction between the 
cytoplasmic and the transmembrane domain. 
 
                               
 
Figure 3.1. Possible relationship in the full-length eukaryotic ClC protein.  
Cα trace of the EcClC dimer and the dimeric structure of the cytoplasmic domain of ClC-Ka are shown. The 
subunits are colored in blue and green, respectively. Bound ions in the EcClC structure are shown as red 
spheres. Dotted lines present the linker between the last transmembrane helix and the N-terminus of the 
cytoplasmic domain.  
 
 To resolve the organization and arrangement of the catalytic and intracellular 
domains it is crucial to determine the structure of ClC proteins that contain both 
components. During the course of this PhD project an effort has been taken in establishing 
Pichia pastoris expression system for eukaryotic ClC homologs (see Appendix 4.3). 
However, the performed experiments showed that the expression of eukaryotic ClC 
proteins still needs to overcome experimental challenges to be useful for structural studies. 
In the future, besides the P. pastoris other expression systems like baculovirus-mediated 
insect cell expression and expression in mammalian cells will have to be explored. To 
increase the chance of finding eukaryotic candidates suitable for crystallization and 
structure determination, the expression screening should be performed in a high-
throughput manner including testing of different proteins, tags and modifications of 
individual constructs.  
 In several cases it has proven useful to turn to prokaryotic homologs for structural 
studies of membrane proteins (Doyle, Morais Cabral et al. 1998; Luecke, Schobert et al. 
2001; Locher, Lee et al. 2002; Yamashita, Singh et al. 2005; Hilf and Dutzler 2008). These 
out 
in 
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proteins are generally more readily expressed, biochemically more stable and more 
amenable to crystallization. There are a number of prokaryotic ClC homologs that share 
the molecular architecture of eukaryotic proteins, containing both the catalytic domain with 
all the conserved features of the selectivity filter and the cytoplasmic domains with both 
CBS subdomains. In this work an extensive screening of prokaryotic ClC homologs for 
expression in E. coli has been carried out. The critical factor in the screening was the 
expression of the membrane proteins under the control of a tunable pBAD promoter and 
the use of C-terminally fused GFP, which serves as a folding indicator and allows a 
straightforward quantification prior to purification. In this broad screen of conditions 
encompassing 27 different homologs only one protein proved to be suitable for 
crystallization experiments.     
 The selected ClC homolog, Rm1ClC, originates from the bacterium Ralstonia 
metallidurans, an extremophile capable of growing in high concentrations of heavy metals. 
The genome of this prokaryote provides a rich source of different membrane transport 
proteins (von Rozycki, Nies et al. 2005). The sequence of Rm1ClC contains the conserved 
features of the ClC family and it is, additionally, unusually compact due to the truncation 
of loops connecting the helices of the transmembrane domain and the short CBS domain. 
The Rm1ClC protein is highly expressed and stable in mild detergents suitable for 
crystallization. However, despite having all the characteristics that makes it a promising 
target for crystallization, full-length Rm1ClC has not given crystals during the course of 
this PhD project despite the exhaustive screening of conditions. It might be interesting to 
speculate about the underlying cause for this behavior. One possibility is that the protein 
exists in multiple energetically equivalent conformations which would prohibit crystal 
lattice formation. While the transmembrane domain and the cytoplasmic domains as 
separate entities are expected to be relatively rigid, the above discussed regulatory 
mechanisms in eukaryotic ClCs would imply that the regions linking the two domains 
might confer flexibility. This hypothesis is to some extent supported by the successful 
crystallization of the transmembrane and the cytoplasmic domain of Rm1ClC in isolation. 
The fact that both the transmembrane and the cytoplasmic domain are stable when 
expressed independently suggests that the interaction between these domains in the context 
of the full-length protein might be weak, thus promoting flexibility.  
 The transmembrane domain of Rm1ClC crystallized readily, but at the same time 
revealed the challenges often observed in membrane protein crystallography. The obtained 
crystals diffracted X-rays only to low resolution and were overall resistant to improvement 
by variations of the detergents used for crystallization and modifications of the expression 
construct. When aiming for the elucidation of novel properties and minor structural 
differences between a new ClC family member and the currently known proteins, high 
resolution structure is essential. Therefore, future crystallization experiments on the 
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Rm1ClC transmembrane domain will include co-crystallization with the selected binders 
(see Appendix 4.1), which might contribute to a better crystal packing and provide crystals 
diffracting to higher resolution.  
 The structure of the Rm1ClC cytoplasmic domain determined in this work is the 
second structure of a CBS domain originating from a prokaryotic ClC protein. While both 
prokaryotic structures, the Rm1ClC and the PtClC cytoplasmic domain (Looser 2008) have 
a typical CBS fold, they do not show dimeric arrangement found to be conserved in the 
eukaryotic ClC proteins. Both prokaryotic domains are monomers in solution and the 
analyzed contacts in the crystals of both proteins do not suggest likely dimeric 
organizations in the context of the full-length proteins. This finding directly opens a 
question on the role of these intracellular components in prokaryotic ClC proteins. It will 
have to be shown whether they play a solely structural role in keeping the R helix in a 
certain conformation required or whether they interact in order to regulate ion transport in 
the protein. An answer to this question will require structural information on the full-length 
protein. In order to reach this long standing goal, future experiments will have to include 
co-crystallization experiments of the Rm1ClC full-length protein with selected binders, 
assuming that some of them might stabilize the cytoplasmic domains in a conformation 
suitable for crystallization. Another way to reveal the arrangement of the cytoplasmic 
domains within the prokaryotic ClC proteins could come from electron paramagnetic 
resonance (EPR) spectroscopy. EPR spectroscopy allows indirect determination of 
structural organization of proteins by measuring distances between introduced spin labels. 
Labeling of the cytoplasmic domains of Rm1ClC might provide information on their 
structural relationship in the full-length protein, but also on their flexibility. Other indirect 
methods, like chemical cross-linking and FRET are valuable alternatives for the analysis of 
the cytoplasmic domain assembly. 
One of the important goals will be to clarify whether the cytoplasmic domains of 
prokaryotic ClCs bind ligands, like some of their eukaryotic counterparts. The binding of 
nucleotides seems unlikely in light of the known structure of the Rm1ClC and PtClC 
domain. However, some other molecules or ions might serve as ligands for these proteins. 
The CBS domains that bind ions and act as ion sensors are found in the transporters MgtE 
(Hattori, Iwase et al. 2009) and OpuA (Biemans-Oldehinkel, Mahmood et al. 2006). In the 
crystal structure of the Rm1ClC CBS domain chloride and zinc ions are detected at 
prominent positions. The affinity of ion binding will have to be tested by titration 
calorimetry and biochemical assays. The screening for other potential ligands will have to 
be continued, which might ultimately lead to the discovery of molecules that induce 
conformational changes in the domain and regulate ion transport. At this point, structural 
and functional analyses will have to go hand in hand to explain the mechanism of 
regulation.    
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A future focus will also have to be on a functional characterization of Rm1ClC by 
electrophysiological recordings and transport assays. It will be important to determine the 
affinities for chloride ions in the selectivity filter. From combined functional experiments it 
should be possible to draw conclusions about the rate of ion transport and reveal whether 
this protein functions as a channel or as a transporter. The presence of valine residue at the 
position of Gluint does not unambiguously allow to deduce whether Rm1ClC functions as 
channel.  
 In summary, in the context of this thesis a prokaryotic ClC protein containing CBS 
cytoplasmic domains has been established as promising model for structural and functional 
studies. The first structural insights into its components have already been obtained. Future 
experiments on Rm1ClC are expected to establish the role of cytoplasmic domains in 
prokaryotic ClC proteins and provide some analogy for understanding the regulatory 
mechanisms in the eukaryotic ClC family members.   
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4 Appendix 
 
4.1 Design of antibodies against Rm1ClC protein 
 
4.1.1 Binding molecules that facilitate crystallization 
 
In X-ray structure determination of membrane proteins the main obstacle after providing 
sufficient amounts of a target protein is to obtain well-ordered three dimensional crystals. 
The amphipatic nature of membrane proteins often makes their crystallization difficult. 
Membrane proteins contain large hydrophobic surfaces that upon solubilization are 
covered by detergent molecules and only relatively small hydrophilic regions needed for 
establishing protein-protein contacts in a three-dimensional crystal lattice. In addition, 
membrane transport proteins often exist in multiple conformations, which is another 
unfavorable property for crystal formation.  
 A strategy for obtaining well-ordered crystals is the use of crystallization chaperons 
that bind to the target protein and increase its crystallization probability (Koide 2009). 
These crystallization chaperons enlarge the hydrophilic part of membrane proteins thereby 
providing additional surface for crystal contacts and reduce a conformational heterogeneity 
in the target by binding to a specific conformation. Several types of binders are nowadays 
used to support crystallization of proteins including antibody fragments, designed ankyrin 
repeat proteins (DARPINs), affibodies (Hogbom, Eklund et al. 2003) etc.  
 Antibody derived binders like Fabs, Fvs and single chain Fvs (scFvs) are still the 
most commonly used chaperones in the crystallization of membrane proteins (Figure 
4.1.1A). Fabs are composed of  variable and constant parts of the light chain and of the N-
terminal halve of the heavy chain of IgGs. They can be generated by partial proteolytic 
digestion of IgGs with papain. Fvs are composed of the variable parts of heavy and light 
chains and are usually linked via a short peptide to provide stable scFvs. Antibody 
fragments can be generated either by a combination of animal immunization and 
hybridoma technology or by in vitro selection from engineered libraries by display 
techniques. Traditional selection approach by animal immunization is often combined with 
the cloning and expression of Fab and Fv fragments in E. coli.  
Over the last decade, many important membrane protein structures were 
determined in the complex with antibody fragments. For instance, the crystallization of the 
ClC homolog from E. coli, EcClC, in the complex with a Fab fragment has enabled its 
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structure determination at 2.5 Å (Dutzler, Campbell et al. 2003). The improvement of 
diffraction quality was due to the increased hydrophilic surface (Figure 4.1.2A).  
 
A B 
 
 
 
Figure 4.1.1. Schematic representation of antibody fragments and DARPINs. 
(A) IgGs are part of the immune system and created through hybridoma technology. They consist of two 
chains, heavy (grey) and light (white) chain. Interaction between the chains and several cysteine bridges 
stabilize the structure. Both chains contain constant (labeled C) and variable regions (labeled V). Variable 
regions carry the complementary defining regions (CDRs) that are important for antigen recognition. Fab 
fragments are generated by proteolytic cleavage in the linker region (red lines).  
Figure derived from: http://www.currentprotocols.com/protocol/ps0609 
(B) Modular composition of DARPINs. The binding modules (N=3 is shown) have a defined structure 
encoded by a consensus sequence. Residue variations at restricted positions (red) assemble the library for 
ribosome display. The N- and C- terminal caps shield the hydrophobic core and generate a stable protein.  
 
 DARPINs are synthetic binding proteins composed of ankyrin repeat modules 
(Figure 4.1.1B) (Binz, Amstutz et al. 2004). They are selected from large libraries by 
ribosome or phage display. Their advantage compared to antibodies is that they are formed 
of a single polypeptide chain free of disulfide bonds, have high stability and high 
expression level in E. coli.. 
 
                 A 
                     
  B 
         
Figure 4.1.2. Crystallization chaperons in membrane protein structure determination.  
(A) Crystallization of complexes of membrane proteins with chaperones can increase the hydrophilic surface 
and be essential for crystal contacts like in EcClC (grey) crystallized with Fabs (green – heavy, blue – light 
chain) (1ots). (B) Crystallization chaperon can also fix a certain conformation and allow structure 
determination of distinct transport states like in AcrB (grey) in complex with DARPINs (red) (2j8s).  
binding modules 
N-cap C-cap 
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So far, the use of DARPINs in membrane protein crystallization has been reported 
only once. Crystallization of the multidrug exporter AcrB with a DARPIN chaperone 
resulted in a higher resolution of this secondary active transport protein (Sennhauser, 
Amstutz et al. 2007). The improved crystallization properties were probably due to the 
selective binding and stabilization of one conformation in the transport cycle of AcrB. The 
formation of novel crystal contacts by an increase of the polar surface was in this case not 
observed. 
 
 
4.1.2 Production and identification of positive hybridoma cell lines 
 
The failed crystallization of the Rm1ClC full-length protein and the poorly diffracting 
crystals of the Rm1ClC transmembrane domain have motivated the production of specific 
binding proteins for future co-crystallization experiments. The production of monoclonal 
antibodies was chosen since this approach has so far been most successful in various 
membrane protein structure determinations. 
 All experiments were carried out in collaboration with CEPower (Wädenswil, 
Switzerland), a company specialized for the generation of monoclonal antibodies. Both, the 
full length and the transmembrane domain of Rm1ClC were used as antigens for the 
immunization of mice. Three mice were immunized with each antigen (total 6 mice). The 
immunization was repeated three times before the isolation of the mouse spleen. In order to 
choose the mouse that shows the best immune response for each antigen, the polyclonal 
sera from the 6 mice were tested for binding to the antigens by ELISA. Interestingly, it was 
observed that the immunization with the full length protein gave a stronger immune 
response than the immunization with the transmembrane domain. After selecting one 
mouse for each construct, the B-lymphocytes from the whole spleen were fused with 
myeloma cells to form immortalized hybridoma cells expressing IgGs. The fusion was 
carried out by standard methods and confirmed by selection on hypoxanthine aminopterin 
thymidine (HAT) medium. HAT medium is a selection medium where the drug 
aminopterin inhibits the dihydrofolate reductase, which results in a block of the de novo 
nucleotide synthesis. The synthesis of thymine and guanine can be bypassed by supplying 
both molecules in the medium. During this selection, only fused cells carrying the 
immortalization from myeloma cells and the hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT) from B-lymphocytes can survive.  
 About 960 stable hybridoma cell lines were isolated for each construct. In order to 
select the lines secreting monoclonal antibodies against Rm1ClC, the supernatants from all 
cultures were screened by ELISA for a reaction against the protein. In the first round of 
selection the ELISA was performed only with the respective construct used for the 
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immunization i.e. the hybridomas obtained by fusing the spleen of the mouse immunized 
with the full-length Rm1ClC were tested against the full-length protein. By this procedure 
52 clones were selected for antibodies selected against the full length protein, and 20 
clones for ones selected against the transmembrane domain. The criterion for selection was 
an ELISA signal higher than 2 times over the background.  
 The selected set of positive hybridoma cell lines was in the second round analyzed 
in more detail. In order to classify the selected monoclonal antibodies based on their 
binding epitope on Rm1ClC three different constructs were tested by ELISA: full length 
protein, transmembrane domain and cytoplasmic domain. The results of these experiments 
are presented in Figure 4.1.1. A strong variation in the ELISA signals coming from 
different antibodies can be noticed. Although in the first round of selection all selected 
clones gave signal higher than two times over the background, for many of them this result 
was not reproduced. The variation of signals recorded in different ELISAs for the same 
samples has been previously observed (Warmuth 2009). Nevertheless, the number of 
clones giving reproducibly strong signals was still satisfying.  
 
 
 
 
 
Figure 4.1.1. Antibody binding against Rm1ClC full-length, transmembrane and cytoplasmic domain. 
A set of monoclonal antibodies from 70 hybridoma cell lines was tested for their binding properties by 
ELISA. Each figure represents an ELISA plate coated with a different antigen. The order of hybridoma 
supernatant in all three plates is the same. The relative intensity of the chemiluminescence is labeled on the y 
axis.  
 
It is interesting to analyze the interaction of the monoclonal antibodies with the 
three different constructs of Rm1ClC. The antibodies binding to the full length protein can 
be divided into two groups depending on their ability to either bind to the transmembrane 
or the cytoplasmic domain. Out of 14 clones that gave a strong signal (> 3×background) 
with the full length protein, ten of them also bind to the transmembrane domain and only 
four of them bind to the cytoplasmic domain. This initial information on binding regions 
can be very useful for later co-crystallization trials. The binders to the transmembrane 
domain are promising candidates for improving the crystal quality since their binding 
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could enlarge the polar surface of the protein and thereby lead to stronger crystal contacts. 
The binders to the cytoplasmic domain, in contrast, could be valuable in obtaining crystals 
of the full length protein by stabilizing the potentially flexible cytoplasmic domains in a 
specific conformation.  
Selected clones that showed a high signal against Rm1ClC were in addition 
characterized by Western blotting (Figure 4.1.2). The characterization of binding against 
the denatured protein by Western blot analysis allows the discrimination between sequence 
epitopes, which show a signal in a Western blot analysis, and structural epitopes, which do 
not show a signal since the structural epitope is lost on a denaturing gel. It is assumed that 
antibodies suitable for co-crystallization attempts should form a stable and rigid complex 
with their native antigen. This implies that they recognize a discontinuous i.e. structural 
epitope. Sequence epitopes can be unstructured N- and C-terminal tails as well as 
unstructured loop regions.  
Purified Rm1ClC full length protein and the transmembrane domain were separated 
by SDS-PAGE and blotted on a PVDF membrane. After blocking, the membrane was 
incubated with the antibody containing supernatants of the selected hybridoma cells, 
followed by incubation with the secondary antibody and detection of chemiluminescence. 
Out of 30 tested clones, 13 showed a signal on the Western blot, which suggests that they 
recognize sequence specific epitopes. It was observed that the antibodies that gave the 
strongest signals in the ELISA were mostly Western positive.  
 
 
 
Figure 4.1.2. Epitope characterization of selected monoclonal antibodies. 
Full-length Rm1ClC (FL) and its transmembrane domain (TM) were separated by SDS-PAGE and blotted on 
the PVDF membrane. Each lane labeled with the blue triangle was incubated with the indicated antibody of 
the selected F1 hybridoma cell lines. The Western positive clones i.e. the once that recognize sequence 
epitopes are: 19, 24, 35, 40, 47 and 50.  
 
 
After the described analyses, a set of 30 hybridoma lines was selected for further 
work (Table 4.1). From these hybridoma cell lines recombinant Fab fragments will be 
generated by cloning of encoding genes. Cloning and expression in E. coli should allow 
TM 
FL 
12    15    19    24   26    30    33    35    36    40    41     44     45   46    47   50 
75 kDa 
50 kDa 
37 kDa 
25 kDa 
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efficient production and purification of recombinant fragments. Purified Fabs will be 
investigated for binding to Rm1ClC and, if promising will be used for co-crystallization 
experiments.  
 
 
   Clone ELISA Western Binding to 
1 F1-1 strong + FL, Dom 
2 F1-3 weaker   FL 
3 F1-12 weaker   FL, TM 
4 F1-15 strong   FL, TM 
5 F1-18 weaker   FL 
6 F1-19 strong + FL, TM 
7 F1-20 weaker   FL 
8 F1-22 weaker   FL 
9 F1-24 strong + FL, TM 
10 F1-25 strong + FL, Dom 
11 F1-26 weaker   FL, TM 
12 F1-28 weaker   FL 
13 F1-30 weaker   FL, TM 
14 F1-33 weaker   FL, TM 
15 F1-35 strong + FL, TM 
16 F1-36 strong   FL, TM 
17 F1-40 strong + FL, TM, Dom 
18 F1-41 strong   FL, Dom 
19 F1-43 weaker   FL, Dom 
20 F1-44 strong   FL, TM 
21 F1-45 weaker   FL, TM 
22 F1-47 strong + FL, TM 
23 F1-50 weaker + FL, TM 
24 F3-4 weaker   TM 
25 F3-8 strong + FL, TM 
26 F3-12 strong + TM 
27 F3-13 weaker + TM 
28 F3-14 strong + FL, TM 
29 F3-15 strong + TM 
30 F3-18 strong   TM 
 
Table 4.1. Hybridoma cell lines selected for cloning of Fab fragments. 
Cell lines designated F1 were generated by immunization with the full length Rm1ClC, and F3 with the 
Rm1ClC transmembrane domain. The reaction of the antibodies in ELISA is qualitatively described. The 
antibodies recognizing sequence epitopes are labeled as Western positive (+). The binding to the full-length 
(FL), transmembrane (TM) and cytoplasmic domain (Dom) is indicated.  
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4.1.3 Material and methods 
 
 Immunization of mice and fusion to myeloma cells. The proteins were prepared 
and supplied to CEPower, where the immunization was carried out. Three mice were 
immunized with 300 µl of 300 µg/ml target protein. This procedure was repeated three 
times and 2 weeks after the last immunization the spleen cells were harvested. The spleen 
B-cell were fused to myeloma cells (∆HGPRT) and cloned by limited dilution. The 
supernatants were tested for secreted antibodies by ELISA. 
 
 ELISA. 96 well MaxiSorp plates (Nunc) were coated with 100 µl of protein 
solution at the following concentration: full length Rm1ClC 30 µg/ml, transmembrane 
domain 20 µg/ml and cytoplasmic domain 7 µg/ml. The coating was carried out by 
vigorous shaking for 1 h at room temperature. Buffer B (10 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 5 mM DM) was used in all steps. The plate was blocked for 1 h with 250 µl/well of 
buffer B + 5 % BSA (w/V). After blocking, 100 µl of hybridoma supernatants (1:1 mixed 
with 2 x buffer B containing 4 % BSA) were incubated for 1h followed by 3 washing steps 
for 5 minutes with buffer B (200 µl/well). For testing the polyclonal sera, 100 µl serum in 
serial dilutions of 1:100 to 1:800.000 in buffer B including 2 % BSA were used. The 
samples were subsequently incubated with 100 µl of goat anti-mouse IgG-HRP antibody 
(Roche) diluted to 1:2000 in buffer B including 2 % BSA for 1h and followed by 3 
washing steps. The signal was developed with 100 µl of TMB substrate (Sigma) and the 
reaction was stopped by addition of 100 µl 1 M HCl. The TMB substrate consisted of 1 
mM TMB, 3 mM H2O2, 25 mM citric acid, 50 mM Na2HPO4, pH 5. The signal was 
measured in the Tecan GENios Microplate Reader by recording absorbance at 450 nm.  
 
 Western blot for antibody characterization. A standard protocol for Western 
blots was used except for the following differences. The SDS-PA gels were prepared with 
only one small well for loading the marker and one big well spread over the entire gel for 
loading the protein sample. After electroblotting and blocking to prevent non-specific 
binding, the membrane was fixed in the Mini-PROTEAN II multiscreen apparatus (Bio-
Rad), which allowed screening of 20 different antibodies per gel without having to cut the 
membrane into small strips. The goat anti-mouse IgG-HRP antibody (1:5000) was used as 
a secondary antibody according to the manufacturer’s instructions (Roche).    
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4.2 Cloning and expression of different constructs of the ClC-1 
cytoplasmic domain 
 
 
ClC-1 is a chloride channel in mammalian skeletal muscles responsible for the 
maintainance of the resting membrane potential (Aromataris and Rychkov 2006). A 
reduction of the sarcolemal chloride conduction due to mutations in the ClC-1 gene results 
in myotonia, a disease that is accompanied by muscle hyperexcitability. Several studies in 
the last few years showed that ClC-1 can be inhibited by intracellular ATP, which acts on 
the common gate and shifts the voltage dependent activation to more positive potentials 
(Bennetts, Rychkov et al. 2005; Tseng, Bennetts et al. 2007). A more detailed analysis 
revealed a dependence of the ATP inhibition on the cytoplasmic pH and the redox state of 
the channel (Zhang, Tseng et al. 2008). The results indicate that the inhibition results from 
a direct interaction of ATP and the cytoplasmic domain of ClC-1, similar to the previously 
discovered nucleotide binding on the cytoplasmic domain of ClC-5 (Meyer, Savaresi et al. 
2007). To reveal the structural basis for ATP regulation in ClC-1, I have investigated the 
expression of its cytoplasmic domain. In order to perform crystallization and co-
crystallization trials with nucleotides, the cytoplasmic domain of ClC-1 needed to be 
produced in a soluble state in sufficient amounts. However, already this first step proved to 
be challenging, since the domain was expressed at the low levels mostly in inclusion 
bodies.  
 The cytoplasmic domain of ClC-1 channel is 398 residues long. Its unusually large 
size of is due to a long linker region connecting the two CBS subdomains (around 150 aa) 
and a long C-peptide (around 110 aa). The linker and the C-peptide regions are predicted to 
be disordered (Figure 4.2.1), which is not a suitable property when aiming for 
crystallization. It appears likely that unstructured regions are responsible for the 
aggregation of the protein upon overexpression.  
 
           
 
Figure 4.2.1. Disorder prediction for the ClC-1 cytoplasmic domain. 
The residues having a high probability for being disordered belong to the linker region between the two CBS subdomains 
(81-215) and to the region of C-peptide (278-398) as predicted by the RONN server (Yang, Thomson et al. 2005). 
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 In order to improve expression and to increase the chance of obtaining crystals of 
the ClC-1 cytoplasmic domain, expression constructs with reduced length of the flexible 
regions were designed. The first modification included a removal of the residues 675 – 797 
in the linker region (Figure 4.2.2A). While the resulting construct named ClC-1-L1 domain 
showed a higher expression level a large fraction was insoluble similar as the full-length 
ClC-1 domain (Figure 4.2.2B). Starting from the construct with a considerably shortened 
liker region, two additional constructs with a shorter C-peptide were generated. In the 
construct ClC-1-L2 a stop codon was introduced after the residue 906 and in the construct 
ClC-1-L3 after the residue 879. In these constructs, the length of the C-peptide was similar 
as in ClC-0 and ClC-Ka, respectively. Both ClC-1-L2 and –L3 showed high expression 
level of soluble protein.  
 
A 
 
 
B 
 
 
 
 
 
     
Figure 4.2.2. Design of ClC-1 cytoplasmic domain constructs and the expression analysis.  
(A) Sequence alignment of the cytoplasmic domains of ClC-1, ClC-0 and ClC-Ka. The secondary structure 
elements are based on the structure of the ClC-Ka domain. CBS1 subdomain is colored in blue, CBS2 in red. 
Residues building the α-helix in the linker regions of ClC-0 and ClC-Ka are marked in grey. The construct 
ClC-1-L1 was generated by introducing two KpnI restriction sites at the presented positions, cutting out the 
gene fragment and subsequent religation. The constructs ClC-1-L2 and -L3 were generated by introducing 
stop codons at the positions labeled with red arrows in the construct ClC-1-L1.  
(B) Expression/solubility test for different CLC-1 domain constructs. The insoluble fraction is labeled with P, 
soluble with S. All three shorter construct show better expression level and solubility compared to the full 
length ClC-1 cytoplasmic domain.  
 
 Purification of all three constructs yielded a high amount of monodisperse protein 
as illustrated in Figure 4.2.3. For crystallization trials only the construct ClC-1-L3 was 
   ClC-1 FL dom       ClC-1-L1 dom 
     P               S              P              S 
 
ClC-1-L2 dom              ClC-1-L3 dom  
         
      P           S                       P          S 
KpnI 
KpnI 
1 
2 3 
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used, since it appeared to be the most promising one because of its compact shape. 
Extensive crystallization screening was performed at two different temperatures (4 and 
20°C), different protein concentrations and in the presence of ATP, ADP and AMP.  
      
            A 
                   
 
B 
 
 
 
Figure 4.2.3. Purification of the ClC-1-L3 domain construct.  
(A) Size exclusion chromatography on S200 column. The protein is monodisperse and elutes at 15.3 ml. The 
blue arrow designates the void volume. (B) SDS-PAGE analysis of the purification steps. S - cell lysate; FT – 
flow trough after metal affinity column; W1 and W2 – wash of metal affinity resin with 0 and 20 mM 
imidazole; E – fraction eluted from IMAC; 3C – protein cleaved with the 3C protease to remove the His-tag; 
2, 8, 9, 10 and 11 – fractions from the SEC as labeled in A.  
 
 
Unfortunately, none of the conditions contained crystals. It is difficult to assign the cause 
for this behavior but it could be that the designed constructs do not contain the optimal 
boundaries and that other constructs with variations in the linker and C-peptide region 
could still crystallize. Yet, even in other constructs the inherent conformational flexibility 
of the protein might still exist and prevent crystal formation.  
 Besides crystallization screening, the expressed ClC-1 domain constructs also 
allowed biochemical analyses. In order to test the oligomeric organization of the ClC-1 
domain, AUC velocity experiments were performed. The sedimentation analysis at 
different protein concentration revealed a monomeric protein (data not shown), an 
unexpected feature when considering the assembly of the other eukaryotic ClC CBS 
domains. However, since it was not the native cytoplasmic domain of ClC-1, which has 
lead to this  observation it will not be further discussed. In order to test whether ClC-1 
cytoplasmic domain binds nucleotides, an isothermal titration calorimetry (ITC) 
experiment was performed. ITC measures the heat that is released upon ligand binding to a 
macromolecule and in that way allows to quantify the enthalpy and binding affinity. The 
titration of ATP to the ClC-1 domain is presented in Figure 4.2.4A. The obtained results 
suggest very weak binding of ATP to the ClC-1-L2 domain construct with the Kd value of 
  S   FT   W1W2   E   3C  M    2    8    9   10   11 
1    2    3    4    5    6    7    8   9  10  11  12  13  14   
15.3 ml 
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about 400 µM. The affinity is, thus, around 15 times lower than the affinity of the ClC-5 
domain for ATP determined by the same method (Figure 4.2.4B). This result also has to be 
taken with caution as it was not obtained on the native cytoplasmic domain of ClC-1.  
 
A       ClC-1 
 
B        ClC-5 
 
 
Figure 4.2.4. Results of the ITC experiments for the ClC-1 (A) and ClC-5 (B) cytoplasmic domains.  
Top: Raw data of the titration of ATP to the protein. Each peak shows the heat released by serial injections of 
ATP. Bottom: The total heat accumulated up to injection i is normalized to the total ATP concentration at 
step i and plotted against the ratio of total ATP concentration at step i to total protein concentration. From the 
sigmoid curve, ∆H per mol complex can be calculated. The solid line is the calculated curve using the best-fit 
parameters. Model: one binding site per protein molecule. The best values for stoichiometry (N), binding 
constant (K), enthalpy (H) and entropy (S) are also shown. The obtained Kd values are: 375 µM for the ClC-
1-L2 domain and 25 µM for the ClC-5 domain. 
 
 
4.2.2 Patch clamp experiments on the ClC-1 channel expressed in Xenopus oocytes 
 
In parallel with the biochemical experiments on the ClC-1 cytoplasmic domain, ClC-1 was 
expressed in Xenopus leavis oocytes and analyzed by electrophysiology. In order to study 
the functional effect of ATP binding to the cytoplasmic domain of ClC-1 excised inside-
out patch clamp experiments were performed. The experiments were carried out similar as 
described by Tseng, Bennetts et al. 2007 and the obtained results are summarized in Figure 
4.2.5. The current mediated by ClC-1 upon applying the voltage protocol A was recorded 
and analyzed. At pH 7.4 the channel is almost completely open at all positive voltages 
(V1/2 = -39 mV). When lowering the pH from 7.4 to 6.2 the open probability shifts to 
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negative potentials. Upon addition of ATP to the intracellular solution at pH 6.2 in most of 
the cases no change in the open probability curve was observed. However, when excising 
the patch in solutions containing 1 mM ATP at pH 6.2 a pronounced effect of ATP was 
observed as shown in Figure 4.2.5. The inhibitory effect of ATP manifests itself in the shift 
of the open probability to more positive potentials. However, this effect was usually not 
reversible and vanished after some minutes. The explanation for this behavior was recently 
reported (Zhang, Tseng et al. 2008) and it is related with the oxidation of ClC-1 that seems 
to play an important role in the channel function. The inhibitory effect of ATP at low pH 
has not been observed under oxidizing conditions. The oxidation of the channel happens 
with time, since the reducing compounds from the cytoplasm are diffusing away.  
 In summary, although the calorimetric and electrophysiological analysis of ClC-1 
revealed interesting features of this channel which hint at a possible interaction with ATP, 
definitive conclusions were not reached. Future investigations that take newly discovered 
features into account including the pH and oxidation dependence of ligand regulation 
might ultimately be more successful in reaching conclusive information on this important 
regulatory mechanism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.5. Effect of pH and cytoplasmic ATP on ClC-1. 
(A) Voltage protocol A: The membrane potential was stepped from the 0 mV holding potential to 
various voltages ranging from +100 to -120 mV in (-20 mV steps) for 300 ms, followed by a step to 
-100 mV for 300 ms. 
(B) Left: Current traces obtained by application of protocol A at the indicated conditions. Right: Fit of 
tail currents to a double exponential function with the program Clampfit allows to determine the 
initial tail current at each voltage.  
(C) The normalized initial tail current is the product of the open probability of the fast and the common 
gate.  
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B 
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pH 6.2 + 1 mM ATP  
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4.2.3 Material and methods 
       
Cloning and expression of ClC-1 domain constructs. Fragments of ClC-1 
corresponding to desired constructs were amplified by PCR and cloned into the modified 
pET28b+ vector (Novagen) to generate fusions with the C-terminal 3C protease cutting site 
and a His6-tag. The linker region was removed by introducing two KpnI sites at specified 
positions with the QuikChange method (Stratagene), followed by digestion, elution and 
relegation of the ClC-1 vector. For expression the E. coli BL21 (DE3) strain was used. The 
cells were grown in LB medium containing 50 µg/ml kanamycin at 37°C to an OD600 of 
1.2 and induced by addition of 0.5 mM isopropyl-D-thiogalactopyranoside (IPTG) at 20°C 
over night. The protein was purified by standard procedures.  
 
ITC. ITC experiments were performed at 6°C with the following concentrations: 
for ClC-1 200 µM protein and 3.5 mM ATP and for ClC-5 500 µM protein and 5 mM 
ATP. Before the measurement both the protein and ATP were dialyzed against 10 mM 
Tris-HCl, 150 mM NaCl to ensure the same buffer composition for both components.  
 
Patch clamp recordings. The human ClC-1 channel in the pTLN vector was used 
for mRNA synthesis using SP6 mMessage mMachine kit (Ambion). For expression, 20 ng 
of ClC-1 mRNA was injected into defolliculated Xenopus leavis oocytes. From 3-5 days 
after injection, excised inside-out patch recordings were performed, using the Axopatch 
200B amplifier and a Digidata 1440A board controlled by pClamp8 software (Axon 
Instrumets, Inc./Molecular Devices). The glass electrodes had a tip size of 1-2 µm and a 
resistance of 4-5 MΩ and were filled with a pipette (extracellular) solution containing: 120 
mM NMG-Cl, 1 MgCl2, 10 mM HEPES, 1 mM EGTA, pH 7.4. The bath (intracellular) 
solution had the same ionic components with the pH adjusted to 7.4 or 6.2. Working 
solutions of ATP were freshly made by mixing the bath solution and 100 mM ATP stock 
solution and subsequent adjustment of the pH.  
Macroscopic chloride currents were recorded upon applying the voltage protocol A 
presented in Figure 4.2.5A. The initial value of the tail current was determined by fitting a 
double exponential function to the tail current using the program Clampfit. The initial 
current of each trace was normalized to the maximal value of the initial tail current 
obtained following the most positive test voltage in the absence of ATP. The normalized 
initial tail current obtained with this protocol represents the product of the open probability 
of the fast gate and of the common gate at the preceding test voltage.   
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4.3 Expression of eukaryotic ClC homologs in Pichia pastoris 
 
For a comprehensive understanding of the mechanisms of ion conduction and gating in 
eukaryotic ClC proteins, detailed structural and functional investigations have to be carried 
out on full length eukaryotic family members. The current bottleneck for the investigation 
of those integral membrane proteins is the difficulty to express them in sufficient 
quantities. Therefore, one of the main challenges during my PhD thesis was the 
establishment of an expression system for eukaryotic ClCs. Since different mammalian 
membrane proteins, including G-protein coupled receptors and ion channels, have been 
successfully expressed in the methylotrophic yeast Pichia pastoris (Macauley-Patrick, 
Fazenda et al. 2005), this system was chosen for expression of eukaryotic ClC channels 
and transporters.  
Several yeast ClC homologs (summarized in Table 4.2), the channel ClC-0 from 
Torpedo marmorata and the human proteins ClC-1, ClC-2, ClC-Ka and ClC-5 were 
selected for cloning and expression in P. pastoris. The applied cloning and expression 
protocols were mostly based on the Invitrogen manuals. All genes were cloned in the 
vector pPICZB resulting in C-terminal fusion with c-myc and His6-tags. After preparation 
of recombinant plasmids in E. coli, the transformation into P. pastoris and expression tests 
were performed. Unfortunately, none of the selected ClC homologs showed expression, 
even though the integration into the Pichia genome was confirmed.  
 
 
Strain with the strain code 
 
 
Gene 
Identity 
to ClC-5 
[%] 
Length 
[aa] 
Mw 
[kD] 
Pichia pastoris GS115 PAS_chr2-1_0471 
Part of this gene 
33 650 71.9 
Pichia pastoris GS115 
 
- 30 936 104.5 
Saccharomyces cerevisiae C1Q_03652 
 
30 779 87.6 
Schizosaccharomyces pombe 972h- SPBC887.02 
 
27 667 73.3 
Schizosaccharomyces pombe 972h- SPBC19C7.11 
 
29 812 90.5 
Yarrowia lypolitica CLIB122 YALI0E09015g 
 
38 772 85.3 
 
Table 4.2. Yeast ClC Homologs. 
List of 6 ClC homologs from yeasts selected for cloning. Identity to ClC-5 was determined by pairwise 
sequence alignments implemented in ClustalW. 
 
 Following unsuccessful expression of different ClC homologs, I pursued with 
another approach. ClC-0 was selected as a target gene and cloned with three different N-
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terminal tags: an His8-tag (MAHHHHHHHH), a Flag-tag (MADYKDDDDK) and a 
StrepII-tag (MAWSHPQFEK). In all three constructs the tag was followed by a cleavage 
site for the 3C protease. The DNA sequence corresponding to the N-terminal tag and 
protease recognition site was optimized for Pichia codon usage. The N-terminally 
modified ClC-0 constructs were cloned into pPICZB vector and standard expression 
procedures were applied. Expression was detected only in the construct containing a N-
terminal His8-tag (N-His8-ClC-0).  
 The expression conditions were optimized by varying media, temperature and time 
of induction. Short expression for 6-8 h after induction at 30°C proved to give the highest 
yields. After that time, the protein was not detectable by Western blot, probably due to 
degradation.  
 The extraction of N-His8-ClC-0 from the membrane was tested on a small scale 
with a set of several detergents including dodecyl-β-D-maltoside (DDM), tetradecyl-β-D-
maltoside (TDM) and Fos-choline-12 (Fos12). The protein was almost completely 
extractable with Fos12 and partially with DDM and TDM (Figure 4.3.1).  
 
                          
 
 
 
 
Figure 4.3.1. Detergent extraction test for N-
His8-ClC-0.  
The membranes were solubilized with 2 % DDM, 2 
% TDM and 1 % Fos12 respectively. The samples 
were centrifuged at high speed (100,000xg) to 
remove insoluble parts. The solubilized (labeled S) 
and not solubilized fractions (labeled P) were 
analyzed by Western blot to determine the amount 
of extracted protein. ClC-0 is extractable with 
Fos12, and partially with DDM and TDM.  
 
 
In order to assess the protein stability in different detergents, the size distribution 
was analyzed by size-exclusion chromatography. In a simple assay, the crude membrane 
extract from a small scale solubilization after centrifugation was applied on a Superdex200 
column. The retention volume of the protein was determined by Western blot analysis of 
the elution fractions starting from the void volume of 7 ml to 13 ml (Figure 4.3.2). The 
results indicated promising behavior of N-His8-ClC-0, since the protein was eluting both in 
DDM and Fos-12 at 10 - 10.5 ml, corresponding to an appropriate molecular weight of the 
dimeric ClC-0. Since DDM is a milder detergent than Fos-12, it was selected for extraction 
and purification in the subsequent experiments.  
 
 
P       S        P        S       P       S               M 
DDM TDM  Fos12 
200 kDa 
150 kDa 
100 kDa 
75 kDa 
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A 
 
B 
 
 
 
 
 
Figure 4.3.2. Size exclusion chromatography of 
N-His8-ClC-0. The membranes of P. pastoris cells 
expressing ClC-0 were solubilized by Fos12 (A) 
and DDM (B). The solubilized fraction was 
injected on Superdex200 column. The eluted 
fractions were analyzed by Western blot with an 
antibody recognizing a His
-
tag. The void volume 
of the column is 7 ml. In both Fos12 and DDM, the 
elution volume of ClC-0 is around 10 ml, which 
would correspond to the approximate molecular 
weight of a dimer surrounded by a detergent 
micelle. The elution volumes matching the 
analyzed elution fractions are indicated.  
 
 The large-scale purification of N-His8-ClC-0 was performed applying usual 
protocols for membrane protein purification. The protein was extracted from the membrane 
with DDM. Additional purification steps included metal affinity and size exclusion 
chromatography. The N-His8-ClC-0 construct showed binding to the metal affinity resin 
and was eluted with increasing imidazole concentration. However, the eluted fraction was 
not of satisfying purity and the protein was detected only by Western blot (Figure 4.3.3). 
Eluted fractions containing ClC-0 were concentrated and injected on a Superdex200 
column. The Western blot analysis of the size exclusion fractions revealed that most of the 
protein was eluting at the void volume due to the formation of high-molecular aggregates 
during the purification.  
 
               A 
                     
B 
 
 
 
Figure 4.3.3. Purification of N-His8-ClC-0 in DDM. 
(A) Size exclusion chromatography on S200 column. The amount of aggregated proteins is high. (B) Western 
blot analysis of the purification steps: S - cell lysate; FT – flow trough after metal affinity column; W1 and 
W2 – wash of metal affinity resin with 0 and 20 mM imidazole; E – fraction eluted from IMAC; 1,2, 3, 4, 5, 
6, 7 and 8 – fractions from the SEC as labeled in A. The reason for the different migration of the two bands 
in fraction 6 is unknown, but they might present glycosylated (red triangle) and not-glycosylated ClC-0 
(green triangle).  
6.5  7.0  7.5  8.0  8.5  9.0  9.5  10.0  10.5  11.0  11.5  12.0  12.5  13.0  
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 In summary, expression screening of several eukaryotic ClC proteins have led to 
the identification of a potential candidate for continuing investigations. The identified ClC-
0 construct showed promising extraction and purification behavior when tested on small 
scale, but large scale expression and purification revealed the tendency for aggregation 
making it unsuitable for crystallographic studies in its current state.  
 
 
4.3.1 Material and methods 
 
Bacterial and yeast strains and media. For cloning and production of 
recombinant plasmids the Escherichia coli strain XL1blue was used. E. coli transformants 
were selected on low salt LB plates with 25 µg/ml zeocin. The protease deficient P. 
pastoris strain SMD1163 (his4, pep4, prb) (Invitrogen) was used for expression. This 
strain was generally grown on YPD medium. For expression studies a combination of YPD 
and YPM medium or a combination of the buffered glycerol-complex medium (BMGY) 
and buffered methanol-complex medium (BMMY) was used. P. pastoris transformants 
were selected on YPDS plates with 100 µg/ml zeocin. The composition of all these media 
was as indicated in the Invitrogen instruction manuals (Pichia Expression Kit and pPICZ 
A, B and C).  
Construction of the expression plasmids and transformation. The target genes 
were amplified from genomic or plasmid DNA and cloned into the plasmid pPICZB. After 
transformation of ligation mixtures into E. coli, plasmids were isolated and the inserted 
genes sequenced. Approximately 10 µg of recombinant plasmids were linearized with 
PmeI and used to transform competent cells of P. pastoris by electroporation. The 
transformation was done according to the protocol in Invitrogen manual Pichia Expression 
Kit (page 59). Transformants were selected on YPDS plates with 100 µg/ml zeocin after 2 
days incubation at 30°C.  
Expression tests. 10 randomly picked transformants were grown in 4 ml of YPD or 
BMGY medium supplemented with 25 µg/ml zeocin overnight at 30°C under vigorous 
shaking. The cultures were pelleted and washed in 4 ml of 0.1 M K-phosphate buffer pH 6. 
The cell pellets were resuspended in 4 ml of induction medium containing 0.5 % methanol 
(YPM or BMMY). The expression was carried out either at 30°C or 23°C. For the time 
course analysis of expression induction time was varied from 4 to 24 h. After expression, 
the amount of cells that correspond to OD600=4 was pelleted and resuspended in 400 µl ice-
cold breaking buffer (50 mM Na-phosphate pH 7.4, 1 mM PMSF, 5 % glycerol and 1 mM 
EDTA). The cells were broken by addition of glass beads (300 mg, 0.6 mm diameter) in a 
Fast prep device (Bio101) for two times 30 s at force 6.5 with 5 min cooling on ice 
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between the runs. The lysates were separated by SDS-PAGE and analyzed for expression 
by Western blot.  
Large scale expression of ClC-0. For large scale expression of ClC-0 4 l culture 
was used. The cells were grown in YPD medium over night at 30°C, washed in 0.1 M K-
phosphate buffer pH 6 to remove glucose and resuspended in BMMY medium to final 
OD600=1. The expression was carried out at 30°C for 6-8 h. Following expression, the cells 
were harvested by centrifugation and resuspended in 60 ml of breaking buffer. The 
suspension was distributed into 4x50 ml Falcon tubes and a total amount of 60 ml of glass 
beads was added. The cells were broken in a Fast prep device for two times 30 s at force 
6.5. The lysate was cleared by low-spin centrifugation (30 min, 10,000 x g, +4ºC). The 
membranes were pelleted from the supernatant by high-spin centrifugation (1.5 h, 100,000 
x g, +4ºC). The protein was extracted from the membrane by 2 % DDM and purification 
performed applying standard procedures. 
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List of abbreviations 
 
 
ADP   Adenosine Di-Phosphate 
AMP   Adenosine Mono-Phosphate 
ATP   Adenosine Tri-Phosphate 
AU   Asymmetric Unit 
AUC   Analytical Ultracentrifugation  
CBS   Cystathionine β-Synthase 
Da   Dalton 
DDM   Dodecyl Maltoside 
DM   Decyl Maltoside 
DNA   Deoxyribonucleic Acid 
DSMZ   Deutsche Sammlung von Mikroorganismen und Zellkulturen 
FRET   Förster Resonance Energy Transfer 
FX   Fragment Exchange 
GFP   Green Fluorescent Protein 
HGPRT  Hypoxanthine-Guanine Phosphoribosyltransferase 
His   Histidine 
HRP   Horseradish Peroxidase 
IgG   Immunoglobulin G  
IMAC   Immobilized Metal Affinity Chromatography  
ITC   Isothermal Titration Calorimetry 
LB   Lysogeny Broth 
MWCO  Molecular Weight Cut Off 
Ni-NTA  Nickel Nitrilotriacetic Acid 
NM   Nonyl Maltoside 
NMR   Nuclear Magnetic Resonance 
OD   Optical Density 
OM   Octyl Maltoside 
PAGE    Polyacrylamid Gel Electrophoresis  
PBS   Phosphate Buffered Saline 
PCR   Polymerase Chain Reaction 
PEG   Polyethylene Glycol 
pS   Picosiemens  
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PVDF   Poly Vinyl Difluoride  
SDS   Sodium Dodecyl Sulphate  
SEC   Size Exclusion Chromatography 
TB    Terrific Broth 
TBS   Tris Buffered Saline 
WT   Wild Type 
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